Sysmex Sustainability Report 2018

Lighting the way with diagnostics

Contents······················································

2

Message from the Chairman and CEO ······························································

3·····························································

5

Management and CSR ·····················································································
Long-Term Management Targets , Mid-Term Management Plan ············································CSR Management ·································································································The UN Global Compact ··························································································

8

Corporate Philosophy and Core Behaviors

Sysmex and Its Relations with Society

8
12
30

Highlight 1：Resolution of Medical Issues through Products and Services

Offering Superior Technologies toHelp Eliminate Malaria ········································································· 31
Highlight 2：Environmental Consideration

Initiatives to Protect
the Environment in the Long Term ··················································· 33
Society ············································································································ 35
Resolution of Medical Issues through Products and Services ··············································· 35
Responsible Provision of Products and Services ······························································ 49
Realization of an Attractive Workplace ········································································ 66
Respect for Human Rights ······················································································· 88
Corporate Citizenship Activities ················································································ 90
Environment ··································································································· 98
Environmental Consideration ···················································································· 98
Governance···································································································· 124

Corporate Governance ···························································································· 124
Compliance ········································································································· 125
Risk Management ·································································································· 135

External Evaluation························································································· 139

Fiscal 2017 Performance Data ·········································································· 143
Social Data ·········································································································· 143
Environmental Data ······························································································· 148
Governance Data ·································································································· 159
Corporate Information/Disclosure System/Editorial Policy-1-······························ 161

Sysmex Group Corporate Philosophy

Sysmex Way
MissionShaping the advancement of healthcare.

Value
We continue to create unique and innovative values,
while building trust and confidence.

Mind
With passion and flexibility,
we demonstrate our individual competence
and unsurpassed teamwork.

Our Core Behaviors
To our Customers
We deliver reassurance to our customers, through unmatched quality, advanced technologies,superior
support, and actions that consistently reflect the viewpoint of our customers. We constantly look out for ourcustomers’ true needs, and seek to generate new solutions to satisfy those needs.

To our Employees
We honor diversity, respect the individuality of each employee, and provide them with a workplace where
they can realize their full potential. We value the spirit of independence and challenge, provide employeeswith opportunities for self-fulfillment and growth, and reward them for their accomplishments.

To our Business Partners
We deliver commitment to our client companies through broad-ranging partnerships.
We strive to be a company that can grow in step with our trade partners, through respect and mutual trust.

To our Shareholders
Our shareholders can rest assured that we will continue to improve the soundness and transparency of ourmanagement policies, while promoting information disclosure and close communications. We commit
ourselves to a consistent yet innovative style of management, in order to achieve sustainable growth andincreased shareholder value.

To Society
We carry out our business in strict compliance with laws and regulations, as well as in adherence to highethical standards.
As a responsible member of society, we play an active role in resolving environmental issues and otherproblems that impact our society today.

-2-Message fromthe Chairman and CEO

Identifying Priority Issues (Materiality)with a View to Resolving the World’s
Medical Issues

high-value testing and diagnostic technologies.
In May 2017, we identified our priority issues (materiality). In
addition to the “resolution of medical issues throughproducts and services” which is the contribution we makethrough our business, the priority issues include the“responsible provision of products and services,” “realizationof an attractive workplace,” “environmental consideration”
and “governance.” Through priority initiatives in these fiveareas, we aim to help resolve social issues and contributetoward the realization of a sustainable society.

In line with our mission of “shaping the advancement ofhealthcare,” which is defined in the “Sysmex Way,” thecorporate philosophy of the Sysmex Group, Sysmex works tocontribute to the development of healthcare and the healthy
lives of people.
February 2018 marked the 50th anniversary of ourestablishment. Since the time of its founding, Sysmex has
been involved with medical testing, playing an important rolein disease prevention, early detection, and determining
courses of treatment. We have created new diagnostic value
to enhance the quality of life (QOL) of patients and otherpeople, and we have striven to establish testing technologies
that help lighten their burden. In the field of in vitro
diagnostics, we currently provide products, services, andsupport in more than 190 countries and regions throughout
the world.

Formulating Long-Term Management
Goals for the Sysmex Group in Response to Increasingly Diverse Healthcare Needs
We expect the global healthcare market to continue growing
as advanced countries endeavor to raise healthcare
efficiency to hold down medical costs. Meanwhile, against a
backdrop of economic development, demand is growing inemerging markets and developing countries to put
healthcare infrastructures in place and increase the quality ofhealthcare. At the same time, artificial intelligence (AI), bigdata analytics, and other leading-edge technologies arebeing applied in the healthcare domain. We also see otheropportunities for further growth, in such areas aspersonalized medicine—including genomic medicine thatincorporates advances in molecular diagnostic
technologies 1 —and regenerative medicine.

The global medical environment is undergoing significant
changes. Advanced countries are characterized by aging
populations and increasingly diverse healthcare needs, andemerging markets are marked by medical infrastructuredevelopments and a rising quality of healthcare. Meanwhile,
addressing three major infectious diseases (HIV/AIDS,
tuberculosis and malaria) is a serious issue in developing
countries. In September 2015, the United Nations adopted
the Sustainable Development Goals (SDGs), which set 17
globally consistent targets. As a healthcare company, Sysmex
aims to contribute toward achieving these goals by providing

Sysmex views these changes in the healthcare environment
and increasingly diverse healthcare needs as business-3-

By creating innovative testing anddiagnostic technologies, we aim to resolve
the world’ s medical issues,
realize a sustainable society,and enhance corporate value.

of healthcare. Furthermore, we have joined the Malaria
Consortium in a bid to eliminate malaria—one of the world’s
three major infectious diseases—and are developing
hematology instruments that will contribute to malaria
testing. Through such endeavors, we are helping to put inplace healthcare infrastructures and raise the level ofhealthcare in emerging markets and developing countries.

opportunities. As such, we have formulated new long-term
management goals for the period ending in fiscal 2025, withthe aim of achieving sustainable growth of the Sysmex
Group and reinforcing the management foundation to
support this growth. We have also established our long-term
vision as a “Unique & Advanced Healthcare Testing
Company”, and our positioning based on this vision. We aim
to achieve further growth by strengthening and expanding
our conventional core business portfolio in the IVD field. In
the primary care domain, involving diagnosis at locations
near patients, we will create new services that takeadvantage of diagnostic techniques accumulated throughIVD and IT. In addition, we will create new diagnostic
technologies that contribute to personalized medicine
through the fusion of our proprietary technologies and newtechnologies achieved through open innovation. We also aim
to transform our business structure by monetizing
businesses centered on the life science field. Furthermore,
we will recruit and foster the human resources essential tosupporting the future expansion of our business activities
and achieving the Group’s strategic goals. At the same time,
we will enhance environmental considerations and initiatives
to reinforce our management foundation, including the areasof corporate governance and risk management.

1 Technologies for identifying diseases by studying the proteins, DNA, RNA,and other molecules contained in tissues and body fluids.
2 A diagnostic reagent kit that is designated to analyze the mutation,
proliferation and fusion of multiple genes having diagnostic significance forcancer.

Celebrating our 50th anniversary in 2018, Sysmex has
formulated a new corporate message, “Lighting the way withdiagnostics,” to promote the Company’s advance to the nextstage. This new message embodies the idea of enhancing
diagnostic value with innovative testing to bring greater
trust and confidence to healthcare.
Through innovative testing and diagnostic technologies, wewill continue taking on challenges as the future of healthcare
unfolds, working to enhance corporate value and realize asustainable society over the medium to long term. I would
like to ask for your continued support and understanding of
our endeavors.
July 2018

In the area of personalized medicine, in fiscal 2017 wewelcomed into the Sysmex Group a pioneer in genetic
analysis technology, Oxford Gene Technology IP Limited of
the United Kingdom, thereby fortifying our technology base.
Meanwhile, Multiplex Gene Panel Testing to Advancing
Personalized Medicine using the cancer-related gene panel 2
testing system, which we jointly developed with the National
Cancer Center, received advanced medical care approval. In
these ways, we aim to use gene testing to augment the level

Hisashi Ietsugu
Chairman and CEO-4-

Sustainability

Sysmex and Its Relations with Society
Sysmexʼs Businesses■ Corporate Philosophy, Core Behaviors
Please click here for information on the Sysmex Way, the corporate philosophy of the Sysmex
Group, and our core behaviors.

■ Sysmexʼs Businesses-5-Click here for “Sysmex Near You,” an introduction of some of the Sysmex products that are in use
around you.

-6-

Sysmex Initiatives on Priority Issues

Click here for information on materiality.

-7-

Management and CSRManagement Plans

The corporate philosophy for the Sysmex Group, the “Sysmex Way,” deﬁnes its mission
as “Shaping the advancement of healthcare.” On this basis, we have established a LongTerm Management Goals and a Mid-Term Management Plan aimed at contributing to theadvancement of healthcare and a healthy life for people around the world.

Sysmex Group Long-Term Management Goals (2025)

Positioning
Creating innovative diagnostic value as a global top-ﬁve company in IVD- Aim to become a global top-ﬁve company through sustained growth in our core businesses- In addition to increasing our share of the IVD market, which continues to grow globally, create
new diagnostic value
A leading company in personalized diagnostics for optimizing medical treatment- Create new testing and diagnostic value that contributes to the selection of treatment methods- Fuse our measurement platforms with new technologies and knowledge acquired through open
innovation and others-8-

A solution provider contributing to the advancement of primary care diagnostics- Leverage the diagnostic technologies and IT we have cultivated in the IVD domain- Provide solutions that contribute to increased access to healthcare
An attractive company providing value and instilling conﬁdence- Earn support from diverse stakeholders through distinctive technologies and business model,
dynamic human resources and sound and advanced corporate management
One Sysmex carrying out high-speed management- Provide attractive workplaces where diverse human resources can exercise their talents- Make use of sophisticated teamwork to achieve eﬃcient and high-speed management

Mid-Term Management Plan (Fiscal Years Ending March 31, 2018 to
2020)

-9-

(1) Enhance proﬁtability through market expansion in the hematology ﬁeld
・Achieve an undisputed No. 1 position in the United States(strengthen sales promotion on the West Coast, introduction at prominentcommercial labs)
・Strengthen sales to second-tier and lower hospitals in China
・Realize high rates of growth in emerging markets(2) Expand the urinalysis testing business by increasing new product sales
・Realize an eﬃcient work ﬂow for urinalysis testing through a new concept(Urine chemistry + sediment + imaging instrument + data management)(3) Bolster proﬁtability by increasing our global share in the hemostasis
ﬁeld
・Accelerate global development by leveraging our alliance with Siemens
・Accelerate introduction of ﬁbrin reagents* (China, Japan, etc.)* Used to test for clotting abnormalities and thrombosis(4) Expand business and improve proﬁtability in the immunochemistry ﬁeld
in Japan, China and other parts of Asia
・Expand business in the hepatic disease domain
・Launch unique parameters in China and other parts of Asia
TM

(hepatic ﬁbrosis test reagents, such as the M2BPGi

assay kit)・Improve proﬁtability by reducing cost of sales and expand sales(5) Establish a foundation for the FCM business
・Launch clinical FCM products
・Step up sales promotion for research and industry use(6) Increase the life science business・Promote the lab assay businesses of RIKEN GENESIS and Inostics
・Enter the clinical PCR market, expand business related to gene testing・Expand the market for rapid detection of lymph node metastasis based on the
TM

OSNA

method(7) Commercialize business in other new ﬁelds

TM・Generate business in ultrahigh-sensitivity HISCL, cervical cancer screening

systems, glucose AUC (postprandial hyperglycemia monitoring system) andother new areas- 10 -

(8) Enhance manufacturing speed and quality
・Strengthen development and production capacity by establishing a biodiagnostic reagent base・Maintain customer trust through high levels of quality and an enhanced
system for stable supply(9) Reinforce IT platforms to optimize operating processes
・Optimize supply chain processes
・Optimize engineering chain processes(10) Strengthen human resource cultivation and human resource
management to support Group growth・Step up recruiting and cultivation of human resources who are next-generation
leaders and who have advanced specialties
・Foster a working environment that embraces diverse human resources(Promote further diversity)<Contribute to a sustainable society>(11) In addition to eﬀorts to resolve healthcare issues through our products andservices, we will work to be environmentally considerate, reinforce corporate
governance and promote diversity, thereby providing unique and new value todiverse stakeholders and contributing to the development of society.

Financial targets (Fiscal year ending March 31, 2020)
Net Sales

Operating income¥350.0 billion (CAGR* = 11.9%)¥72.0 billion (CAGR* = 11.7%)(Operating margin of 20.6%)

ROE

20% or more

Operating cash ﬂow¥55.0 billion

Free cash ﬂow¥30.0 billion

Exchange rate assumptions: 1USD=¥110, 1EUR=¥115, 1CNY=¥16*CAGR (compound annual growth rate): For ﬁscal years ending March 31, 2018 to 2020- 11 -

CSR Management

Basic Policy and Structure
Message from the Executive in Charge
By practicing the “Sysmex Way,” we are working toward the realization of a sustainable
society.
Sysmex believes its CSR is to build trust and conﬁdence among
stakeholders by putting into practice the “Sysmex Way,” the corporate
philosophy for the Sysmex Group.
To practice CSR, Sysmex has identiﬁed priority issues (materiality). We are
addressing these issues in accordance with our action plans: a Mid-Term
CSR Plan through ﬁscal 2019 and an annual plan. Important CSR themes,such as identifying materiality and formulating mid-term CSR plans, arediscussed and reported at management meetings. In addition, we haveestablished the CSR Promotion Department, which is dedicated to theformulation of CSR activity plans and the dissemination of CSR information.
Sysmex will continue working toward the creation of a fulﬁlling and healthysociety through its business activities, provide a working environment thatallows diverse human resources to maximize their skills, and work
proactively to address global environmental problems, which are growing
increasingly severe. In these ways, we are contributing toward therealization of a sustainable society.

- 12 -

Yukio Nakajima
Member of the Managing Board
and Senior Executive Oﬃcer
Senior Managing Director
CFO

Basic Policy
Our CSR is to put the “Sysmex Way” into practice, thereby building trust and conﬁdence
among stakeholders.
The “Sysmex Way,” the corporate philosophy for the Sysmex Group, indicates the way the most basic
corporate activities ought to be conducted, consisting of three elements necessary for continued
growth through contributing to society: Mission, Value and Mind. The mission expresses the
expansion of our business from activities centered on the ﬁeld of in vitro diagnostics̶a focus since
our establishment̶to the broader healthcare domain with its even closer connection to humanhealth. In this manner, the mission asserts our aim of contributing toward the realization of a society
ﬁlled with abundance, health and joy.
The Sysmex Wayʼs Core Behaviors clarify provision of speciﬁc value to customers, employees,
business partners, shareholders, society and all our stakeholders. For example, to provide
reassurance to all members of society we carry out our business in strict compliance with laws andregulations, as well as in adherence to high ethical standards. We also consider it important to play
an active role in resolving environmental issues and other problems that impact our society today.
Please click here for our corporate philosophy and core behaviors.

CSR Management Structure
We have set up various committees, headed by executives, to promote activities according to key
CSR-related themes, including compliance, risk management and the environment. We have alsoestablished the CSR Promotion Department as the specialized department for planning, promoting
CSR activities and disseminating CSR-related information both inside and outside the Company.
Important CSR themes, such as identifying materiality and formulating mid-term CSR plans, arediscussed and reported at management meetings attended by members of the Managing Board. We
also analyze expectations and requests from society and extract our tasks from this information.
Related departments then reﬂect the tasks in their execution plans and activities, resulting in a PDCA
cycle.

- 13 -

CSR Management

Stakeholder Relations
Stakeholder Communications
Through communication with its stakeholders, Sysmex checks whether it is responding tostakeholdersʼ requests and expectations through its business activities. The results are reﬂected invarious business activities.
Main Dialogue Achievements in Fiscal 2017
Dialogue with Customers
Conducted survey on degree of customer satisfaction in each region
Held scientiﬁc seminars in each region
Held user group meetings to communicate accurate product knowledge in each region
Held customer training program incorporating customer feedback in each region
For details, see “Responsible Provision of Products and Services.”
Dialogue with Employees
Conducted employee questionnaires and interviews
Held hearings for all employees about their aspirations in relation to career design (voluntary
reporting system)1
Held dialogues with labor unions2
1 Sysmex Corporation
2 Sysmex Corporation, Sysmex Shanghai, Jinan Sysmex, Sysmex Wuxi, Sysmex Vietnam, Sysmex Thailand, HYPHEN BioMed

For details, see “Realization of an Attractive Workplace.”
Dialogue with Business Partners
Conducted supplier brieﬁngs
Held meeting for distributors
For details, see “Responsible Provision of Products and Services.”
Dialogue with Shareholders and Investors
Held Ordinary General Meeting and informal meeting with shareholders
Held the Technology Presentation for institutional investors and analysts
Held informational meetings and Company tours for individual investors
For details, see the “IR Library.”- 14 -

Dialogue with Members of the Local Community
Held event for local community interaction at R&D core Technopark
Engaged in dialogue with community through social contribution activities around the world
For details, see “Corporate Citizenship Activities.”

Stakeholder Dialogue
Sysmex identiﬁes priority issues, materiality, and develops speciﬁc action plans, which it pursues
through its CSR activities. We recently engaged in dialogue with a third-party expert concerning
Sysmexʼs materiality, as well as our thoughts and directions for promoting CSR going forward.

“Sysmexʼs Materiality and CSR Ideals”
Date: December 19, 2017
Location: Sysmex Corporationʼs head oﬃce
Participants:＜Stakeholder＞
Katsuhiko Kokubu Professor, Graduate School of Business Administration,＜Sysmex＞

Kobe University

Noriko Okada

Executive Vice President, Corporate Communication Division

Emiko Takahashi

Vice President, CSR Promotion Department, Corporate＜Moderator＞
Eriko Nashioka

Communication Division
Representative Director of IEMA, CPA

Katsuhiko Kokubu

Eriko Nashioka- 15 -

Stakeholder Comments (Excerpt)
Category

Comments
As a company involved in healthcare and based in Kobe, the epicenter

The Signiﬁcance of CSR at
Sysmexof the Great Hanshin Earthquake, Sysmex is deeply aware of its
responsibility to society. Sysmex needs to have a broad understandingof societyʼs needs in order to remain a company that society considers
to be necessary.
Out of all the numerous issues society faces, it is important to clarify thereasons for selecting speciﬁc materiality items and taking action on

Materiality

them.
Rather than frequently revising materiality items, it is best to pursue
activities for around three years, employing the PDCA cycle.
KPIs are necessary when pursuing CSR activities, but it is not necessary

Setting KPIs for CSR

to assign numerical targets to all issues. It is ﬁne to set numerical

Activities

targets as KPIs for areas that require improvement; for areas that do
not require improvement, the KPI could be to maintain target levels.
CSR should be positioned as a topic for debate at meetings of theManaging Board; it is important to link CSR and governance.

CSR Ideals

The Social Contribution Point Program is a good example of how
employees take a leading role in promoting CSR and of support for
employeesʼ corporate citizenship activities.

Sysmexʼs Comments
We plan to reaﬃrm why materiality is important to us and consider the timing of revisions andthe setting of KPIs. We will take on board the opinions we have heard today as part of ourbroad understanding of societyʼs needs, and incorporate them into our CSR activities going
forward.

- 16 -

CSR Management

Materiality
Considering Materiality
Sysmex has identiﬁed priority issues, materiality, with a view to realizing a sustainable society andachieving sustainable growth for the Group. We are currently developing a speciﬁc action plan basedon these identiﬁed materiality and are taking actions accordingly.

Identifying Materiality
The Process of Identifying Materiality
We analyzed societyʼs requirements based on international guidelines,
such as the GRI Sustainability Reporting Guidelines (G4), the United
Nations Sustainability Development Goals (SDGs) and ISO 26000, as
well as screening content from sustainability assessment bodies. We
compared these requirements against the current state of theSysmexʼs CSR activities, extracting and identifying related aspects.
We then conducted an overall assessment of the related aspects
identiﬁed in STEP 1 along two axes: the degree of importance for
Sysmexʼs stakeholders (size of impact on decision-making bystakeholders) and, from the perspective of risks and opportunities, thedegree of importance for Sysmex (size of the Companyʼs impact on theeconomy, environment and society). Through this process, we
discovered the most important aspects requiring priority initiatives.
The materiality organized as a result of STEP 2 were approved at a
management meeting chaired by the chairman and CEO.

- 17 -

STEP 1 Understand and Organize the Issues

STEP 2 Prioritize
Sysmexʼs business activities impact society in various ways throughout the value chain. The Sysmex
Group comprehensively evaluates these impacts along two axes, according to the “degree ofimportance for Sysmexʼs stakeholders” and, from the perspective of risks and opportunities, by the“degree of importance for Sysmex.” We then select aspects of topmost importance requiring priority
initiatives. The Company contributes to society by promoting CSR initiatives across the value chain.

- 18 -

Recognized Social Issues, Expectations of Sysmex
In advanced countries, as populations age the need is growing to
reduce healthcare costs and extend healthy lifespans. Emerging
markets and developing countries, meanwhile, face the issues ofbuilding healthcare infrastructure in line with population growth andensuring the availability of healthcare. We recognize the need tocontribute to the resolution of these various healthcare issues throughresearch and development.

Main CSR-Related Aspects*
Resolution of medical issues through business activities
Improvement in accessibility to medical services by means such as familiarizing products
Securing of product quality and safety
Environmental consideration through the product lifecycle

Recognized Social Issues, Expectations of Sysmex
The scope of corporate responsibility is broadening. In addition to thequality of raw materials, companies are being called on to take into
account human rights, labor practices and consideration for theenvironment in their procurement activities. We believe in theimportance of working with our business partners for the responsible
provision of products and services.

Main CSR-Related Aspects*
Securing of product quality and safety
Assessment and management of the supply chain

Compliance

Environmental consideration through the product lifecycle- 19 -

Recognized Social Issues, Expectations of Sysmex
In recent years, societyʼs demands have increased in relation to
product quality and safety. Accordingly, we believe in the importanceof thorough compliance with laws, regulations and standards andassurance of high product quality and safety.

Main CSR-Related Aspects*
Securing of product quality and safety
Reduction in environmental burden through activities at business oﬃces
Environmental consideration through the product lifecycle

Compliance

Recognized Social Issues, Expectations of Sysmex
We believe in the importance of addressing environmental issues, suchas reducing GHGs through improved distribution eﬃciency and raising
the recycle rate.

Main CSR-Related Aspects*
Environmental consideration through the product lifecycle

Recognized Social Issues, Expectations of Sysmex
As a global company, we develop business in countries and regionsthat face healthcare issues, and we are called on to help address theseissues.
Furthermore, we believe in the importance of creating long-term,
trust-based relationships with customers through initiatives to enhancecustomer satisfaction, appropriate information disclosure and stableproduct supply.

Main CSR-Related Aspects*
Resolution of medical issues through business activities
Improvement in accessibility to medical services by means such as familiarizing products
Appropriate disclosure of information regarding products and services- 20 -

ComplianceRecognized Social Issues, Expectations of Sysmex
We believe in the importance of building long-term trust-based
relationships with customers through initiatives to boost customer
satisfaction, the collection of quality information globally and in atimely manner, responses in the event of troubles, and sharing
information globally about bugs and malfunctions, as well as corrective
and preventive action.

Main CSR-Related Aspects*
Reduction of environmental burden through activities at business oﬃces
Appropriate disclosure of information regarding products and services

Compliance* CSR-related aspects: Aspects selected after analyzing GRI Guidelines (G4), United Nations Sustainability Development Goals(SDGs), ISO 26000 and other international guidelines, and screening content from SRI and other assessment bodies, andreﬂecting on the status of Sysmexʼs CSR activities.

Sysmexʼs Materiality Matrix- 21 -

STEP 3 Conﬁrm Suitability, Establish Materiality
Sysmexʼs Materiality
Materiality

GRI Standard Related Perspective

Resolution of medical issues throughproducts and services
Resolution of medical issues throughbusiness activities
Improvement in accessibility to medical

Indirect economic impact
Local communities

services by means such as familiarizing
products

Responsible provision of products
and services
Securing of product quality and safety
Appropriate disclosure of information
regarding products and services.
Assessment and management of the

Supplier environmental
assessment
Supplier social assessment
Customer health and safety
Product and service labelingsupply chain

Realization of an attractive
workplace
Provision of a comfortable working
environment
Development of human resources

Employment
Training and education
Diversity and equal opportunity

Promotion of diversity

Environmental consideration

Raw materials

Environmental consideration through theEnergyproduct lifecycle

Water

Reduction in environmental burden

Emission into the atmospherethrough activities at business oﬃces

Eﬄuents and waste

Ethics and integrity

Governance

GovernanceCorporate Governance

Environment Compliance

Compliance

Anti-corruption

Risk Management

Anti-competitive behavior
Socioeconomic compliance- 22 -

SDGs Targets

Recognition of the Issues, Approaches
Resolution of Medical Issues through Products and Services＜Recognition of the Issues＞
In relation to aging populations in advanced countries, in recent years the need has been
growing to reduce healthcare costs and extend healthy lifespans. At the same time, theestablishment of medical infrastructure is unable to keep pace with growing populations inemerging markets and developing countries, and some 400 million people around the world are
not receiving necessary levels of healthcare*. Boosting access to healthcare services istherefore an issue.
Meanwhile, the Sustainable Development Goals (SDGs) set targets for human health andwelfare, prompting growing expectations for global companies to undertake initiatives to resolve
medical issues.
Under these conditions, the in vitro diagnostics (IVD) domain, which plays an important role indisease prevention, early detection and determining courses of treatment, is expected tocontribute to a healthy society by creating new value and solving healthcare issues, including
the three most deadly infectious diseases (HIV/AIDS, tuberculosis, malaria).
Sysmex believes the resolution of medical issues through its business activities and activities
that improve access to healthcare contribute to social sustainability and will bolster corporate
value through the creation of new technologies and markets.
*Source: WHO “Universal Health Coverage”＜Sysmexʼs Approach＞
Since the time of our founding, Sysmex has expanded its product lineup and strengthened its
services and support in response to testing needs, working to provide accurate test data swiftly.
In recent years, we have been conducting research and development on gene testing and otheradvanced, high-value testing and diagnosis technologies that lead to early detection andtreatment with a view to realizing personalized medicine. To boost access to healthcare in
emerging markets and developing countries, we are promoting business activities aimed atraising local levels of healthcare by enhancing lab quality and promoting the training ofhealthcare professionals.
By leveraging the unique technologies we have cultivated to date, as well as our global network,
we will continue to contribute toward the development of healthcare and the healthy lives ofpeople.
Please click here for information on activity results in relation to the resolution of medical
issues through products and services.

- 23 -

Responsible Provision of Products and Services＜Recognition of the Issues＞
A recent spate of issues involving product quality and recalls have drawn attention to societyʼs
demands for product and service quality and safety. Furthermore, in recent years the scope ofcorporate responsibility has expanded to encompass the entire supply chain, including business
partners. The Sustainability Development Goals (SDGs) also include goals related to the
responsibility of manufacturers.
Sysmex engages in the global development of business in the healthcare ﬁeld, involves peopleʼs
lives and health. Accordingly, we work to ensure the quality and safety of our products andservices, disclose information appropriately and conduct CSR-considerate procurement
activities. We believe these moves are important in earning the trust of our stakeholders.
＜Sysmexʼs Approach＞
Sysmex has created a global quality management system, through which it is consistently
striving to maintain or increase quality levels. As initiatives to enhance customer satisfaction,
we oﬀer services and support that are closely tailored to customersʼ needs, creating aframework we call “Voice of Customer (VOC)” to incorporate customer input into our productdevelopment and quality improvements, and provide the most recent scientiﬁc information.
Furthermore, as a company developing its business globally we are reinforcing our systems fordelivering a stable supply of products, promoting CSR-considerate procurement activities andaiming to grow in a sustainable manner in tandem with our business partners.
Going forward, we will continue striving to earn the trust of our stakeholders and instillingconﬁdence by oﬀering responsible products and services.
Please click here for information on activity results in relation to the responsible provision of
products and services.

- 24 -

Realizing an Attractive Workplace＜Recognition of the Issues＞
In order to achieve sustainable growth, it is considered important for companies to promote
diversity and create decent and attractive workplaces. Also, the SDGs include goals pertaining togender equality, decent work and reduced inequalities.
Sysmex considers human resources an important management asset necessary for sustainablegrowth. We believe that creating attractive workplaces helps ensure superior personnel,
reinforcing our corporate competitiveness.
＜Sysmexʼs Approach＞
Sysmex has in place a human resource development system that develops capabilities in an
ongoing and systematic manner. We promote diversity and inclusion and have introduced
various systems to create a workplace that provides peace of mind and enables diverse
employees to maximize their skills.
As we strive toward sustainable growth, we will continue in our eﬀorts to build a workplace inwhich diverse human resources can maximize their potential and provide opportunities for theirindividual growth.
Please click here for information on activity results in relation to the realization of an attractive
workplace.

- 25 -

Environmental Consideration＜Recognition of the Issues＞
We recognize that mitigating climate change; using water, mineral and other resources; andprotecting biodiversity are critical to sustainability of the global environment. As the going into
force of the Paris Agreement and the Sustainable Development Goals (SDGs) demonstrate,around the world a growing number of initiatives make addressing the environmental problem apriority issue, and companies are being called on to play a greater role.
As a company developing its operations globally, Sysmex recognizes increasingly serious
environmental issues as a topmost priority. We also understand that large-scale environmental
damage due to climate change is a signiﬁcant business risk because they have the potential tohalt our resource procurement and manufacturing functions.
＜Sysmexʼs Approach＞
To guide the Groupʼs environmental management over the long term, along with long-term
management goals for the Sysmex Group, Sysmex has formulated the Sysmex Eco-Vision 2025.
This vision sets long-term environmental targets to be achieved by ﬁscal 2025. We arepromoting environmental preservation across product and service life cycles and throughout thevalue chain of our business activities.
Going forward, along with the pursuit of sustainable growth we will continue striving to reduce
environmental impact̶a vital social issue.
Please click here for information on activity results in relation to environmental consideration.

- 26 -Governance＜Recognition of the Issues＞
Numerous corporate scandals related to corporate governance, risk management andcompliance have come to light in recent years, and their impact on society has increased.
In this environment, Japanʼs Corporate Governance Code went into eﬀect in June 2015, callingon companies to take governance into consideration in non-ﬁnancial areas, as well as on theﬁnancial front. In addition to strengthening governance and internal control, companies arebeing called on to buttress their management foundations for promoting risk management andcompliance. Sysmex believes that reinforcing governance helps ensure stakeholder trust and is
an important management issue in terms of enhancing medium- to long-term corporate value.
＜Sysmexʼs Approach＞
Sysmex has established the Audit and Supervisory Committee and is strengthening thesupervisory function by external members of the Managing Board, as well as enhancing theManaging Boardʼs eﬀectiveness and reinforcing governance in other ways. In line with thesechanges, we are putting in place systems to fortify the groupwide risk management function
and have established a Compliance Committee and an internal reporting system as initiatives tostrengthen our base with a view to sustainable growth.
We will continue aiming to maximize the overall corporate value of the Group throughmanagement robustness, better transparency and improved management speed and eﬃciency.
Please click here for information on activity results in relation to governance.

- 27 -

Objectives and Results
Fiscal 2017 Objectives

Fiscal 2017 Results

Fiscal 2018 Objectives

Resolution of Medical Issues through Products and Services
Continue participating in the Malaria
Consortium, which connects
Promote activities to prevent theindustry, government and academia

Continue activities to prevent the

spread of three major infectious

Develop and launch hematology

spread of three major infectious

diseases

analyzers that can measure malarial

diseases

Promote support measures to raise

plasmodia and other infected red

Promote support activities to raise

the level of healthcare in emerging

blood cell parameters1

markets and developing countries

Promote scientiﬁc support activities

the level of healthcare in emerging
markets and developing countries

in Mongolia and other emerging
markets and developing countries
Responsible Provision of Products and Services
Conducted brieﬁngs for business
partners on such topics as CSR
procurement and overseas laws andConduct CSR awareness activities
for business partners
Enhance CSR survey topics

regulations (participatingcompanies: 233)

Used the common SAQ2 created by

GCNJ3 to conduct CSR surveys of all
business partners (implementation
rate at primary suppliers in Japan:
81%)

Expand scope of CSR surveys toinclude secondary suppliers inJapanConduct CSR surveys(implementation rate for primaryand secondary suppliers in Japan:
80% or more)
Follow up with primary suppliers inJapan based on CSR survey results

Realization of an Attractive Workplace
Utilize diverse human resources

Obtained certiﬁcation for Sysmex

and promote diverse working styles Harmony Co., Ltd., as a special

Formulate and implement diversity
promotion plans

Rate of employment of people

subsidiary for promoting theRate of employment of people

with disabilities: 2.0%

employment of people with

with disabilities: 2.2% or more

(Group companies in Japan)

disabilities(Group companies in Japan)

Percentage of female managers:

Rate of employment of people

Percentage of female managers:

10%

with disabilities: 2.0%

12%

(Sysmex Corporation)(Group companies in Japan)(Sysmex Corporation)

Completed introduction of aworking-at-home system (131registered employees, of whom 99
used the system)
Conducted education and training
for female leaders
Percentage of female managers:
8.62%(Sysmex Corporation)- 28 -

Environmental Consideration
Promote environmental activities toCompleted the formulation of
Set medium- to long-term Group

Sysmex Eco-Vision 2025 and mid-environmental objectives

term environmental objectives(ﬁscal 2017–2019)achieve the objectives of EcoVision 2025
Reduce CO2 emissions
Reduce water consumption
Promote resource circulation
Protect biodiversity

Governance
Promote compliance activities
related to competition laws andanti-bribery
Evaluate the eﬀectiveness of theManaging Board

Revised the guidebook oncompetition laws
Conducted training related to antibribery
Evaluated the eﬀectiveness of theManaging Board

1 For research use; only in Japan
2 CSR procurement self-assessment tool set
http://ungcjn.org/activities/topics/detail.php?id=229
3 Global Compact Network Japan- 29 -

Promote measures to reinforce
Group complianceContinue and improveeﬀectiveness evaluations of theManaging Board

Management and CSR

The UN Global Compact
Participating in the UN Global Compact
Sysmex signed the United Nations Global Compact inFebruary 2011 to proactively promote its CSR initiatives.
Sysmex refers to the 10 principles of the Global Compact andthe Sustainable Development Goals (SDGs), which the United
Nations adopted in September 2015, when identifying priority
issues (materiality) and promoting CSR activities.
Click here for information about the relationship between
the Sustainable Development Goals (SDGs) and the priority

The UN Global Compact

issues to be addressed (materiality).
Click here for information about the UN Global Compactʼs
10 Principles

The Sustainable Development Goals (SDGs)- 30 -

Highlight1

Resolution of Medical Issues
through Products and Services

Offering Superior
Technologies to Help
Eliminate Malaria
Recognition of the Social Issue
Malaria is one of the world’s three major infectious diseases. Although thenumber of infections and deaths due to malaria has been falling for the past
several years, annually around 200 million people are infected and some450,000 die from the disease. In Africa, one child under the age of five diesfrom malaria every two minutes*.

Malaria Infections and Deaths
Malarial infections
per year200

Aroundmillion people

The Sustainable Development Goals (SDGs) adopted by the United Nations in2015 address a number of medical issues, and the World Health Organization(WHO) has set the goal of cutting malaria-related deaths, and the number ofpeople infected by the disease, by 90% by 2030, compared with 2015 levels.
*Source: World Malaria Report 2017

Deaths per year
Around450,000
peopleMalarial Infections Globally(Millions 240
of People)

Sysmex’s Policy on Addressing Medical Issues
Sysmex has identified the “resolution of medical issues through products andservices” as a priority issue (materiality item) with a view to realizing asustainable society and achieving sustainable growth for the Company. Byleveraging our technologies, we aim to contribute toward measures to fightthe three major infectious diseases in the IVD field.

200

Target90

160%
Reduction

120
80
40
0

2000

2015

Source: World Malaria Report 2010,
World Malaria Report 2017

Relation to the SDGs
The Sustainable Development Goals (SDGs) adopted by the United Nations consist of 17 goals to be
met by 2030. Goal 3, to “Ensure healthy lives and promote well-being for all at all ages,” targets thefollowing objectives.
●Reduce maternal mortality●Reduce the mortality of newborns andchildren under five years of age●Eradicate AIDS, tuberculosis, malaria andtackle other communicable diseases●Reduce premature mortality from
non-communicable diseases●Ensure access to essential healthcare
services, medicines and vaccines●Develop the skills of, and conduct training
for, health workers in developing countries- 31 -

2030(Target)(Year)

COMMENT

Comment from a Stakeholder

Partnership Aimed at Overcoming Tropical Infectious Diseases
Not Present in Japan
We have succeeded in eradicating malaria in Japan; nobody in this country is infected. Overseas, however,the situation remains largely unchanged. With the emergence of drug-resistant malarial plasmodia andinsecticide-resistant mosquitos, in some countries the number of infections and deaths have actually
increased. Changing this situation and protecting from malaria the children who represent the future of
the world requires a well-concerted, three-pronged approach: prevention, diagnosis and treatment. I find itvery encouraging that Sysmex and other Japanese companies that aim to contribute to global health aretaking the lead in a consortium to eliminate malaria through superior tools and specific strategies. I havegreat expectations for the success of this effort and its subsidiary benefits.

Kiyoshi Kita
Nagasaki University
School of Tropical Medicine
and Global Health
Dean, Professor

Specific Initiatives for Eliminating Malaria
Developing Products to Help Eliminate Malaria

Promoting a Partnership to Eliminate Malaria

Sysmex has developed and begun selling1 the XN-30
multi-parameter automated hematology analyzer, whichallows the detection of blood infections from malarial
plasmodia.

Such worldwide issues as malaria cannot be resolved by asingle company. Rather, it calls for strong partnerships thatleverage the strengths of industry, the government, andacademia, as well as nonprofit organizations and local
communities.

As well as measuring infected red blood cell parameters suchas malarial plasmodia2, the XN-30 provides information
indicating the quantity of infected red blood cells and the typeof malarial plasmodia present. This information is important,as the treatment method generally varies depending on thetype of malarial plasmodia. We are also working ontechnologies to identify asymptomatic carriers—people whohave malarial plasmodia in their bodies but do not have theillness themselves—as addressing this situation is considered
one way of preventing the spread of the infection.

Since 2016, Sysmex has been participating in the Malaria
Consortium, a joint effort between industry, government,
and academia. We are taking on a role in the field of blood
testing.
The Malaria Consortium proposed "P3 (Public -Private
Partnership) from Japan for Malaria Elimination" in Asia andAfrica to the Japanese government in April 2018. It aims at
malaria elimination by combining Japanese companies'
technologies.

The XN-30 is being used for basic research. The ResearchInstitute for Microbial Diseases at Osaka University is using
this instrument in an effort to discover new anti-malarial drugs.
In addition to our next model, which will feature certain
improvements, going forward we will seek to obtain regulatory
approval in various countries so that the instrument can beused in laboratories and other clinical facilities.
1 In Japan only

Malaria Consortium Initiatives

2 Research parameter

Preventing
Occurrence

XN-30 Features•Develop insecticide-treated mosquito
nets, sprays and mosquito-repellant paint•Develop infection-preventing drugs•Provide health guidance

1. Fast(measurement inapproximately 1 minute)Testing and
Diagnosis

2. Simple and accurate
No need for the technicalskills required forconventional testing by
microscope

Drug Discovery andTreatment

3. Highly sensitive
Capable of measuringmalarial plasmodia and otherinfected red blood cells atconcentrations of 20cells/µL

XN-30 multiparameter
automated hematology analyzer- 32 -•Gene testing•Blood testing: Sysmex’s role

•Develop drugs for treatment

Highlight2

Environmental Consideration

Initiatives to Protect
the Environment in the Long Term
Recognition of the Social Issue
Global environmental sustainability—curtailing climate change; utilizing water,
mineral and other resources; and protecting biodiversity—is becoming an urgent
issue. As the enactment of the Paris Agreement and the adoption of the
Sustainable Development Goals (SDGs) show, around the world environmental
initiatives are considered priority issues, and expectations for the role of thebusiness sector are increasing.

Keeping the rise in

Measuresaverage air temperature toto Address
Climate Changeor less

2℃

The Paris Agreement calls for keeping therise in average air temperatures well
below 2°C above pre-industrial levels, andfor efforts to hold this rise to 1.5°C.

Sysmex’s Policy on Undertaking
Environmental Activities
As a company that is developing its operations globally, Sysmex has identified
materiality issues that include “environmental consideration throughout the
product life cycle” and “reduction in environmental burdens through activities atbusiness offices,” and is working proactively to reduce its environmental impact.
Furthermore, we have revised our environmental policy in line with our transition
to ISO 14001:2015, an international environmental management system, and aresteadily pursuing environmental initiatives throughout the Group.

Relation to the SDGs
The Sustainable Development Goals (SDGs) adopted by the United Nations consist of 17
goals to be met by 2030. Goal 6, to “ensure access to water and sanitation for all;” goal 7,
to “ensure access to affordable, reliable, sustainable and modern energy for all;” goal 12, to“ensure sustainable consumption and production patterns;” and goal 13, to “take urgent
action to combat climate change and its impacts,” target the following objectives.
●Substantially improve the efficiency ofwater usage, ensure the sustainable
extraction and provision of fresh water,and resolve water shortages●Reduce waste emissions by promoting
prevention, recycling and reuse●Double the rate of improvement
in energy efficiency●Reinforce the ability to preventand respond appropriately to thedangers and natural disasters
resulting from climate change- 33 -

People Facing
Water Shortages

40%
or moreof the world’s
population

By 2050, around 3.9 billion people (morethan 40% of the global population) living
in river basins are forecast to face severe
water shortages.

Source:OECD Environmental Outlook to 2050 (2012)

COMMENT

Comments from the Environmental Management Officer

We are promoting environmental conservation acrossthe entire life cycle in an effort to realize a sustainable society.
Resolving global environmental issues requires a medium- to long-term perspective. To date, Sysmex has
formulated long-term environmental objectives and engaged steadily in measures to reduce its
environmental impact. Even so, companies are now being called upon to increase their environmental
responses. We have recently formulated long-term management goals for the period ending in fiscal 2025.
Along with our aim of further growth, we have recast our long-term environmental objectives. We will stepup our environmental consideration to achieve a balance between economy and society.
In addition to setting clear reduction targets to be achieved by fiscal 2025, we are engaging inenvironmentally-friendly business activities such as reducing the consumption of energy and water fromthe use of our products.

Junzo Yamamoto
Member of the Managing Board andSenior Executive Officer, Managing Director

Formulating Sysmex Eco-Vision 2025
Along with the Sysmex Group’s long-term management goals,
we have formulated Sysmex Eco-Vision 2025, which concludes
in Fiscal 2025.

Major Changes from Eco-Vision 2020*● Expanded the scope of environmental consideration across theentire value chain and all business activities

This vision clarifies Group-wide targets, taking into accountthe social situation, needs and expectations related toenvironmental issues, including climate change and recycling,
as well as the Group’s environmental impact and scope. We
will step up our environmental conservation efforts across our
product and service lifecycles—spanning development,
manufacturing, sales, service and support—as well as ourvalue chain.

● Set targets for biodiversity protection● Expanded the coverage of business sites (accounting for 80% ormore of sales)* The long-term environmental action plan setting targets to be achieved byfiscal 2020 (set in fiscal 2010).
Please see the “Environmental Management” section for results based on
this plan.

Long-Term Environmental Vision
Sysmex remains committed to protecting the global environment by setting environmental objectives for the
product/service life cycle and the value chain of its business activities through the year ending March 31, 2026.
1. We reduce CO2 emissions to contribute to prevention of climate change.
2. We promote resource consumption reduction and resource circulation to help to enhance sustainability ofnatural resources.
3. We contribute to biodiversity protection under a full awareness of the impact of our business activities on thenatural environment.

Long-Term Environmental Objectives (Fiscal 2025)
CO2
Reduce CO2 emissions

15

By% when using
instruments

50

% in
By
business activities
By

Reduce water consumption

Promote resource circulation

15

Increase the recycle rate
in business activities

15

to

By
% when using
instruments% inBybusiness activities

93% or higher

Protect biodiversity
Expand the line using
alternatives to animal-derived
substances

15% when shipping
Base year: Year ended March 31, 2017

- 34 -

Society

Resolution of Medical Issues through Products andServices

In relation to aging populations in advanced countries, in recent years the need has been growing to
reduce healthcare costs and extend healthy lifespans. At the same time, the establishment of medical
infrastructure is unable to keep pace with growing populations in emerging markets and developing
countries, and some 400 million people around the world are not receiving necessary levels of
healthcare*. Boosting access to healthcare services is therefore an issue.
Meanwhile, the Sustainable Development Goals (SDGs) set targets for human health and welfare,
prompting growing expectations for global companies to undertake initiatives to resolve medical
issues.
Under these conditions, the in vitro diagnostics (IVD) domain, which plays an important role indisease prevention, early detection and determining courses of treatment, is expected to contributeto a healthy society by creating new value and solving healthcare issues, including the three mostdeadly infectious diseases (HIV/AIDS, tuberculosis, malaria).
Sysmex believes the resolution of medical issues through its business activities and activities that
improve access to healthcare contribute to social sustainability and will bolster corporate value
through the creation of new technologies and markets.
* Source: WHO “Universal Health Coverage”

Since the time of our founding, Sysmex has expanded its product lineup and strengthened its services
and support in response to testing needs, working to provide accurate test data swiftly. In recent
years, we have been conducting research and development on gene testing and other advanced,
high-value testing and diagnosis technologies that lead to early detection and treatment with a viewto realizing personalized medicine. To boost access to healthcare in emerging markets and developing
countries, we are promoting business activities aimed at raising local levels of healthcare byenhancing lab quality and promoting the training of healthcare professionals.
By leveraging the unique technologies we have cultivated to date, as well as our global network, wewill continue to contribute toward the development of healthcare and the healthy lives of people.
- 35 -

Resolution of Medical Issues through Products and Services

Resolution of Medical Issues through Business
Activities
Innovation Management
We believe that it is our mission to contribute to ongoing developments in healthcare and humanhealth. As such, we are working to create testing and diagnostic technologies to realize healthcare
optimized for individuals.

An R&D Structure That Generates Combinations of a Variety of Technologies
Sysmex develops technology platforms to analyze genes, cells and proteins. Through the multifaceted
application of these platforms, we create new testing and diagnostic technologies that are useful topatients. At Technopark, our hub for R&D, a congregation of researchers and engineers in a host ofﬁelds̶electrical, mechanical, biological, chemical and IT, among others̶interact, collaborate, andengage in R&D on instruments, reagents and software in response to customer needs. We have built
up a global R&D structure comprising R&D facilities in the United States, Germany and othercountries.
In addition to expanding our own technology platforms, through open innovation we are pursuingcollaboration with research institutes, universities and medical institutions in Japan and overseas. As
part of this eﬀort, we have set up an open innovation lab within Technopark, where we can conductcollaborative R&D with researchers from outside the Company, and we are promoting R&D toward
the realization of personalized medicine.
About Personalized Medicine- 36 -

Click here for details on the R&D structure.
Click here for information on open innovation.

Topics Related to Our R&D Structure (From Press Release in Fiscal 2017)
RIKEN GENESIS Establishes RIKEN GENESIS Innovation Genome Center to Provide Lab-Assay
Services for Genetic Testing
Sysmex Acquires UK Company to Expand into New Business Domains toward Personalized Medicine
̶Expanding Our Portfolio and Reinforcing Our Technology Base in the Life Science Business
Sysmex Opens New R&D Facility with a View toward the Realization of Personalized Medicine
Sysmex, RIKEN GENESIS and MKI Sign Comprehensive Collaboration Agreement with a View to
Joint Promotion of Genomic Medicine
Commencement of Collaborative Research on Measurement of Exosomes in Blood from Cancer
Patients
Japanʼs ﬁrst-ever industry-academia alliance to realize the development of innovative medicine inJapan̶Implementation of a one-stop bioresource project in Kyoto University, and theestablishment of KBBM Co., Ltd. as a model of “industry-in-the-academia” industry-academia
partnership

Contributing to the Early Detection and Treatment of Cancer
As of 2015, there were some 17.5 million cancer patients around the world, with deaths from cancer
numbering an estimated 8.7 million. Between 2005 and 2015, the number of cancer cases increased
by 33%. Of this ﬁgure, 16.4% was attributable to societyʼs aging, 12.6% to population growth and4.1% to increasing age-speciﬁc incidence rates. Although varying widely by country and region,around the world it is said that one in three men and one in four women will contract cancer at somepoint in their lives, making cancer one of the most prevalent diseases*.
Through genetic testing and other technologies, Sysmex's working to contribute to the early detection
and treatment of cancer, helping to improve the quality of life of individual patients.
* Source: Global Burden of Cancer 2015

- 37 -

Promotion of R&D in the Field of Cancer Diagnosis
Sysmex Corporation has signed a comprehensive collaborationagreement with the National Cancer Center (2013), and we haveengaged in joint development on more than 10 projects. In 2015,
in the aim of accelerating R&D in the ﬁeld of cancer diagnosis toencourage the proliferation of genomic medicine1 and clinicalsequence testing2, we opened the Sysmex Cancer Innovation
Laboratory (SCI-Lab) within the National Cancer Center Japan
Hospital. This lab meets ISO151893 international standards forclinical laboratories.
We operate this lab in conjunction with RIKEN GENESIS, a Sysmex
Corporation subsidiary with extensive experience in gene analysis.
The lab employs next-generation sequencers to conduct clinicalresearch involving comprehensive genetic testing to measurearound 100 gene types related to various types of cancer. This
research is expected to contribute to decisions on appropriate
treatment methods and use of drugs.
We will continue to collaborate closely with the National Cancer
Center Japan and RIKEN GENESIS, promoting research in the aimof realizing new cancer diagnosis methods and clinical sequence
testing as soon as possible.
1 This type of medicine involves analyzing the relationship between genetic
information and disease in order to predict the onset risk of diseases and aid inselecting the most eﬀective course of treatment.
2 Comprehensive analysis of disease-related genes for diagnosis and prevention ofcancer and similar diseases.
3 This international standard speciﬁes requirements for quality and competence in
medical laboratories.

- 38 -

Sysmex Cancer Innovation
Laboratory(SCI-Lab)

1

Providing a Lab Assay Service for Research , with a View toward the Realization of
Personalized Medicine
Sysmex Corporation provides a lab assay service for research
related to gene testing through the Sysmex BMA laboratory andthe Sysmex IMP laboratory in the Kobe Biomedical Innovation
Cluster (Port Island).
In December 2017, in collaboration with our subsidiary, Sysmex
Inostics, we launched a lab assay service (for research) using
BEAMing technology for detecting minute quantities of cancer-

Sysmex BMA laboratory

derived DNA in the blood in Japan, following our oﬀering of theservice in Germany and the United States. As a result, we expect
to reduce the burden of specimen transport for customers in Japan(research institutions, universities, medical institutions andpharmaceutical companies), and report results more quickly.
In addition, we provide the Curebest™ 95GC Breast assay service2,
which provides research data to predict recurrence by analyzingbreast cancer tissue. By providing a variety of research-use assay
services such as these, we aim to contribute to personalized
medicine, or healthcare that is optimized for individual patients.
1 Provision of laboratory testing results as services
2 An analysis service for measuring the expression amounts of 95 genes related tobreast cancer prognosis

1

Proliferation of Regenerative Medicine by Making Use of iPS Cells

iPS cell transplantation therapy is divided into two methods: autologous transplantation, where cells
produced from iPS cells derived from a patientʼs own body are used, and allogeneic transplantation,
which uses cells produced from iPS cells derived from a donor who meets certain criteria (allogeneic
iPS cells).
At issue with autologous transplantation is the signiﬁcant time and cost required to prepare cells fortransplantation. Allogeneic transplantation, on the other hand, may have the potential to provide cellswith assured quality for transplantation therapy timely, stably and inexpensively, because allogeneic
iPS cells are managed in cell banks2, and cells for transplant are produced systematically instandardized processes. For this reason, allogeneic transplantation appears to hold promise for the
proliferation of regenerative medicine. That said, since allogenic transplantation̶the treatment
method using donor-derived allogeneic iPS cells̶may induce post-transplant immunorejection3, it isnecessary to develop a new testing method to conﬁrm prior to transplantation whether cells are
suitable for transplant, including the possibility of immunorejection.
- 39 -

In July 2016, Sysmex Corporation, HEALIOS K.K. and Sumitomo Dainippon Pharma Co., Ltd.,
commenced joint R&D on a pre-transplant immune reaction testing method for using retinal pigment
epithelial (RPE) cells derived from allogenic iPS cells. Sysmex will use its imaging ﬂow cytometry andprotein analysis technologies to develop the pre-transplant immune reaction testing method for RPE
cells derived from allogenic iPS cells that have been jointly developed by HEALIOS and Sumitomo
Dainippon Pharma targeting patients with macular degeneration4 and other ocular diseases. Throughcollaborative R&D employing leading-edge technologies, we will contribute to the popularization ofregenerative medicine.
1 An abbreviation for induced pluripotent stem cells, iPS cells that are produced from human skin cells or others by transfectionof several factors are capable of diﬀerentiation into many types of cells organizing
2 To produce ﬁnal products on a sustained and stable basis, cells that have been prepared from a single cell under deﬁned
conditions (cultivation in advance) are dispensed into multiple containers and stored under deﬁned conditions. For iPS cells, a
project of “iPS Cell Stock for Regenerative Medicine” is underway by using cells harvested from healthy Japanese volunteers.
3 In this reaction, the body works to protect itself by resisting the invasion of foreign substances, activating immune cells to block
the invasion. As this reaction is central to the success or failure of tissue and cell transplants, currently immunosuppressive
agents are used to control the rejection reaction.
4 Retinal maculae play an important role in the ability to see, but damage due to advancing age can cause degeneration,
resulting in illness in which the eyesight is impaired. In one type of age-related macular degeneration, the macular structure
takes on an “atrophic form” along with advancing age. In another, the “exudative form,” new vessels form just below the retina(neovascularity), causing damage to the maculae.

Topics Related to the Proliferation of Regenerative Medicine Using iPS Cells (From Press
Release in Fiscal 2017)
Sysmex Invests in Megakaryon Corporation to Contribute to the Practical Realization of Platelet
Preparations Derived from iPS Cells

The Spread of Testing Having a Low Physical and Economic Impact
Sysmex is pursuing R&D aimed at the realization of testing to reduce the physical and economic
burden on patients, ensuring that as many people as possible have access to appropriate healthcare.

Creating a Next-Generation Diagnostic Drug for Alzheimerʼs Disease
In line with aging populations, the number of people around the world diagnosed with dementia isrising each year. Some 9.9 million people develop dementia every year, and globally the number ofpeople with dementia is expected to rise from 46.8 million in 2015 to 74.7 million in 2030 and 131.5
million by 2050*.
Early detection and early treatment can slow the progress of Alzheimerʼs disease, so early diagnosis
is extremely important. However, issues exist with the brain imaging examinations and cerebrospinal
ﬂuid examinations that are necessary for the diagnosis of Alzheimer's disease. These issues include
an insuﬃcient number of facilities for examinations, high costs and the invasiveness of the testing.
- 40 -

Sysmex Corporation has signed a comprehensive agreement in the ﬁeld of dementia with Eisai Co.,
Ltd., which has a wealth of knowledge and technologies related to drug discovery in the ﬁeld of
Alzheimer's disease (February 2016). While we have the technology to measure genes, proteins andcells with a high degree of sensitivity, by leveraging each otherʼs technologies and knowledge, thetwo companies aim to discover next-generation diagnostic drugs that will enable early diagnosis,
selection of the treatment options and the regular monitoring of the eﬀects of treatment for
dementia.
* “World Alzheimer Report 2015,” Alzheimerʼs Disease International

Sysmex Super-Resolution Fluorescence Microscope Wins Good
Design Gold Award 2017
The super-resolution ﬂuorescence microscope developed
by Sysmex Corporation received the Good Design Gold
Award 2017 (Ministry of Economy, Trade and Industry
Award).
This microscope, which enables the observation of themorphology of proteins measuring only tens ofnanometers, is being used in joint research for Alzheimerʼsdisease with Eisai Co., Ltd.

Super-Resolution Fluorescence Microscope

In addition to its functionality, speciﬁc areas in which the product was considered superior, andtherefore selected for the Good Design Gold Award, included the fact that it needs less dedicatedspace than conventional super-resolution ﬂuorescence microscopes and does not require a
specialized environment such as a darkroom, enabling its introduction at facilities where installingthose conventional microscopes are problematic. The product also earned high marks for its
exterior design, which is simple and evokes a sense of innovation.

Further Product Popularization through the Expansion of Our Product Lineup
Sysmex provides products and services in the hematology, urinalysis and immunochemistry ﬁelds inmore than 190 countries around the world. Global demand for testing is increasing each year,
evidenced by evermore sophisticated healthcare in advanced countries and the establishment ofhealthcare infrastructure in emerging markets. In tandem with this demand, there exists a growing
need for automated system products that boost productivity in line with facility characteristics,
including laboratory scale, the number of tests processed, and the number of clinical laboratory
technologists. Sysmex proposes myriad combinations and systems that conform to the environmentsof customer facilities by making products more compact, faster and adopting a modular concept*.
* Individual modules can be combined to create a diverse variety of product conﬁgurations. The series also allows for ﬂexibility intesting throughput, increasing or reducing capacity in line with customer needs.

- 41 -

Product and Service Topics (From Press Releases in Fiscal 2017)
Sysmex to Launch the Semi-Automated Urine Chemistry Analyzer UC-1000, a Compact Model in
the Field of Urine Qualitative Analysis, in Overseas Markets
Sysmex Expands XN-Series Product Lineup in the Hematology Field̶Achieving Further Productivity
Improvements in Hematology Testing Through Footprint Reduction
Sysmex to Commence Sales of “Revohem PT” Reagent for Measuring Prothrombin Time, a Key
Testing Parameter for Monitoring Anticoagulation Therapy̶First Japanese PT Reagent Using
Recombinant Protein Mass Produced by Silkworms
Sysmex Launches the Revohem FVIII Chromogenic, a Coagulation Factor VIII Assay Reagent̶
Helping to Diagnose and Assist in Treatment of Hemophilia A
Insurance Coverage of Lymph Node Metastasis Testing for Non-Small-Cell Lung Cancer Using the
OSNA™ Method
Sysmex Acquires CLIA Waiver for New Automated Hematology Analyzer̶The First AutomatedHematology Analyzer to Receive Such Approval
Sysmex to Commence OncoBEAM™ Lab Assay Services (for Research) in Japan, as well as inGermany and the United States, to Analyze Genetic Mutations Related to Circulating Tumor DNA
Sysmex to Launch the Automated High-sensitive Immunoassay System for Research Applications
HI-1000̶Promoting R&D on New Biomarkers Aimed at Achieving Personalized Medicine throughLiquid Biopsy- 42 -

Resolution of Medical Issues through Products and Services

Improvement in Accessibility to Medical Services
by Means such as Familiarizing Products
People in some parts of the world have diﬃculty in receiving appropriate healthcare due to poverty or
because healthcare environments and systems and frameworks for providing healthcare areunderdeveloped.
Addressing one of its responsibilities as a company developing its business globally, Sysmex isworking to improve access to healthcare so that as many people as possible can receive appropriate
healthcare.

Initiatives Targeting the Three Major Infectious Diseases
Known as the three major infectious diseases, HIV/AIDS, tuberculosis and malaria claim about 3
million lives each year. Of the many infectious diseases that exist, these three have long existed on a
global scale. In recent years, the spread of therapeutic drugs and vaccines has helped to stem thescale of infection, but economic, social and cultural factors also come into play, and the medical
services required for prevention and treatment have not yet reached many poor and sociallydisadvantaged people. Impaired health can also aﬀect economic growth, as it lowers labor
capabilities, reduces labor productivity and leads to rising healthcare costs.*
By leveraging the detection technologies it has accumulated in the area of clinical testing, Sysmex ismoving forward with the development of products that assist in diagnosing disease. We are alsocollaborating with government and academia on initiatives to address the three major infectious
diseases.
* Source: “Knowing the Three Major Infectious Diseases”, Friends of the Global Fund, Japan

Initiatives to Eliminating Malaria
Malaria is one of three major infectious diseases. Although the number of cases has trended
downward over the past several years, each year some 200 million people are infected and around
450,000 die from the disease1. Africa accounts for more than 90% of these deaths, with one childunder the age of ﬁve losing its life by the disease every two minutes2. To eliminate malaria, Sysmex isworking to improve access to healthcare through its ﬁelds of business, the testing and diagnostic
domains.
For detailed activity highlights, see “Oﬀering Superior Technologies to Help Eliminate Malaria.”
1 “WHO World Malaria Report 2017”
2 Malarianomore.org.uk- 43 -

Participating in the Global Health Innovative Technology Fund (GHIT Fund)
Sysmex is working on development of testing
technologies targeting malaria, dengue fever, HIV/AIDS
and other diseases, as well as developing products tocontribute to the diagnosis of infectious diseases inemerging markets and developing countries. Since
2015, we have also participated in the Global HealthInnovative Technology Fund (GHIT Fund) which states
its vision for action as “one in which the crushingburden of infectious disease no longer prevents billions
of people in the developing world from seeking the levelof prosperity and longevity now common in theindustrialized world.” The GHIT Fund has entered its

GHIT Fund Frameworksecond phase of activity (2018-2022), shifting from theinitial focus on product development toward activities toprovide these products to the people who need them.
Sysmex will continue to participate in the fundʼs secondphase activities. By promoting activities aimed atdeveloping and providing new reagents for infectious
diseases through Japanese technological innovation, we
will contribute toward the eradication of infectious
disease in developing countries.

Annual Deaths from the Three Major Infectious Diseases in 2016

- 44 -

Providing Healthcare Opportunities through the Donation of Mobile Laboratories
Regions lacking electrical equipment and other infrastructure
cannot make immediate use of the products and services provided
in advanced countries, pointing to the need to provide products
and services suited to the needs of those regions and their people.
In some regions, knowledge of healthcare is insuﬃcient, and there
exists a lack of understanding about the eﬀects of testing andtreatment. Patient education and awareness are important issues
in such areas.

Mobile laboratory

In 2016, at the Tokyo International Conference on African
Development (TICAD VI) in Kenya, we unveiled a mobile lab1. We
donated this vehicle to the Beyond Zero Campaign2, which is
working to raise awareness of maternal and child health andmeasures to address infectious diseases. We see introducing amobile lab as a way to oﬀer a regular traveling clinic, as well as toeducate and promote awareness among patients in the aim of
reducing the percentage of deaths from infectious diseases bycontributing to their early detection and treatment.
Sysmex will continue working to provide appropriate healthcare toas many people as possible and aims to help resolve the worldʼ shealthcare issues by enhancing awareness of healthcare among
patients.
1 Sysmex Corporation exhibited this lab in collaboration with Toyota Tsusho
Corporation and Hino Motors, Ltd.
2 This awareness campaign on maternal and child health and measures to address
infectious diseases was launched by the wife of Kenyaʼs President Kenyatta in
January 2014. In addition to spurring government eﬀorts and raising awarenessamong the people, the campaign aims to distribute mobile laboratories throughout
the country and includes such activities as a charity marathon supervised by Ms.
Kenyatta.

Cooperation with a Program for Improving the Health of Mothers and Children
In December 2017, Sysmex Corporation participated in the “the Project for Improvement of Maternaland Child Health Department in Lambaréné Region,” in cooperation with the Fiscal year 2017 Grant
Assistance for Grass-Roots Human Security Projects in Gabonese Republic, Africa. Through thiscooperation, we installed our automated hematology analyzer and provided training to medical staﬀ
at the hospital. We aim to improve the health of mothers and children by increasing free testing
opportunities for pregnant and nursing mothers who live in areas with less access to healthcare.

- 45 -

Helping to Raise Local Healthcare Levels
As one of its initiatives to help the development of healthcare infrastructure and raise healthcare
levels in Asia, Sysmex has supported eﬀorts to raise the quality of healthcare testing in six countries:
China, Mongolia, Cambodia, Myanmar, Thailand and the Philippines. We are also providing laboratory
quality control support and supporting the education of healthcare professionals in the Africancountries of Namibia, Zambia and Zimbabwe.

Collaborating with the Japan International Cooperation Agency (JICA) to Promote Quality
Control Support at Clinical Laboratories to Match International Standards
Sysmex provides laboratory quality control support in the Republicof Namibia, Africa, which faces shortages of healthcare personnel
and healthcare infrastructure, as well as the issue of ensuring thequality of healthcare.
Speciﬁcally, Sysmex is providing a mentorship* program thatmakes use of the Sysmex Quality Guidance Manual̶a quality
control system operational manual for clinical laboratories
conforming to international standards̶to facilities under thejurisdiction of the Namibia Institute of Pathology, which is overseenby the Namibian government.
To date in Africa, we have already been engaging in the same typeof initiatives to raise laboratory quality by working with the healthministries of Zambia and Zimbabwe. We will use this track record
as a steppingstone to promote horizontal development into
surrounding African countries.
* Rather than simply managing people, mentorship is the concept of seeking the
growth and success of all people related to a business after making theorganizationʼs directions and values clear. This concept encompasses managementthat motivates people, provides guidance on position and skills that leads towardenhanced capabilities, and provides a framework to invigorate an organization.

- 46 -

Operator training at a lab (Namibia)

Conducting Scientiﬁc Support Activities to Standardize and Raise the Quality of Clinical
Testing
To date, Sysmex Corporation has entered into agreements with government institutions in China,
Mongolia, Cambodia, Myanmar, Thailand and the Philippines to conduct scientiﬁc support activities
aimed at enhancing the quality of clinical testing.
The accumulation of expertise and standardization related to “blood morphology testing,” which isessential to the diagnosis, treatment and follow-up assessments for leukemia and other blood
disorders, has become a social issue in Mongolia in recent years. As its support activities so far in theﬁelds of hematology, clinical chemistry and immunochemistry have earned high marks, in July 2017
Sysmex Corporation expanded its support to include the ﬁeld of blood morphology testing. In addition
to providing technological and academic expertise to local clinical laboratory technologists, by
supporting the construction and operation of a nationally implemented external quality control
framework for a blood morphology testing, we aim to help improve the level of healthcare in
Mongolia.
Going forward, Sysmex will continue with initiatives aimed at standardizing and increasing the qualityof clinical testing in emerging markets and developing countries.

- 47 -

Supporting the Education of Healthcare Professionals
In addition to preparing healthcare infrastructure in place, having in place appropriately trained
healthcare professionals is an essential part of improving access to healthcare. Sysmex provides
educational support to raise the quality of clinical laboratories and to standardize and raise the qualityof clinical testing. We also conduct seminars and study sessions targeting healthcare professionals,
imparting leading-edge scientiﬁc information.
Click here for information on Customer Relations- 48 -

Society

Responsible Provision of Products and Services

A recent spate of issues involving product quality and recalls have drawn attention to societyʼs
demands for product and service quality and safety. Furthermore, in recent years the scope ofcorporate responsibility has expanded to encompass the entire supply chain, including business
partners. The Sustainability Development Goals (SDGs) also include goals related to the responsibilityof manufacturers.
Sysmex engages in the global development of business in the healthcare ﬁeld, involves peopleʼs lives
and health. Accordingly, we work to ensure the quality and safety of our products and services,disclose information appropriately and conduct CSR-considerate procurement activities. We believethese moves are important in earning the trust of our stakeholders.

Sysmex has created a global quality management system, through which it is consistently striving tomaintain or increase quality levels. As initiatives to enhance customer satisfaction, we oﬀer services
and support that are closely tailored to customersʼ needs, creating a framework we call “Voice ofCustomer (VOC)” to incorporate customer input into our product development and quality
improvements, and provide the most recent scientiﬁc information. Furthermore, as a company
developing its business globally we are reinforcing our systems for delivering a stable supply of
products, promoting CSR-considerate procurement activities and aiming to grow in a sustainable
manner in tandem with our business partners.
Going forward, we will continue striving to earn the trust of our stakeholders and instilling conﬁdence
by oﬀering responsible products and services.

- 49 -

Responsible Provision of Products and Services

Securing of Product Quality and Safety
Product Quality and Safety Policies
Sysmex has constructed a system to ensure compliance with laws and regulations around the world
based on the Quality Policy, the Core Behavior and the Sysmex Corporation Quality Compliance Policy,
and we act accordingly.

Quality Policy
By shaping the advancement of healthcare, our global business activities
contribute to the creation of a fulﬁlling and healthy society.

Core behavior
1. We understand our customer's needs, and provide products and solutions that meet or
exceed their expectations.
2. We act based on our customer's viewpoints by realizing that "Quality is customer satisfaction".
3. We seek to reassure our customers by establishing the highest quality assurance standards
and using them to enhance the quality of all aspects of our business.
4. We continually create innovative value for our stakeholders by developing and applying new
and unique technologies and knowledge.
5. We comply with all relevant national or regional regulations and standards to provide safe
products.
6. We maintain and continually improve the eﬀectiveness of our quality management system.
7. We establish quality objectives consistent with this quality policy, and measure our
performance against them.
Revised in May 2007

- 50 -

Quality Management
Building a Global Quality Management System
All of Sysmexʼs production facilities* have obtained certiﬁcation
under the international standards ISO 9001 or ISO 13485.
In addition, we regularly hold the Global RAQA (regulatoryaﬀairs/quality assurance) Meeting, at which people in charge of
quality assurance at Group companies in Japan and overseas gather.
In this way, we are working to share quality information throughout
the Group and reinforce our structure.

Global RAQA Meeting* Wholly owned subsidiaries

Sustainable Improvement Programs
Reinforcing Structures for Maintaining and Enhancing Quality
Used in laboratory testing, Sysmexʼs products play a vital role in protecting peopleʼs lives and good
health. Being fully aware of this responsibility, Sysmex is making constant eﬀorts to maintain andimprove product quality by building various systems, not to mention complying with safety standards
around the world at the design and development stages.
In the product development stage, we verify product quality by setting ﬁve "quality gates" in theprocess leading up to market launch. Also, when we market products that are manufactured byothers, we verify their quality by conducting audits of the manufacturers and meticulously inspecting
the products. As well as these eﬀorts, in the unlikely event of a defective product we have systems inplace to quickly identify and respond to the problem.
At factory sites, each month we monitor manufacturing processes and the status of suppliernonconformities. We designate appropriate quality improvements at suppliers with highnonconformity rates, and have a system of ensuring quality through regular quality audits. In
addition, our global quality complaint processing system allows us to gather quality information in atimely way from markets around the world. When we receive information about a bug or malfunction,
we immediately look into the cause and cease distribution of the product. Sharing information
globally about bugs and malfunctions, as well as corrective and preventive actions, helps us maintainand enhance product quality.

- 51 -

Employee Training
Focusing on Specialized Quality and Safety Training
In addition to quality policy education for all employees, Sysmex
Corporation conducts basic and specialized quality education
targeting speciﬁc departments and job types. In ﬁscal 2017, we
conducted training on good vigilance practice (GVP) for safety
management employees in charge of manufacturing and sales.
This training was aimed at gathering safety management
information related to the causes of health hazards and ensuring
an accurate understanding of how to use this information. Being acompany that provides products and services in more than 190
countries and regions around the world, we conduct education on
individual countriesʼ regulatory systems for engineers indevelopment divisions, making a thorough eﬀort to develop
products in accordance with laws and regulations.

- 52 -

Group training

Responsible Provision of Products and Services

Appropriate Disclosure of Information Regarding
Products and Services
Quality and Safety Information
Sharing Customer Feedback within the GroupA direct link exists between a manufacturerʼs ability to provide safe, quality products and the trust it
engenders.
Sysmex established the Vigilance Division to ﬁeld the various inquiries it receives from outside theCompany, as well as to investigate and analyze the information it receives; share this information
with the design, manufacturing and other divisions; and improve quality. In addition, we have put inplace a structure for incorporating this information in the next generation of new products.
Product Quality and Vigilance Control System- 53 -

Recall and Repair Information Posted on Our Website
Sysmex posts information about product recall and repair on its website under “Important ProductNotices”.
Please click here for important product notices. (Information for Japanese market)

Working Aggressively to Stamp out Counterfeit Reagents
To assure accurate testing results, Sysmex asks its customers at healthcare facilities to use Sysmex
branded instruments and reagents together. In recent years, however, reagents whose names andcontainer shapes have been disguised to look like Sysmex reagents have been found in circulation insome areas. The use of such counterfeit reagents cannot guarantee the reliability of testing results
and, in some cases, can be harmful to patients' health.
For this reason, Sysmex continuously monitors markets for counterfeit reagents. When they are
discovered, we work with local government institutions and judicial organs to ensure the swift andthorough enforcement of our intellectual property rights. We also caution medical institutions against
the use of counterfeit reagents by placing advertisements in newspapers.

- 54 -

Responsible Provision of Products and Services

Assessment and Management of the Supply Chain
Core Behaviors
We deliver commitment to our client companies through broad-ranging partnerships. We strive to be
a company that can grow in step with our trade partners, through respect and mutual trust.

Supply Chain Management
Promoting CSR Procurement in the Supply Chain
Sysmex considers procurement fundamental to supporting its business activities. We have formulated
a procurement policy in line with core behaviors, and we select suppliers and build supply chain
management on this basis. We have also created green procurement standards that indicate ourfundamental perspective regarding environmental consideration in relation to procurement activities.
Sysmex has publicized its statement on the Sysmex UK website indicating its appropriate response to
the U.K. Modern Slavery Act, which went into eﬀect in March 2015 and provides for the elimination offorced labor, child labor, human traﬃcking, exploitation and other such practices in the supply chain.
Click here for information on green procurement.
Click here for information on the U.K. Modern Slavery Act (Sysmex UK website).

- 55 -

Procurement Policy
In "shaping the advancement of healthcare," the Mission set forth in the Sysmex Way corporate
philosophy, we deliver commitment to our business partners through equitable and fairprocurement activities. We also strive to be a company that can grow in step with our trading
partners in a spirit of mutual trust and encouragement. Operating in strict compliance with laws,
regulations, and contracts, and adhering to high ethical standards, we carry out consistentprocurement of components and raw materials that meet the levels of quality required byhealthcare providers. We closely follow these policies in our endeavors to supply products that
customers worldwide can use with conﬁdence. Similarly, we hope that our business partners will
cooperate with us in the following seven areas as we continue to create and enhance unique andcreative values.

We ask our valued business partners to:
1. Assure quality to the requisite degree for healthcare products
2. Build a system for reliable supply
3. Reﬁne technological capabilities that contribute to the development of healthcare
4. Create stable business foundations and formulate business continuity plans (BCP)
5. Promote business activities and CSR in compliance with the laws, regulations and social
conventions of host countries
6. Carry out environmental management to help conserve the global natural environment
7. Supply products at reasonable prices and engage in aggressive cost-reduction programs
Revised in March 2014

Conducting CSR Surveys
To conﬁrm its business partnersʼ CSR activities, Sysmex Corporation conducts surveys of existing andnew business partners on the status of these activities. In ﬁscal 2017, we surveyed some 230
existing business partners and three new ones.
From ﬁscal 2017, we adopted the common CSR survey form prepared by Global Compact Network
Japan in our survey of existing business partners. This survey contained a number of survey items,
including those related to human rights, labor practices, corruption, the environment and conﬂict
minerals. (Refer to the PDF ﬁle of the common CSR survey for details.)
We elected not to conduct business with new business partners that had problems with their CSR
initiatives. In addition to CSR surveys, we conducted management interviews at new business
partners.
We conduct the same sort of initiatives for overseas business partners. In particular, people in chargeof procurement make local visits to determine the status of child labor and the workplaceenvironment, conﬁrming that no problems exist.
Click here for information on the CSR/Sustainable Procurement Self-assessment Tool Set, thecommon CSR survey form prepared by Global Compact Network Japan.
- 56 -Aiming to Improve the Quality of Supplied Parts and Raw Materials
Sysmex Corporation designates a Quality Assurance Agreement that clearly deﬁnes quality
requirements. Counterparties sign this agreement after conﬁrming their understanding of our
procurement policy. We conﬁrm the quality of supplied parts and conduct quality audits when we
determine that corrective or preventive measures are needed.
We conduct quality audits of new suppliers and ensure that appropriate quality control is in place.

Relations in the Supply Chain
We strive to enhance relations with our business partners so we
can conduct business together based on their understanding of ourbusiness directions and procurement policy.
In ﬁscal 2017, we held supplier brieﬁngs for major business
partners in Japan. We explained our procurement policy, CSR
activities, overseas legal and regulatory trends, and other aspectsof CSR. In this way, we strive to ensure mutual understanding and

Supplier brieﬁng

strengthen relations.

Conducting Internal Awareness Activities to Ensure Compliance with ProcurementRelated Legislation
Sysmex Corporation has in place an electronic procurement system (Sysmex Trade Mission, or STM).
In addition to preventing the reduction of payments to inappropriate levels, as well as avoiding
product returns, each year we conduct training on this system. Also, all members of the Procurement
Department undergo training on the Subcontract Law. For people newly assigned to this department,
we also provide training on our procurement policy, CSR, green procurement and procurement risk.

- 57 -

Responsible Provision of Products and Services

Customer Relations
Enhancing Customer Satisfaction
Conducting Customer Satisfaction Surveys in Japan and Overseas
Sysmex conducts customer satisfaction surveys in a variety of countries and regions. We feed backthe opinions and requests we receive to the appropriate divisions, so they can make use of thisinformation in their routine business activities.
Sysmex America surveys all customers who purchase blood testing instruments, conducting
satisfaction surveys each year. In ﬁscal 2017, 97% of customers responded that they were satisﬁed.
Also, Sysmex ranked top among manufacturers of hematology analyzers in an IMV ServiceTrak
survey (sponsored by IMV) of customer satisfaction for 17 consecutive years.
In ﬁscal 2017, Sysmex Shanghai conducted customer satisfaction surveys of approximately 2,300
hospitals all over China, receiving high marks in multiple categories, such as after-sales service
quality and response speed.
We also conduct regular customer satisfaction surveys in the EMEA* and Asia Paciﬁc regions.
* EMEA: Europe, the Middle East and Africa

Enhancing Service and Support
Responding to Inquiries Rapidly and Responsibly
In Japan, Sysmex Corporation maintains a Customer Support Center, where experienced staﬀ
members with expert knowledge cater to customers 24 hours a day, 365 days a year (separate
agreement required). By creating a database containing maintenance histories and the details of pastinquiries from customers to ensure quick reference, the center responds to inquiries and requests
both quickly and carefully.
Requests and other comments received through the support center and other means is gathered by
the Voice of Customer (VOC) Group. After analyzing this information from various angles, it isprovided as feedback to related divisions so it can be utilized in new product development andoperational improvements. In ﬁscal 2017, we gathered some 18,000 customer comments in theJapanese market. We have received a positive response to instruments with new functions andinstruments that we have added as a result of customer input, which are indicated by the VOC markwe use in our product catalog.

- 58 -

To provide customers with even better service, in ﬁscal 2017 Sysmex Spain strengthened its
customer service center functions. Several times each year, its employees visit customer companies
to hear requests directly. By engaging in dialogue in this manner, the company is working to build
better relationships.

Inquiries to Customer Support Center

Responding to inquiries at theCustomer Support Center

See “Fiscal 2017 Performance Data” for results over the past three years.

Utilizing Networks to Provide Customer Support
At hospitals and other healthcare institutions, instrument andreagent precision is controlled to maintain consistent testing datareliability. In most cases, the condition of instruments and reagentsis checked by comparing the measurement results of materials
known as “control substances” with reference values and results ona daily basis. Sysmex supports customersʼ quality control byproviding control substances in various ﬁelds.

Customer Support Center

Customer instruments are connected to the Customer Support Center via our online Sysmex Network
Communication Systems (SNCS). Measured values of control substances sent via the SNCS from
customer instruments are received by the Customer Support Center, which tallies and compares
these values with its other data results on the same instruments, detects signs of abnormalities andreturns the analysis results to the customer. SNCS employs a remote service that enables
communication with customers. With this system, we can share data processing screens and use
Web cameras to conﬁrm the status of instruments.
This service also helps to prevent trouble by using information from the sensors placed on
various section of instruments, such as the number of operations, maintenance periods, and log andtemperature information.
- 59 -Disseminating Information That Is Useful for Customers
As part of our customer support activities, we disseminate
information on the “Support Information” section of our website.
Up-to-date information is sent out using an e-mail magazine
distribution service. We also oﬀer a “personal page” function for
managing content and viewing histories. In these ways, we areconsistently enhancing functionality to facilitate customer use.
“Support Information” site

Utilizing ISO to Increase the Quality of Clinical Testing
Recently, the ﬁeld of clinical testing has met with strong demand for improvement in the quality oftest results, and awareness of international standards is increasing around the world. One suchstandard is ISO 15189 (Medical laboratories - Requirements for quality and competence). The numberof clinical laboratories that have obtained this certiﬁcation is increasing, with the certiﬁcation having
become obligatory in some countries.
Sysmex has received certiﬁcation under the ISO/IEC 17025 international standard for clinical testing
calibration institutions and the ISO 15195 standard, verifying that Sysmex meets the international
standards for the quality of the calibration service it provides on its automated hematology analyzers.
We are the ﬁrst company in Japan to receive the accreditation in the ﬁeld.
A calibration certiﬁcate that Sysmex issues is accepted as a globally recognized document that ISO
15189 requires to ensure traceability and traceable calibration. As of March 31, 2018, Sysmex had
issued such certiﬁcates on more than 3,690 instruments.
Furthermore, SNCS/eQAPi1, an external quality assessment service Sysmex provides, is the ﬁrst inJapan in any industry to receive certiﬁcation under ISO/IEC 170432 (Conformity assessment̶General
requirements for proﬁciency testing).
1 Sysmex Network Communication Systems (SNCS) is a service that uses a network to provide quality assurance on diagnostic
instruments, monitor failure and oﬀer maintenance support. eQAPi is an external quality assurance service that covers multiple
instruments and reagent manufacturers.
2 International standard on conformity assessment - general requirements for proﬁciency testing.

- 60 -

ISO/IEC 17025:
International standard on
general requirements for thecompetence of testing andcalibration laboratories

Name of Entity

Certiﬁcation dateCertiﬁcation
numberISO/IEC 15195:
International standard as areference measurementlaboratory for clinical testing

ISO/IEC 17043:
International standard on
conformity assessment general requirements for
proﬁciency testing

Reference Measurement

Reference Measurement

Laboratory, Sysmex

Laboratory, Sysmex

Corporation

Corporation

February 14, 2014

March 17, 2015

February 12, 2014

RNL00440

RCL00440

PTP00010

Quality Control Services,
Sysmex Corporation

M19.2 Number

Scope ofcertiﬁcation

concentration

M19 Number concentration

M19.3 Mass concentration(red blood cell count, white(red blood cell count, whiteblood cell count, platelet

blood cell count, platelet

count, hematocrit value,

count, hematocrit value,

hemoglobin concentration)

M51 Medical testing(urinalysis, hematology,
clinical chemistry ,immunology, other testing)hemoglobin concentration)

Remarks

First accreditation in JapanFirst accreditation in Japanin the area of blood cellin the area of blood cell

count

count

First accreditation in Japanin all industries

Scientiﬁc Activities
Sysmex holds seminars targeting healthcare professionals in Japan and other Asian countries toprovide them with most up-to-date medical information. We also work with various countriesʼ
ministries of health, other national institutions and major academic societies on scientiﬁc activities
aimed at helping to increase the level of healthcare.

- 61 -

Holding Scientiﬁc Seminars for Clinical Professionals
Sysmex hosts scientiﬁc seminars and study sessions in various
regions for doctors, clinical technologists and other healthcare
professionals working on the front lines.
We began oﬀering scientiﬁc seminars in 1978 to provide the mostrecent information in the ﬁeld of clinical testing and share thatknowledge. June 2017 marked the 40th year of such seminars.
The theme of the ﬁscal 2017 seminar was “Further Leaps Forward

40th Sysmex Scientiﬁc Seminar(Japan)in Hematologic Disease Medicine: the Forefront and Future
Prospects.” The seminar took place at 15 venues in Japan and, for the ﬁrst time, was transmitted tothree overseas locations (Mongolia, South Korea and Indonesia). A record 1,855 people attended theseminar. This ﬁgure brought the cumulative number of participants above 40,000.
Through initiatives such as this, we build trust-based relationships with numerous healthcare
professionals. At the same time, the accumulated medical knowledge helps to raise the quality ofhealthcare.

Principal Scientiﬁc Seminars Held for Healthcare Professionals
RegionTheme

Japan and other parts of“Further Leaps Forward in Hematologic Disease Medicine:Asia

the Forefront and Future Prospects”

China

BelgiumJapan

TurkeyIranIndonesia

Attendees
1,855 people

20th Scientiﬁc Seminar “Clinical Applications of Hematology

Approximately

and Urinalysis”

1,500 people

7th European Scientiﬁc Symposium
66th Congress of the Japanese Association of Medical
Technologists, “Recent Topics in Lung Cancer Screening”
2nd Scientiﬁc Symposium
10th International and 15th Nationwide Congress on Clinical
Testing

Approximately
500 people
Approximately
300 people
Approximately
300 people
Approximately
200 people

7th Sysmex Scientiﬁc Seminar- 62 -

Approximately
170 peopleOverseas Case Study (Asia Paciﬁc): Conducting Support Activities to Raise the Quality ofClinical Testing
Sysmex is working with governments and academic societies in Asiaʼs emerging markets anddeveloping countries to support the standardization of through external quality control program. In
ﬁscal 2017, we provided external quality control in Mongolia, Thailand, the Philippines and Cambodia.
We also signed an agreement related to scientiﬁc support in Myanmar. Through these eﬀorts, we areworking to raise the quality of clinical testing in various countries.
Click here for information on the resolution of medical issues through business activities.

- 63 -

Responsible Provision of Products and Services

Stable Supply
Establishing a Stable Supply Structure
As a healthcare company, we recognize that we have an obligation to provide a stable supply of
quality products and services. To fulﬁll this role, Sysmex operates factories in Japan and overseas andhas established a global supply structure to meet demand eﬃciently.
We have also been proactive in securing multiple business partners from which to procure raw
materials, allowing to achieve cost eﬃciencies and providing a backup structure.

Response in Times of Disaster (BCP)
Almost every year, disasters occur worldwide, killing a great many people and causing signiﬁcantdamage to the local and world economies. In the past 30 years (1984-2013), more than 2.47 million
people have been killed and more than US$2.4 trillion in damage has occurred*. Earthquakes andother large-scale natural disasters occur frequently in Asia, a situation that calls for disaster
preparedness and quick response when disaster strikes.
Sysmex has formulated a business continuity plan (BCP) to ensure the continuity of important
operations in the event of an earthquake, tsunami or other large-scale disasters, as well as rapid
recovery.
To diversify risk related to reagents, we procure key raw materials from multiple sources. Also, we
select production locations based on the concept of local production for local consumption. At thesame time, we are building a system through which factories can provide supplies to each other inemergencies, and we have secured alternative transportation routes. We have created an internal
BCP manual on product supply and conduct simulation training that assumes a disaster situation.
Just after the earthquakes in Kumamoto occurred in April 2016, we set up a product supply
countermeasures headquarters that quickly ascertained the status of all suppliers, determined thedegree of impact on our product suppliers and worked rapidly to select alternative products. As aresult, there was no impact on our production plan.
* Source: Ministry of the Cabinet, website page on "Disaster Management in Japan"

Click here for information on disaster countermeasures.

- 64 -

Responding to Demand Increases
Expanding Factories and Installing Equipment in Preparation for a Rise in Global Demand
Sysmex works to respond swiftly to changes in global demand for its instruments and consistently
ensure a stable supply of its products. To achieve these goals, we maintain appropriate inventory
levels of each product at each location, ensure that inventories are located near their markets, andcommunicate with local subsidiaries to accurately determine the demand status.
We are also building new factories and expanding equipment in anticipation of further growth indemand for reagents. In July 2017, we completed the expansion of our reagent factory in the UnitedStates, Sysmex Reagents America, and commenced full-ﬂedged production. By increasing production
capacity to 1.8 times its former level, we expect to be able to provide a stable supply to meetdemand growth in the Americas over the medium to long term. Going forward, we will continue
working to bolster production capacity in line with demand in each region. We will also create regional
logistic hub functions in each region to further ensure stable supply.
We will continue improving production lines and logistics to ensure a stable supply of products tomeet global demand.

- 65 -

Society

Realization of an Attractive Workplace

In order to achieve sustainable growth, it is considered important for companies to promote diversity
and create decent and attractive workplaces. Also, the SDGs include goals pertaining to genderequality, decent work and reduced inequalities.
Sysmex considers human resources an important management asset necessary for sustainablegrowth. We believe that creating attractive workplaces helps ensure superior personnel, reinforcing
our corporate competitiveness.

Sysmex has in place a human resource development system that develops capabilities in an ongoingand systematic manner. We promote diversity and inclusion and have introduced various systems tocreate a workplace that provides peace of mind and enables diverse employees to maximize theirskills.
As we strive toward sustainable growth, we will continue in our eﬀorts to build a workplace in which
diverse human resources can maximize their potential and provide opportunities for their individual
growth.

- 66 -

Realization of an Attractive Workplace

Provision of a Comfortable Working Environment
Fair Evaluation and Treatment
Equitable Personnel Evaluation Based on Abilities and Accomplishments
Sysmex values the spirit of independence and challenge, provides employees with opportunities for
self-fulﬁllment and growth, and rewards them for their accomplishments. We remunerate employees
appropriately, according to factors such as their occupations and qualiﬁcations, and base salaries are
the same, regardless of gender.
Based on the principle of fair treatment, our basic approach toward evaluation is to "reward
employees for capabilities that contribute to the enhancement of corporate value as well as for
producing accomplishments." In addition to evaluating employees for their successes, we evaluate
the processes of producing achievements (competency evaluations). To achieve fairness and ensurethat employees understand their evaluations, we show employees their evaluation results and theirsuperiors' comments.

Basic Principles of the Personnel Management System
1. Ensuring long-term employment
Establishing a double-linear-type competence-based rating frame that enables a diversity of
employees to maximize their skills, and providing opportunities for self-realization andgrowth
2. Promoting the development and cultivation of diverse human resources
Establishing competence-based rating standards and promoting cultivation of humanresources and normalization of career advancement through clariﬁcation of promotion
criteria
Evaluating not only accomplishments but also the processes of producing achievements(realization capability) in order to promote human resource development and the reform ofcorporate culture
3. Rewarding employees for capabilities that contribute to the enhancement of corporate
value as well as for producing accomplishments
Simplifying the relationship between evaluation and reward
Creating a remuneration structure that is easy for everyone to understand and thatrewards employees in accordance with their contribution, role, competency andaccomplishments- 67 -

Supporting Employee Career Design
Sysmex Corporation employs a voluntary reporting system for all employees. Under this system, eachyear we hold hearings for each employee to learn about their medium- to long-term career, overseas
work and job category aspirations. The system aﬀords each employee with the opportunity toconsider their own career directions and life plan, as well as to aﬀect their own skills development
and placement according to the content of their reports.
The ﬁscal 2017 hearing included reporting by 90.8% of employees.

Promoting and Improving the Treatment of Contract and Temporary Employees
Sysmex Corporation actively hires contract employees and temporary employees as regularpersonnel. We have clariﬁed our internal regulations for hiring people working ﬁxed-term contracts,oﬀering them fair opportunities for promotion. We put this information on our intranet to encouragethorough understanding of these rules.
To provide a more comfortable working environment, we extended the ﬂex-time system and began
applying our welfare programs “cafeteria plan*” to contract employees, as well as regular employees.
This system enables employees to eﬃciently arrange their own working hours to suit individual
circumstances, such as visiting the hospital or raising children. Going forward, we will revise oursystems as appropriate to enhance our treatment of employees.
* Under this system, each year the Company provides employees with “cafeteria points,” which they can use as they choose to
pay the costs of speciﬁc types of welfare (to improve the work-life balance).

See “Fiscal 2017 Performance Data” for results over the past three years.

Introducing Internal Awards Systems to Motivate Employees
Sysmex introduced the Group CEO Award system for recognizing individuals, divisions or groups that
contribute most signiﬁcantly to the realization of the Sysmex Way, our Group corporate philosophy,
sharing these achievements throughout the Company each year. We provide awards for one
individual and one group.
To motivate R&D engineers and heighten awareness of intellectual property, we have also introduced
three patent award systems: the Patent Grand Prize/Patent Prize of Distinction, the Patent Meisterand the Filing Commemoration Prize. In addition, we present a Quality Award for success in quality
improvements.

- 68 -

Eﬀorts to Enhance Employee Satisfaction
Sysmex conducts "corporate culture surveys" once every two years targeting all employees of theSysmex Group. Employee satisfaction is one aspect of the surveys. Survey results are fed back toindividual departments, where they serve as a basis for enhancing satisfaction levels further.
Departments whose survey scores are ﬂat receive visits from human resources department
members, who oﬀer advice on improvements. Members of human resources departments conduct
interviews at the individual as well as the departmental level, to identify problems and consider
improvement measures for reforms of organizational culture.

Understanding of and Support for a Work-Life Balance
Promoting the Use of Systems that Support a Work-Life Balance
Sysmex Corporation provides a dedicated site on the Internet to provide easy-to-understandexplanations of its programs for supporting a work-life balance. We also hold brieﬁngs to promoteawareness. In addition, we promote the use of these programs during diversity roundtables, where
employees exchange opinions freely on such broad-ranging themes as careers, work-life balance andcultural understanding.
Click here for information on diversity roundtables.

- 69 -

Systems to Support a Balance between Work and Child Rearing
Providing a Host of Leave Systems and Supporting Child-Rearing with an In-House
Daycare Center
Sysmex Corporation has created diverse programs to provide
support, from pre-natal to child-rearing. In addition to leavesystems for fertility treatments and morning sickness, we oﬀer
child nursing leave until a child reaches two years of age (above
the statutory requirement), a system for shorter working hours
until a child reaches junior high school age, a working-at-homesystem and a ﬂex-time system that diﬀers by type of work. Whenan employee needs to take time oﬀ work to nurse a child, they can
do so under a program that allows them to use accumulated paid

In-house daycare center,
Sysmex Kids Park

leave in half-day increments in addition to statutory leave. We also
strive to smooth the return to work following childcare leave byconducting seminars prior to returning to work and distributing
newsletters to employees on childcare leave.
In line with the growing demand for male employees to participate
in childcare, we are considering a system that would allow men to
take special leave prior to their spouse giving birth, oﬀering two

Next-generation support certiﬁcation
logo (nicknamed "Kurumin")additional days to be taken within one month of the birth to make any necessary preparations.
Employees are also eligible for "nurturing leave," under which they can take special leave of threeconsecutive days to care for children up to one year of age.
We have set up Sysmex Kids Park, an in-house daycare center that accepts babies and toddlers, at
Technopark, our core R&D base. The center oﬀers short-term as well as fulltime daycare, so that
employees whose spouses work on a part-time basis or who ﬁnd it diﬃcult to take care of theirchildren due to caretakersʼ illness, bereavement or other circumstances may also temporarily utilize
the service.
In recognition of its planned implementation of such systems, Sysmex Corporation received the nextgeneration support certiﬁcation logo (nicknamed "Kurumin"*) from the Ministry of Health, Labour andWelfare.
* Based on the Act on Advancement of Measures to Support Raising Next-Generation Children, companies that formulate
business plans as general business operators, meet the targets designated by these plans, and meet certain standards may
receive “Kurumin” certiﬁcation as “companies that support child-rearing” by the Minister of Health, Labour and Welfare.

- 70 -

Systems Related to Children- 71 -

Other Systems to Support a Work-Life Balance
Supporting Nursing Care, Corporate Citizenship Activities and Others
Among its programs aimed at realizing a work-life balance, Sysmex Corporation has prepared various
types of programs related to nursing care.
We have introduced a program of that allows employees who need to attend family members in
hospital to take short-term nursing care leave and accumulated paid leave for up to 40 days in halfday increments. We also have a working-at-home system that enables employees to care for family
members who require nursing care or other types of support.
In addition, we have introduced a unique “income indemnity system” to provide a nursing care leavestipend, aiming to help oﬀset the loss of income from taking leave, as well as unexpected expenses,
for people taking one month or more of nursing care leave. Furthermore, we have a system forrehiring employees whose careers have been interrupted due to nursing care.
We hold brieﬁng sessions to explain the purpose of these systems, as well as how to prepare fornursing care to alleviate the uncertainties surrounding it.
As well as these programs, we have introduced a volunteer leave system (up to10 days of leave in a
year, two of which are accounted for as paid leave) and a system of donor leave, whereby internalorgan and other donors receive up to ﬁve days each time. These systems are aimed at making iteasier for employees to take leave and support a work-life balance in various ways.

- 72 -

Systems Related to Nursing Care

Supporting a Return to the Workplace Following Leave
To facilitate a smooth return to work following leave for child rearing or nursing care, three months
prior to their return to work Sysmex Corporation provides employees with tablets and notebook PCs
that give them access to internal email and allows intranet access. This system provides support froman IT perspective.
Enabling access to Company information in real time facilitates communication with the workplace,helping to alleviate a sense of feeling lost upon their return and eliminate gaps returning employees- 73 -

feel with the people in the workplace. When returning employees start to use these devices, we also
provides them an opportunity to meet with superiors in their departments.

Activities at Other Group Companies
Company

Activity
Introduction of a ﬂex-time system and a working-at-home system
Introduction of a childcare leave system (for fathers and mothers)
that exceeds statutory requirements
Introduction of family support systems (child-rearing support, familyleave, assistance payment when employees need to use support

Sysmex America

systems oﬀered by outside institutions when family members are ill)
＜Third-Party Awards and Commendations＞
Selected for the Companies that Care Honor Roll for 10 consecutive
years
Click here for information on selection for the Companies that Care
Honor Roll.
Introduction of a ﬂex-time system and a working-at-home system
Establishment of a parent–child room
Introduction of a childcare leave system (for fathers and mothers)Child-rearing support system (assistance payment when employees
need to use support systems oﬀered by outside institutions)Sysmex Europe＜Third-Party Awards and Commendations＞
Selected as a Great Place to Work for three consecutive years
Received the Family Friendliness award from the German Federal
Ministry for Family Aﬀairs, Senior Citizens, Women and Youth (June2017)

Sysmex Shanghai

Introduction of a ﬂex-time system
Child-rearing support system (medical insurance assistance)
Introduction of a ﬂex-time system and a working-at-home system
Child-rearing support systems (medical insurance assistance,

Sysmex Asia Paciﬁc
Sysmex Malaysia
Sysmex Indonesia

provision of scholarships)＜Third-Party Awards and Commendations＞
Named the HR Asia Best Companies to Work for In Asia 2017(sponsored by HR Asia) (Sysmex Asia Paciﬁc, Sysmex Malaysia)

Parent–child room (Sysmex Europe)- 74 -

Employee-Related Data
Click here for employee-related data.

- 75 -

Realization of an Attractive Workplace

Development of Human Resource
Basic Policy on Human Resource Management
As a global company based in Japan, we promote the development of and cultivate the capabilities ofdiverse human resources based on the assumption of long-term employment. We also reward
employees for capabilities and successes that contribute toward increased corporate value.

Core Behaviors
To our Employees
We honor diversity, respect the individuality of each employee, and provide them with a workplace
where they can realize their full potential.
We value the spirit of independence and challenge, provide employees with opportunities for selffulﬁllment and growth, and reward them for their accomplishments.

Development of Human Resources
Promoting Global Human Resource Development
Throughout the Group, Sysmex has more than 8,445 employees (as of March 31, 2018) building its
business globally, with overseas employees accounting for more than 58% of this total. In order to
put into practice the “Sysmex Way,” our Group corporate philosophy, under these circumstances andinstill conﬁdence in people around the world, augmenting the skills of individuals is important. We
believe it is also essential to foster communication among diverse human resources, encouraging themutual sharing of values and fostering new insights that will lead to new values and deepen culturalawareness through the joining of creative forces.
In this spirit, we have created a groupwide global human resource development system in ﬁscal
2014. We cultivate a sense of unity in business activities and the workplace and develop nextgeneration human resources. We are also reinforcing networks within the Group and undertaking
various measures to foster intercultural understanding.

- 76 -

Human Resource Development Based on Four Concepts
Based on its four concepts for human resource development (“linktraining, evaluation and work (show results),” “promote
globalization of the Sysmex Group,” “invest in ongoing humanresource development” and “be a company that cultivates humanresources and personal growth”), Sysmex Corporation operates a
training system oﬀering selective, rank-based and elective trainingthat seeks to nurture personnel in a planned and gradual manner.
In ﬁscal 2017, on average each employee underwent 15.4 hours

New employee trainingof training, and average per-employee expenditure amounted to ¥103,000*.
We have also opened the Global Communication Center (GCC) in Ashiya, Hyogo Prefecture, to serve
as a gathering place for people of diverse cultures and values, both inside and outside the Company.
At the GCC, we conduct various types of training based on Sysmexʼs human resource development
system, as well as cross-divisional study sessions and joint retreats for global personnel.
* This ﬁgure indicates training provided by the Human Resources Division and excludes certain types of training, such as selfdevelopment and training related to specialized work for divisions.

See “Fiscal 2017 Performance Data” for results over the past three years.
Three Core Training Systems
Training Type
Selective training

Objective
Cultivate global leaders
Cultivate future management personnel
Acquire the minimum level of understanding and expertise in management and issue

Rank-based training

resolution required at each level
Promote communication between departments

Elective training

Obtain practical expertise, knowledge and skills on business execution(Sysmex College)

Gain various types of business management expertise

Global Communication Center(theater room)- 77 -

Main Programs for Cultivating Human Resources
Program / Measure

Objective, Overview
Promote exchanges of Japanese and overseas personnel,

Global Personnel Exchange Program

strengthen ties through deeper mutual understanding
Dispatch young employees to overseas Group companies to help

Global Apprentice Program

them gain work experience

Training at the Monozukuri Training Center

R&D Innovation Activities
Sysmex Academy(Sysmex Europe)

Provide hands-on training in the knowledge and skills necessary to
manufacture Sysmex instruments
Strengthen teamwork and proposal-making capabilities among
R&D personnel
Gain product-related knowledge and skills

HR Academy

Enhance “soft skills,” such as team-building, leadership and(Sysmex Europe)

language proﬁciency

Sysmex University(Sysmex Asia Paciﬁc)Cross-cultural experience training

Online training that can be used by all employees

Interacting with employees in otherregions through operational
experiences- 78 -

Realization of an Attractive Workplace

Promotion of Diversity
Diversity and Inclusion
Signiﬁcance of the Initiatives
Sysmex considers human resources an important management resource for achieving sustainablegrowth, and we have evolved from the practice of “diversity,” which simply welcomes diverse humanresources, to the more extensive practice of “diversity and inclusion.” This approach involves creatinga working environment that is suitable for a wide variety of human resources.
Through synergies arising from diﬀerent values, perspectives, experiences and capabilities, we areworking to create a culture of innovation and generate value.

Working to Achieve Diversity and Inclusion
To promote diversity and inclusion, in April 2017 Sysmex Corporation established the Diversity
Promotion Section within its Human Resources Division. Sysmex is working to cultivate anorganizational culture that promotes further understanding of diversity and LGBT*. In ﬁscal 2017, we
set up a diversity portal site on our intranet to disseminate information and promote understanding.
We also conduct awareness surveys related to diversity, welcoming frank comments from employees
and developing our initiatives in this regard.
Sysmex America conducts measures based on its aﬃrmative action program, aiming to erase
prejudice and discrimination.
* Acronym referring to sexual minorities (lesbian, gay, bisexual and transgender)- 79 -

Ensuring Diverse Human Resources
Aiming to Equalize Employment Opportunities
Sysmex Corporation recruits new employees based the evaluation of individuals, without regard fornationality, race, gender, age, employment history or disability status. Speciﬁcally, we instituted yearround hiring to oﬀer equal opportunities to people who had already graduated or had studied
overseas and therefore might be at a disadvantage.
To ensure our ability to recruit personnel around the world, we conduct Company brieﬁngs andinterviews overseas, as well as conducting Web-based brieﬁngs and interviews. As in the previous
year, we continued to host interns in ﬁscal 2017, strengthening our measures to help overseas
human resources gain a better knowledge of Sysmex. Due to such eﬀorts, foreign nationals
accounted for 7.8% of new graduates hired in ﬁscal 2017.

Promoting Employment of People with Disabilities
Sysmex encourages the employment of people with disabilities.
Targeting long-term employment, we design working conditions tomaximize individualsʼ aptitudes and skills. In ﬁscal 2017,
employment of people with disabilities amounted to 2.04% ofGroup employees in Japan.
In April 2017, we established Sysmex Harmony Co., Ltd., in Kobe,
Hyogo Prefecture, a special subsidiary*. By creating a workplace
where people with various sorts of physical, intellectual andpsychological disabilities can work in keeping with theircharacteristics and disabilities, we aim to foster an environment inwhich everyone, regardless of disability, can work and growtogether enthusiastically and with peace of mind.
For the past 15 years, Sysmex Europe has worked with anorganization that endeavors to support the independence of people
with disabilities. The company subcontracts packaging work at a
manufacturing line of its reagent factory in Germany to people withdisabilities. We strive to maintain high levels of motivation among
these workers through sharing our mission, as well as throughperiodic training and support from employees.
* A subsidiary that has been certiﬁed by the director of a public employment security
oﬃce for special consideration in the employment of people with disabilities. Having
labor regulations separate from the parent company enables such subsidiaries togive more consideration to work capabilities and labor conditions of people withdisabilities in their labor regulations and workplace environments, thereby making iteasier to increase employment for people with disabilities.

- 80 -

Operations at Sysmex Harmony

Employing Seniors - System for Reemploying Post- Mandatory Retirement Age Workers
Sysmex Corporationʼs mandatory retirement age is 60, but we have in place a system for rehiring
until age 65 people who have retired at the mandatory retirement age and still wish to work. In ﬁscal
2017, 38 people who had reached the mandatory retirement age were rehired according to internal
rules.

Promoting Womenʼs Career Activities
Sysmex Corporation has been an active proponent of diversity. In addition to respecting theindividuality of our employees, we strive to provide them with a workplace where they can realize
their full potential. One aspect of these activities involves establishing an in-house daycare center,
providing childcare leave that exceeds statutory requirements. Also, based on the Act on Promotionof Womenʼs Participation and Advancement in the Workplace, in April 2016 we formulated the “Action
Plan Under the Act on the Promotion of Womenʼs Active Participation,” to cultivate female leaders andpromote diverse working styles.
As a result of these eﬀorts, the percentage of female employees at Sysmex Corporation has risen
from 19.9% in ﬁscal 2005 to 29.4% in ﬁscal 20171. The percentage of female managers has also
increased over that period, from 2.4% to 8.6%2. Also, the percentage of female managers for theSysmex Group as a whole was 15.2% in ﬁscal 2017.
1 Based on the number of people employed.
2 Director level or above

Receiving the Highest-Level “Eruboshi” Certiﬁcation as an Excellent Company Based on
the Act on Promotion of Womenʼs Participation and Advancement in the Workplace
Sysmex Corporation honors the individual of each employee and provides
them with a workplace where they can realize their full potential. In
September 2016, we met all ﬁve criteria set by the Ministry of Health, Labourand Welfare for the promotion of womenʼs participation and received thehighest ranking, Level 3, as an “Eruboshi” company, indicating superior
initiatives to promote the active participation of women.
Click here for information on the Act on the Promotion of WomenʼsParticipation and Advancement in the Workplace (Ministry of Health, Labourand Welfare)- 81 -“Eruboshi” markPercentage of Female Managers (Sysmex Corporation)

Percentage of Female Employees* (Sysmex Corporation)* Based on the number of people employed.

Promoting and Showing Understanding
Diversity Education
Sysmex Corporation holds diversity roundtables, where employees exchange opinions freely on suchbroad-ranging themes as careers, work-life balance and cultural understanding, creating a communitythat goes beyond internal divisions. In ﬁscal 2017, we held these roundtables six times, including
some in English.
Sysmex America and Sysmex Europe have formed employee groups to conduct diversity educationand promote diversity in an eﬀort to foster understanding.

- 82 -

Realization of an Attractive Workplace

Occupational Safety and Health
Assurance of Safety and Health at Workplaces
Explicitly Ensuring “Safety and Health at Workplaces” in the Global Compliance Code
Sysmex's Global Compliance Code clearly states the Company's goal of "8-4 Assurance of safety andhealth in the workplace" and we are conducting a number of activities in this vein.
Click here for information on the Global Compliance Code

Promoting Cooperation between Executives and Employees on Safety and Health
To ensure the health and safety of its employees, Sysmex Corporation has formulated Safety and
Health Regulations and strives to create a safe working environment. In ﬁscal 2016, we established
the Central Health and Safety Committee (meets twice each year), which targets Group companies inJapan. This committee aims to reinforce and enhance domestic Group companiesʼ occupational safety
and health systems. To this end, the committee formulates policies and targets, ascertains the statusof occupational health at individual business sites, considers improvement measures and reports its
results to executives via the Risk Management Committee.
The committee set companywide safety and health targets for ﬁscal 2017: zero work-related injuries,
and the promotion of health and productivity management for an increase in employee vitality andproductivity through investment in improving employee health. Each of our companies and oﬃces
worked to carry out these initiatives, centered on their Safety and Health Committees.
Health and Safety Committee meetings are held regularly at each oﬃce. In addition to examples ofnear misses, the committee tours workplaces to eliminate identiﬁed risks and, from a risk
management perspective, determine causes and introduce preemptive short- and long-term
measures.
As preparation for an accident or sudden illness, employees are given safety training on appropriate
emergency and evacuation measures and how to handle machinery and raw materials that arepotentially dangerous. We also hold comprehensive ﬁre drills based on a hypothetical large-scaledisaster. We conduct training on the use of AEDs and hold regular courses to train citizen emergency
response personnel. In particular, we hold initial-response drills that involve checks to be performedin the event of a disaster: quickly conﬁrming and ensuring employeesʼ safety, checking and sharing
the disaster situation of oﬃces and customers as well as the status of product supplies.
Sysmex Brazil has acquired OHSAS 18001* certiﬁcation, an international standard for occupational
health and safety management systems.
- 83 -

* This standard, issued in 1999 based on BS 8800, which was, developed by the British Standards Institute (BSI) in 1996,
consists of some 30 certiﬁcation bodies and standardization organizations in various countries.

Frequency of Work-Related Injuries / Severity Rate (Sysmex Corporation)

Preventing Overwork
To prevent overwork, we focus on reducing long working hours, which can impair physical and mental
health. In addition to complying with related legislation, we have in place internal standards forworking outside regular hours or on holidays that are stricter than the guidelines set by the Ministryof Health, Labour and Welfare. When employees exceed these standards, we will communicate thisfact with their superiors and seek to make workplace improvements. We ask employees to submit a
voluntary check form and, if necessary, meet with an industrial physician.
In April 2018, we began automatically recording when individual PCs were booted up and switchedoﬀ in an eﬀort to ascertain working hours. We also began training aimed at preventing overwork andintroduced speciﬁc measures.

- 84 -

Promoting Health and Productivity Management
Maintaining and Improving Employees' Health
Sysmex Corporation believes that maintaining andimproving employeesʼ physical and mental health is an
essential part of creating a safe and comfortableworkplace. We encourage employees to undergo
thorough physical examinations and cancer tests
speciﬁcally for women, in addition to regular healthcheckups, for the early detection of illness. As acompany in the business of handling medical
instruments, our employees could come into contact
with infectious substances in the course of their duties.
For this reason, in addition to statutory special health examinations we conduct our own medical
checkups twice each year that include testing for hepatitis B and C. In December 2015, we registeredas a partner company in the Cancer Screening Corporate Action1 and Know about Hepatitis2 projects.
We also trained employees who received education as hepatic medicine coordinators. In November
2016, we signed the Agreement to Promote an Increase in the Rate of Cancer Screening with Hyogo
Prefecture.
Kokoro no Health Checks are also performed annually to conﬁrm mental health and uncover any
harassment-related situations. We track results over time and strive to make workplace
improvements.
Furthermore, we provide channels for health consultations throughout the Company, and have inplace systems where employees can meet with industrial physicians and public health nurses. We
also have established an employee assistance program (EAP), enabling employees to seek help easily.
As welfare facilities to encourage health maintenance, on the grounds of the Solution Center Sysmex
provides sports grounds and tennis courts, as well as a gymnasium with ﬁtness equipment, alongwith systems for ongoing assistance in using sports facilities. We hold events and seminars as needed
to raise employee awareness of physical health maintenance. We have also introduced a “cafeteria
plan3” which includes programs to promote health, and employee cafeterias oﬀer healthy menu
options. In commemoration of our 50th anniversary of establishment, in January 2018 we began
soliciting global “personal health challenge declarations” from employees and developing healthpromotion measures.
As a result of these activities, in February 2018 we were recognized for the second time by the
Ministry of Economy, Trade and Industry for excellence in health management of “companies thatexcel in health management” (White 500).

- 85 -

1 This project is undertaken on behalf of the Ministry of Health, Labour and Welfare. The ministry aims to raise Japanʼs cancer
screening rate to 50% through workplace initiatives.
2 The Ministry of Health, Labour and Welfare campaign aims to encourage early detection and treatment by disseminating easyto-understand information about hepatitis and the importance of testing for the hepatitis virus.
3 This is part of our system of welfare programs. Each year, the Company provides employees with “cafeteria points,” which they
can use as they choose to pay the costs of speciﬁc types of welfare (to improve the work-life balance).

In addition to the eﬀorts described above, overseas Group companies engage in a variety ofmeasures to ensure employee health.

Company

Activity
Establishment of an in-house ﬁtness room

Sysmex America

Provision of a health and ﬁtness allowance
Subsidies for health checks and inﬂuenza vaccines
Establishment of an in-house ﬁtness room

Sysmex Europe

Provision of a health management program in which sports professionals
and dieticians are invited to provide advice
Provision of free lunches at the cafeteria
Establishment of a 24-hour telephone counseling system related to health

Sysmex UK

Third-party stress risk assessments
Provision of free fruit and water at the cafeteria
Assistance with sports club membership fees

Sysmex Spain

Provision of health management programs related to relaxation and diet
Provision of free fruit in the cafeteria

Sysmex Partec
Sysmex Shanghai
Sysmex Taiwan

Provision of sporting courses in which employees can participate at lunch
time or after work
Establishment of an in-house ﬁtness room
Provision of a half-day health check each year for each employee andhis/her spouse or one parent
Assistance with sports club membership fees

Sysmex Asia Paciﬁc

Introduction of commendations for participating in health events conductedby health ministries and an award system
Provision of free fruit in the cafeteria

Sysmex Malaysia

Supporting for marathons and cycling events through lending folding
bicycles to employees and other measures

Sysmex Indonesia

Provision of free fruit and water

Sysmex Vietnam

Holding of sports activities targeting all employees

Sysmex Korea

Establishment of in-house ﬁtness and refreshment rooms- 86 -

Realization of an Attractive Workplace

Respecting Workersʼ Rights
Upholding the Freedom of Labor Association and Recognizing theRight to Collective Bargaining
Participating in the UN Global Compact and Supporting the ILOʼs Core Labour Standards
Sysmex respects workers rights to labor association and collective bargaining, based on its
participation in the UN Global Compact and support for the ILOʼs Core Labour Standards.
All Sysmex Corporation employees, except executive employees and some in managerial posts, aremembers of the Sysmex Union, the in-house labor union. In ﬁscal 2017, membership accounted for
62% of employees. Overseas Group companies, including Jinan Sysmex, Sysmex Wuxi, Sysmex
Thailand, Sysmex Vietnam and HYPHEN BioMed, have also formed labor unions.

Labor–Management Dialogue
Engaging in Dialogue with Labor Unions at Group Companies
Each year, Sysmex Corporation engages in collective bargaining with the Sysmex Union.
In addition to regular council meetings, in ﬁscal 2017 labor and management met to discuss healthenhancing activities, the management of working hours, welfare and beneﬁt systems and othermeasures. We also hold similar types of dialogue with labor unions of overseas Group companies.

Employee Opinions Reﬂected in Management
To reﬂect employee opinions at the managemet level, Sysmex conducts a Corporate Culture Survey
once every two years, covering all employees. We analyze the results of this survey and promote
improvement initiatives targeting any problems or issues.

- 87 -

Society

Respect for Human Rights
Policies and Initiatives Related to Respect for Human Rights
Adhering to the Universal Declaration of Human Rights, ILOʼs Core Labour Standards,
and the UN Global Compact
In accordance with the item of the Sysmex Global Compliance Code, “8. To Respect Human Rights
and to Improve Occupational Health and Safety,” we practice corporate management that respects
the human rights of all employees and engage in initiatives to enhance the working environment. This
code is in keeping with the Universal Declaration of Human Rights provision that “All human beings
are born free and equal in dignity and rights” and the gist of the ILOʼs Core Labour Standards, which
deﬁne minimum labor standards that must be preserved in the workplace. To ensure that theseperspectives are eﬀectively put into practice, Sysmex has clariﬁed conformance rules and action
guidelines proscribing discrimination, harassment, forced labor and child labor. We also conductvarious types of training to ensure employee awareness. Sysmex began participating in the UN Global
Compact in February 2011, and we have clariﬁed our corporate stance in relation to the compactʼs 10
principles regarding human rights, labor, the environment and anti-corruption.
In view that it promotes human genome and genetic analysis research, as well as clinical research,
Sysmex has established an internal committee to ensure thorough consideration for subjectsʼ humanrights, and we follow speciﬁc guidelines in this regard.
Click here for information on the Global Compliance Code.
Click here for information on research ethics.

- 88 -

Identifying Risk to Human Rights (Human Rights Due Diligence)
According to item “8. To Respect Human Rights and to Improve Occupational Health and Safety” of
the Sysmex Global Compliance Code, we believe it is necessary to conduct “human rights due
diligence,” which involves identifying negative impacts on human rights, and preventing or reducing
them through our business activities throughout the entire supply chain. Speciﬁcally, we haveincorporated into CSR surveys of our business partners such topics as prohibiting forced and childlabor and eliminating discrimination due to gender, disability, race or other factors. To ensure that
Sysmexʼs activities are not involved or complicit in human rights abuses, we ascertain impacts onhuman rights in advance and put in place measures to ensure prevention. With the U.K. Modern
Slavery Act going into eﬀect, Sysmex UK has publicized its statement in this regard on its website
and operates in compliance with this act.
Click here for information on the U.K. Modern Slavery Act (Sysmex UK website).
Click here for information about procurement policies that take into consideration human rights inthe supply chain.

Consultation and Reporting Systems Related to Human Rights
Sysmex has established internal reporting systems in Japan and overseas to handle human rights
consultations, including those related to sexual harassment and workplace bullying.
Click here for information on our internal reporting system

Education and Training On Understanding Respect for Human
RightsConducting Training to Prevent Human Rights Abuses
Sysmex strives to prevent human rights abuses by conducting training on prevention of harassment
and regulations related to labor standards.
In ﬁscal 2017, we conducted training for 130 newly appointed managers on such topics as
harassment, including LGBT*, personnel administration and the Workers Dispatch Act. We also held
training for new employees and mid-career hires.
* Acronym referring to sexual minorities (lesbian, gay, bisexual and transgender)- 89 -

Society

Corporate Citizenship Activities
Policy on Corporate Citizenship Activities and Philanthropy
Sysmex actively carries out corporate philanthropic activities to promote a healthy society andvibrant community, and also facilitates our employees' personal participation in volunteer eﬀorts.
Contribution to a healthy society
Sysmex actively utilizes its resources in the healthcare ﬁeld to carry out philanthropic activities
and promote the building of a healthy society.
Cooperation toward a vibrant local community
Sysmex acts as a responsible and socially-conscious corporate citizen by cooperating with thelocal community through donations, sponsorships and involvement in philanthropic programs.
Facilitation of employees' volunteer eﬀorts
Sysmex will facilitate employees' participation in volunteer eﬀorts as citizens of the world,
members of Sysmex group that contribute to healthcare in the world, and emphasize
community involvement and development.
Established May 2012

- 90 -

Corporate Citizenship Activities

Corporate Citizenship Activities
Sysmex contributes toward the creation of a healthy society and the establishment of a vibrantcommunity through activities based on “To society” deﬁned in Sysmex Wayʼs Core Behaviors and its
policy on corporate citizenship.

Creation of a Healthy Society
Participation in the Kobe Medical Industry Development Project
The Kobe Medical Industry Development Project aims to create a focal point among members of thehealthcare industry in Kobe through industry–government–academia cooperation.
Sysmex has set up labs within the Translational Research Informatics Center (TRI), one of the
projectʼs core facilities, and the Center for Biomedical Research Activities (BMA), where we promoteclinical research and collaborative research with a variety of healthcare institutions and othercompanies.

Contributing to Healthcare by Funding University Courses
Since ﬁscal 2004, Sysmex Corporation has contributed funds to a course of assessment of clinicaltesting at the Kobe University Graduate School of Medicine and promoted joint research on newclinical testing technologies. This course is currently collaborating with Sysmexʼs Central ResearchLaboratories on the development of highly precise yet simple diagnosis technologies for determining
the risk of cardiovascular disease by evaluating the function of high-density lipoproteins.
In ﬁscal 2017, we established two new funded courses in the ﬁeld of international clinical cancer
research. The courses aim to apply leading-edge technologies, such as artiﬁcial intelligence androbotics technology, to the surgical domain and establish surgical treatment methods for cancer thatare minimally invasive and oﬀer complete cures. In collaboration with these funded courses, Sysmex
will promote R&D of next-generation medical care and new medical devices by utilizing its liquidbiopsy technologies and Medicaroidʼs robotics technologies.

Contributing to Healthcare through Foundations
In 1984, Taro Nakatani, the founder of TOA MEDICAL ELECTRONICS CO., LTD. (current Sysmex
Corporation) established the Nakatani Foundation of electronic Measuring Technology Advancement.
In 2012, the foundation changed its name to the Nakatani Foundation for Advancement of Measuring
Technologies in Biomedical Engineering. The foundationʼs core activity is to provide grants for leadingedge technology development in the ﬁeld of biomedical engineering measurement, providing awards
to researchers and oﬀering technology exchange grants.
- 91 -

From the time of its launch through ﬁscal 2017, the foundation has provided 445 grants amounting toa cumulative* ¥1,680 million.
* The cumulative amount of grant money includes long-term and large-scale research grants and special research grants, which
are for multiple years.

Activities
Theme

Content

Human Resource

Cultivation of engineers in collaboration with a university (Shanghai

Cultivation

Medical Instrumentation College)

HealthcareRelated
Physical Support

Company
Sysmex Shanghai

Joint development of a system to operative vehicles for supplying
drugs as a disaster countermeasure (collaboration with the Hyogo
Pharmaceutical Society and Shinkai Transport Systems)

Sysmex Corporation

Click here for details.
Participated as a partner company in the Cancer Screening
Corporate Action, a national project aimed at achieving a 50% rate

Sysmex Corporation

for cancer screening
Production of illustrated books to promote education and awareness
Awareness

Participation in the Making Strides charity walk to eliminate breast

Activities

cancerSysmex Corporation
Sysmex America

Participation in the Rowing against Cancer Charity, a charity event

Sysmexto eliminate cancer

EuropeCooperation in the Wacoal Pink Ride movement to eliminate breast

SysmexcancerMalaysia

Hosting of JICA trainees (44 people from 37 countries)

Sysmex Corporation

Contributions toInternational
Cooperation
Donation to the Global Health Innovative Technology Fund (GHIT
Fund)
Donation to ILFAR, an NPO dedicated to building an HIV/AIDS
treatment infrastructure in Kenya
Donations andSponsorship

Sysmex Corporation

Sysmex Corporation

Donation to the Zero Malaria 2030 Campaign (Malaria No More
Japan, a designated NPO), a publicity activity toward creating a

Sysmex Corporation

malaria-free world
Donation to Kindney Kids NZ, an organization that provides support

Sysmexto children with kidney disease

New ZealandDonation to the Ronald McDonald House, which provides

Sysmexaccommodation to children with diseases, as well as their parents

New Zealand- 92 -

Illustrated books to promote
education and awareness（Sysmex Corporation）

Participated in charity walk “Making
Strides 2017,” aiming to eradicate
breast cancer（Sysmex America）

Participation in the Rowing against
Cancer Charity, a charity event toeliminate cancer（Sysmex Europe）

Establishment of a Vibrant Community
Sponsorship of the Kobe Marathon 2017
Sysmex Corporation has been a special sponsor of this event since
its inception. With a theme of “Thanks and Friendship,” the Kobe
Marathon is meant to express the gratitude of the people of theKobe area to everyone who assisted in the reconstruction of theregion following the Great Hanshin-Awaji Earthquake.
As a special sponsor of the Kobe Marathon 2017, held in
November 2017, we provided runnersʼ bib numbers and exhibitedat the Kobe Marathon EXPO. We also ﬁelded volunteers who
provided operational support.

Employee volunteers handing out
water

Holding Events for Communication with the Local Community
Every year, Sysmex Corporation invites community residents to its
oﬃces to strengthen its relationship with the local community. In
May 2017, we opened the gardens at Technopark for an event inwhich some 750 members of the local community joined andstrolled about the grounds. On the day, we held a lecture themed
on “diabetes and post-prandial blood glucose.” Participants also
took part in a health check using ASTRIM FIT, our product forchecking estimated blood hemoglobin levels without sampling.
Technopark Festa (Sysmex
Corporation)- 93 -

Helping to Repair Homes for Low-Income People and Being Selected for the Companies
That Care Honor Roll
Sysmex America supports activities conducted by Habitat for Humanity, an international NGO. This
organization takes part in eﬀorts to provide homes for low-income people in more than 70 countries
around the world. The company provided donations for home repairs and support through employee
volunteers. The company was also selected for the Companies That Care Honor Roll 2018, sponsoredby Companies That Care, a U.S. nonproﬁt organization. For 10 consecutive years, Sysmex America
has been selected for this honor roll, which identiﬁes companies of excellence in a variety of areas,such as cultivating leaders, employee compensation, extensive welfare, work–life balance, a pleasantworking environment and volunteer activities in the region.

Helping to repair homes for lowincome people through Habitat for
Humanity(Sysmex America)

Selected for the Companies That
Care Honor Roll for the 10thconsecutive year
(Sysmex America)- 94 -

Activities
Theme

Content

Company

Holding of on-site lecture, “Blood Is Important”
Hosted the Try-yaru Week workplace experience program
Cultivation of the
Next Generation

Participation in the Science Fair in Hyogo, an event including
companies, universities and research institutions

Sysmex Corporation

Hosting of overseas interns
Participation in Global Human Resource Development Community, apublic–private partnership study-abroad program
Support to
Stimulate theLocal Economy
andOpening of Minato Ijinkan to the public

Sysmex Corporation

Contribute to
CulturalDevelopment
Support for the
Promotion of

Signing of aﬃliation agreements with ﬁgure skaters Mai Mihara andKaori Sakamoto

SportsSponsorship of Vissel Kobe, a Japanese professional J. League

NatureForest conservation activities through the Sysmex Forest

soccer clubPreservation and

Clean-up Activities Employee clean-up activities around business oﬃces
Introduction of Ride High, an in-house charity to support poor
childrenParticipated in the “My Future Project” to support poor students,
provided work experience opportunities and conducted education
Local
Communities

Sysmex Corporation

Support for vocational training of youths with disabilities (helping
make ice cream)
Participated in the “PERTIWI Soup Kitchen,” which provides support
for the homeless, distributing food to around 1,000 people
Invited orphans and held an exchange event with employees- 95 -

Sysmex Corporation

Sysmex UK

Sysmex Hong Kong

Sysmex Asia Paciﬁc

Sysmex Malaysia
Sysmex Malaysia

On-site lecture (Sysmex Corporation)

My Future Project, employment
support for poor students (Sysmex
Hong Kong)

PERTIWI Soup Kitchen, support for
homeless people(Sysmex Malaysia)

Events interacting with orphans(Sysmex Malaysia)

Employee Volunteer Activities
Sysmex encourages employee volunteer activities. To
promote these activities, we have introduced a Social
Contribution Point Program. Under this program,
employees earn points for participating in social
contribution activities, as well as social contribution
events sponsored by the Company, and the Company
makes donations based on the number of points. Some
37% of Sysmex employees in Japan, or 1,319 people,(Left) © UNICEF/UNI150956/Asselin(Center) © UNICEF/UNI108970/Asselin(Right)© UNICEF/UNI179689/Markisz
Courtesy of: Japan Committee for UNICEF

participated in this program, resulting in around ¥1.60 million in donations. Japan Heart, an NPO
receiving donations through the Social Contribution Point Program held an event inviting child cancer
patients and their families to Kidzania Koshien. Fifteen Sysmex employees volunteered to take part in
the activity, accompanying participants and taking photos.
Employees at business oﬃces planned volunteer activities, donating used books and clothes to NPOs
and foster homes.

- 96 -

Volunteer activities at Kidzania
KoshienDonations of used books and clothing
to foster homes

Employees at Sysmex, which provides the testing instruments used for blood
donations, are also active participants in blood donations. Sysmex Corporation
has been registered as a “blood donation supporting company” since ﬁscal 2014,
and around 400 employees of Group companies in Japan took part in blood
donations in ﬁscal 2017.
Sysmex America, Sysmex Thailand, Sysmex Indonesia and Sysmex New Zealandalso regularly conduct blood donation activities.

- 97 -

Sustainability

Environmental Consideration

We recognize that mitigating climate change; using water, mineral and other resources; andprotecting biodiversity are critical to sustainability of the global environment. As the going into forceof the Paris Agreement and the Sustainable Development Goals (SDGs) demonstrate, around theworld a growing number of initiatives make addressing the environmental problem a priority issue,and companies are being called on to play a greater role.
As a company developing its operations globally, Sysmex recognizes increasingly serious
environmental issues as a topmost priority. We also understand that large-scale environmental
damage due to climate change is a signiﬁcant business risk because they have the potential to halt
our resource procurement and manufacturing functions.

To guide the Groupʼs environmental management over the long term, along with long-term
management goals for the Sysmex Group, Sysmex has formulated the Sysmex Eco-Vision 2025. Thisvision sets long-term environmental targets to be achieved by ﬁscal 2025. We are promoting
environmental preservation across product and service life cycles and throughout the value chain of
our business activities.
Going forward, along with the pursuit of sustainable growth we will continue striving to reduce
environmental impact̶a vital social issue.

- 98 -

Environmental Consideration

Environmental Management
Environmental Policy
Environmental Policy
By shaping the advancement of healthcare, our global environmental conservation activities
contribute to the creation of a fulﬁlling and healthy society.

Core behaviors
1. We deliver reassurance to all people by carrying out business activities in an environmentallyconscious manner.
2. We promote environmental management in throughout the life cycles of products andservices and the value chain of our business activities, so that we can contribute to climatechange mitigation, sustainable resource use (waste reduction, recycle, water conservation),
protection of biodiversity, and proper control of chemical substances.
3. We comply with all applicable national or regional environmental regulations, standards andagreements.
4. In order to improve environmental performance, we continually improve our environmental
conservation activities and work diligently prevent pollution and minimize the impact our
products and services have on the environment.
5. We contribute to society through environmental conservation activities as a member of thecommunity, while educating and raising the environmental consciousness.
6. We establish environmental objectives consistent with this environmental policy, and measure
our performance against them.
Revised April 2018
Click here for information on “11. To Preserve the Global Environment” in the Sysmex Global

Compliance Code.

- 99 -

Sysmex Eco-Vision 2025
Formulating Sysmex Eco-Vision 2025
To coincide with the formulation of the new long-term management goals for the Sysmex Group, we
formulated “Sysmex Eco-Vision 2025”. These set forth the long-term environmental vision that
Sysmex aims to attain by 2025, and requires us to promote environmental conservation more thanever throughout the product/service life cycle and across the entire value chain of our businessactivities.
For details on Sysmex Eco-Vision 2025, see the activity highlight in the “Initiative to Protect theEnvironment from a Long-Term Perspective.”

Environmental Management System
Group Environmental Management System
Sysmex has formulated Global Environmental Management Regulations to clarify the responsibilities
and roles of each Group company. We have assigned a managing director, a member of the Managing
Board, of Sysmex Corporation as an environmental management oﬃcer to oversee and control Groupenvironmental management.

Promoting the Acquisition of ISO 14001 Certiﬁcation
Sysmex is working toward the acquisition of ISO 14001, the international standard for environmental
management, for the Groupʼs principal aﬃliated companies. As of April 30, 2018, we had acquired
certiﬁcations at 16 Group companies, and the percentage of employees at locations that had received
certiﬁcations amounted to 60% of the total number of Group employees.
By centralizing the environmental activities at Group companies in Japan, we are working to ascertain
the state of progress on activities and any issues, as well as to reinforce management activities, andfour companies (Sysmex Corporation, Sysmex International Reagents, Sysmex RA and Sysmex
Medica) comprising nine locations have obtained integrated certiﬁcation. As a result, we are now able
to systematically share information related to environmental management. Also, in ﬁscal 2016 wecompleted the transition to the amended ISO standards (ISO 14001:2015).

- 100 -

Status of ISO 14001 Certiﬁcation
Company
Sysmex Europe(Acquired ISO 50001
certiﬁcation)

Scope

Site

Manufacture of reagents for clinicaltesting
Sales and after-sales services forclinical testing instruments, various

Reagent factory

testing information systems and-healthcare-related software

Development, design, manufacture,sale and after-sale service of clinicaltesting instruments, various types ofanalyzers, testing reagents, testing

1999

October 2011

Kakogawa Factory

Sysmex Corporation

NovemberHead oﬃce

types of analyzers, testing reagents,
Sysmex Deutschland

Acquired in

April 2000

Technopark

February 2002

Head oﬃce

February 2002

Solution Center

November
2005

i-SquareFebruary 2015

Ono Factory

March 2001

Seishin Factory

June 2007

Sysmex Medica-

March 2001

Sysmex RA-

June 2008-

February 2009

information systems and healthcareSysmex International
Reagents

Sysmex Brazil

Sysmex America

related software, as well as sale ofcustom proteins

Manufacture and sale of reagents forclinical testing
Sales and after-sales services forclinical testing instruments, various-

types of analyzers, testing reagents,

Decembertesting information systems andSysmex Reagents America

healthcare-related software, as well2009-

as manufacture of testing reagents
Design, development, installationand support of healthcare
information systems and services,
as well as sales and after-sales
Sysmex New Zealandservices for clinical testing-

May 2011-

February 2012

instruments, various types ofanalyzers, testing reagents, testing
information systems and healthcarerelated software
Sales and after-sales services forclinical testing instruments, various
Sysmex France

types of analyzers, testing reagents,
testing information systems andhealthcare-related software- 101 -

Company
Sysmex India

Scope
Manufacture of reagents for clinicaltesting
Sales and after-sales services for

Site

Acquired in-

March 2012

Head oﬃce

clinical testing instruments, various
types of analyzers, testing reagents,
Sysmex Asia Paciﬁc

testing information systems andhealthcare-related software, as well

Reagent factory

April 2012as manufacture and sale of reagentsfor clinical testing
Sales and after-sales services forclinical testing instruments, various
Sysmex Espanatypes of analyzers, testing reagents,-

April 2012-

June 2013-

January 2016

testing information systems andhealthcare-related software
Sysmex Wuxi

Jinan Sysmex

Development and manufacture ofreagents for clinical testing
Manufacture and sale of reagents forclinical testing

Conducting Environmental Auditing
In line with environmental management system requirements, we perform regular internal andexternal environmental audits at locations that have obtained ISO 14001 certiﬁcation.
In ﬁscal 2017, four nonconformities were found during internal environmental audits of the fourGroup companies and nine locations for which certiﬁcation in Japan has been integrated. One slightnonconformity was found in external environmental audits. Corrective measures have been
completed.

- 102 -

Long-Term Environmental Objectives and Results of Mid-Term
Environmental Objectives
Long-Term Environmental Objectives of the Sysmex Group Environmental Action Plan
(Sysmex Eco-Vision 2020) and Sysmex Group Medium-Term Environmental Objectives
and Results
Sysmex Eco-Vision 2020
Long-term Environmental
Objectives (Revised Edition)

Mid-term Environmental
Objectives (FY2015 –2017)

Activities/Achievements in FY2017

Continued working to reduce
electricity use and achieve better
compactness in the developmentof new productsContinued eﬀorts to develop
alternatives for animal-derived
substances in reagents
To reduce waste, increased thenumber of instrument varieties
Promote eco-friendly

Promote eco-friendly

employing reusable packaging

products and service

products and service

materials

modelsmodelsIncreased the percentage ofcustomer inquiries and service
requests resolved via telephone
and network services(compatibility with remoteconnection) (thereby reducing

Environmental

CO2 emissions by decreasing theconsciousness

number of visits made using

in product life

vehicles)cycle process

Click here for details
For exports, promoted shift from
air to ocean transport
Optimized product package sizes
and conducted loading
simulations to increase container
Reduce carbon dioxide

Reduce carbon dioxide

emissions for logistics byemissions for logistics by

50% (per unit of non-

45% (per unit of non-consolidated sales)1

consolidated sales)1

Base year: FY2010

Base year: FY2010

loading eﬃciency
Promoted local procurement ofdisposable products
Results (per unit of nonconsolidated sales):Fiscal 2017: 4.924(t-CO2/hundred million yen)
Base year: 7.252(t-CO2/hundred million yen)
Against base year: Down 32%
Click here for details- 103 -

Sysmex Eco-Vision 2020
Long-term Environmental
Objectives (Revised Edition)

Mid-term Environmental
Objectives (FY2015 –2017)

Activities/Achievements in FY2017

Environmental

Reduced use of electricity byconsciousness

improving production eﬃciency

at business(Sysmex International Reagents)

oﬃces

Reduced CO2 emissions by using
solar power (Sysmex
Europe(Reagent factory inGermany）, i-Square)
Switched to high-eﬃciency air
conditioning units (Solution
Reduce greenhouse gas

Reduce greenhouse gas

Center)emissions at businessemissions at businessConverted to the use ofoﬃces by 50%(per unit ofoﬃces by 40% (per unit ofrenewable energy for electricity

2

2

consolidated sales)

consolidated sales)(Sysmex Europe, Sysmex

Base year: FY2008

Base year: FY2008

Deutschland, Sysmex Europe(reagent factory in Germany))
Results (per unit of consolidated
sales):
Fiscal 2017: 7.16
(t-CO2/hundred million yen)
Base year: 10.07(t-CO2/hundred million yen)
Against base year: Down 29%
Click here for details
Reused as a road paving
material the glass waste
formerly processed at landﬁlls

Achieve a recycle rate ofAchieve a recycle rate of(Technopark, Solution Center)

93% or higher at all

92% or higher at all

Reused packaging material on

business oﬃces

business oﬃces

purchased items (Sysmex Wuxi)

3

3

Results:
Fiscal 2017: 91.3%
Click here for details- 104 -

Sysmex Eco-Vision 2020
Long-term Environmental
Objectives (Revised Edition)

Mid-term Environmental
Objectives (FY2015 –2017)

Activities/Achievements in FY2017

Reused reverse-osmosis (pure)wastewater throughimprovement of ultrapure water
plant (Sysmex Asia Paciﬁc)Reduce water usage at

Reduce water usage at

Reused industrial waste waterreagent factories by 10%

reagent factories by 7%

after treatment (Sysmex India)(per unit of amount of(per unit of amount ofResults (per unit of production):

4

4production)

production)

Fiscal 2017: 23.2

Base year: FY2008

Base year: FY2008(m³/thousand boxes)
Base year: 21.5
(m³/thousand boxes)
Against base year: Up 8%
Click here for details

1 Scope of data: Sysmex Corporation
2 Scope of data: Factories and major business oﬃces (13 factories, 7 business oﬃces)[Factories]
Sysmex Corporation (Kakogawa Factory, i-Square), Sysmex International Reagents (Ono Factory, Seishin Factory), Sysmex
Medica, Sysmex RA, Sysmex Europe (Reagent factory in Germany), Sysmex Brazil, Sysmex Reagents America, Sysmex India,
Sysmex Asia Paciﬁc, Jinan Sysmex, Sysmex Wuxi
[Major Business Oﬃces]
Sysmex Corporation (head oﬃce, Technopark, Solution Center), Sysmex Europe, Sysmex America, Sysmex Shanghai, Sysmex
Asia Paciﬁc
3 Scope of data: Factories and major business oﬃces where products and/or chemical substances are handled (13 factories, 3business oﬃces)[Factories]
Sysmex Corporation (Kakogawa Factory, i-Square), Sysmex International Reagents (Ono Factory, Seishin Factory), Sysmex
Medica, Sysmex RA, Sysmex Europe (Reagent factory in Germany), Sysmex Brazil, Sysmex Reagents America, Sysmex India,
Sysmex Asia Paciﬁc, Jinan Sysmex, Sysmex Wuxi
[Major Business Oﬃces]
Sysmex Corporation (head oﬃce, Technopark, Solution Center)4 Scope of data: Reagent factories (9 factories)
Sysmex International Reagents (Ono Factory, Seishin Factory), Sysmex Europe (Reagent factory in Germany), Sysmex Brazil,
Sysmex Reagents America, Sysmex India, Sysmex Asia Paciﬁc, Jinan Sysmex, Sysmex Wuxi

Environmental Risk Assessments
Performing Environmental Risk Assessments
As part of the Groupʼs risk management, Sysmex assesses the impact of business activities on
increasingly severe environmental issues from the perspectives of compliance and environmental
impact, in an eﬀort to reduce risk and create business opportunities. We conduct risk assessments
once every two years under its risk assessment system.

- 105 -

Environmental Education
Conducting Environmental Education and Training
Sysmex Corporation conducts general education for all employees to foster an awareness of the
impact of the Groupʼs environmental activities and individual operations. We conduct specialized
training for individuals designated by their divisions as people responsible for and in charge ofenvironmental management system promotion. We also conduct specialized and emergency response
training for each division, as necessary.
Examples of Environmental Education (Fiscal 2017)
General environmental training (e-learning): For all employees at business sites having integrated
ISO certiﬁcation
Regulatory system seminar: For people in charge of business sites and development- 106 -

Environmental Consideration

Environmental Consideration through the Product
Lifecycle
Eco-friendly products and services
Environment-Friendliness in Product Design
Sysmex has formulated regulations related to product life cycle management in an eﬀort tocontribute to energy conservation and waste reduction when customers use our products. These
guidelines, aimed at conserving IVD instrumentsʼ use of electricity and lowering reagent quantities,
are incorporated into technical development.
Examples of Initiatives
MethodResults of Initiatives
Reduced resources used in containers and packaging materials

Adopting Concentrated

Substantially reduced waste generated at laboratories

Reagent

By reducing weight and volume, improved transportation eﬃciency and reduced
CO2 emissions

Use of Environmentally

By switching to more environment-friendly and safer reagents, eliminated theConsiderate Raw Materials

need for processing waste liquid with neutralizing agents

XN-Series Using Reagent Concentrated 25 Times Compared with Conventional Reagents- 107 -

Environmental Consideration in the Production of Raw Materials
To curtail the use of natural resources, Sysmex has established a
production method using recombinant silkworms as an alternative
to the use of animal-derived proteins in its reagents.
In the past, producing these substances used substantial amountsof energy. However, as silkworms can be cultivated in typicalrooms, simply by using shelves and breeding containers andproviding them with food, we anticipate a stable supply, as well as
energy savings and waste reduction.

Silkworms to produce proteins

We use proteins produced by silkworms in Revohem PT, a reagent we launched in ﬁscal 2017. This is
the ﬁrst such product to obtain regulatory certiﬁcation.
Our protein production contracting service business using this technology has also been fully
operational since ﬁscal 2012, and we are already taking orders from a number of pharmaceuticalcompanies.

Comparison of Method Using Silkworms and Conventional
Method (Revohem PT)- 108 -

* Comparison of in-house product (through joint research with Tokyo City
Univercity)

Response to Laws and Regulations on Harmful Substances
Application of the revised RoHS Directive* (which was amended in July 2011) to Sysmexʼs diagnostic
instruments and diagnostic instruments for animals began in July 2016.
Sysmex has completed parts surveys and the switchover to alternative parts on products destined for
the European Union, and we declared our compliance in ﬁscal 2015.
* A directive prohibiting the use of hazardous substances in electrical and electronic devices sold in the European Union. This
directive calls for the cessation of use of heavy metals (lead, cadmium, mercury and hexavalent chromium) and speciﬁed
bromine containing ﬂame retardants (PBB and PBDE).

Environmentally Conscious Procurement (Green Procurement)
Cooperating with Business Partners to Promote Environmentally Conscious Procurement
Sysmex has established Green Procurement Standards, which describe its fundamental stance on
environmental considerations in procurement activities.
We also conduct annual CSR surveys of our business partners to check whether they have in placepolicies on environmental management, as well as targets and plans for CO2 reduction and energy
conservation.
Click here for information on our procurement policy.
History of Revisions and Updates of Disclosure Information Related to Green Procurement- 109 -

Green Procurement Standards
Through our global corporate activities in the healthcare ﬁeld, we are contributing to the creationof a fulﬁlling and healthy society.
1. Objectives
In accordance with its environmental policy, the Sysmex Group strives to fulﬁll its corporatesocial responsibility by promoting global environment conservation. Accordingly, we endeavor
to promote the manufacture of environmentally friendly products by encouraging the
procurement of raw materials and parts that have low impact on the global environment.
Sysmex aims to cultivate motivated environmental conservation activities among our suppliersand enable us to work together toward the development of a sustainable society.
2. Green Procurement Initiatives
The Sysmex Group practices "green procurement" to ensure that its procurement activities
promote a reduction in the environmental impact of the Company's products and reduce theenvironmental impact of all production activities, including those of our suppliers. We promote
the two items below as speciﬁc green procurement initiatives.
1) Promote the procurement of raw materials and parts that have lower environmental impact.
2) Expand business with suppliers that take a proactive approach toward environmental
conservation.
3. Scope of Application
These standards apply to the procurement of raw materials, parts and products by Sysmex
Group companies.
4. Control of Chemical Substances in Products
The Sysmex Group requires the selection of materials and parts for the products it develops
and produces to be based not only on the requisite quality, performance and economic
feasibility, but also on the minimization of environmental impact. Therefore, raw materials
and parts that do not employ the chemical substances described below shall be adopted:
1) Substances prohibited according to restrictions on chemical substances contained in
products shall not be contained.
2) Those in which the chemical substance amounts deﬁned under restrictions on chemical
substances contained in products shall be monitored.
3) Those for which the environmental impact of the chemical substance in terms of
atmospheric pollution, water contamination, soil pollution, etc. shall be low.
4) Environmental impact data for materials shall be disclosed.
5) In relation to packaging materials, when all of the aforementioned factors are identical, thatwith the lowest volume of contained chemical substances shall be selected.
Revised November 2014

- 110 -

1. Conﬁguration and Operation of Environmental Management Systems
When commencing transactions with business partners, the Sysmex Group indicates clearly
the importance it places on motivated environmental conservation activities. To this end, we
conﬁrm whether potential suppliers have in place environmental management systems
certiﬁed by third parties.
1) ISO 14001 certiﬁcation
2) Simpliﬁed environmental management system certiﬁcation
2. Provision of Environmental Information on Raw Materials and Parts
The Sysmex Group asks suppliers to provide the following environmental reports incooperation with Sysmex's environmental conservation activities.
1) Data on harmful chemical substances contained in raw materials and parts
2) Certiﬁcation against the use of substances targeted by European RoHS regulations
3) Information on raw materials and parts compliant with European RoHS regulations
3. Environmental Measures by Suppliers to Their Outsourcing Partners
The Sysmex Group also asks suppliers to request that their outsourcing partners conﬁgure
environmental management systems and cooperate in providing environmental information.
We ask suppliers to take responsibility for managing their outsourcing partners in this respect.
Revised November 2014

Specifying Prohibited Substances, Substances to Be Reduced and Target Countries
Based on its green procurement standards, Sysmex discloses the following items in dealing withchemical substances (substances with environmental impact) contained in the products it
manufactures and sells, as well as their constituent parts, devices and materials.
1. Prohibited substances (substances whose use is prohibited), revised on May 31, 2018
Prohibited substances
2. Substances to be reduced (substances whose use must be reduced) , revised on May 31,
2018
Substances to be reduced
3. List of target countries (countries and regions whose environmental laws and regulations
provide the basis for prohibited substances and substances to be reduced), revised on May
31, 2017
List of target countries- 111 -

Environment-Friendly Logistics
Eﬀorts to Lower CO2 Emissions in Japan-Domestic and Inter-Regional Transportation of
Products
As Sysmexʼs global business continues to expand, it is working tocurtail CO2 emissions by reviewing its logistics processes andsystems as distribution grows increasingly diverse and moving
forward with packaging reforms.
As a result, in ﬁscal 2017 we achieved a 32% reduction comparedwith ﬁscal 2010, the base year under Sysmex Eco-Vision 2020. We
have also set CO2 reduction targets when shipping under Sysmex
Eco-Vision 2025, which we formulated in ﬁscal 2018, and arecontinuing with our initiatives.

Reefer container

Results of Reviewing Logistics Processes, Systems and Packaging
MethodResult of Reviews
We shifted our mode of transporting reagents, which are considered hazardous

Modal Shiftmaterials, from aircraft to ship, using reefer containers*, for reagents destinedfor Germany. This move reduced the annual aircraft transport volume by around
380 tons.

Increasing Transportation
Eﬃciency

Following the China region, we set up a regional logistics hub warehouse in
Sysmex Asia Paciﬁc. Concentrating transportation within the region is reducing
CO2 emissions.
To reduce transport frequency, we have stepped up loading simulations. As aresult, we have improved our container loading ratio from 52% (ﬁscal 2013) toLoading Simulations

more than 70% (since ﬁscal 2015).
In the Sysmex Asia Paciﬁc supply chain, we have introduced the “container
optimizer” to automatically calculate optimal loading ratios, resulting in eﬀective
transport.

* A container with equipment to maintain its internal temperature at a speciﬁed level- 112 -

CO2 emissions from logistics

Notes: Range of calculation is CO2 from warehouse in Japan to customers within
Japan and that to overseas seaport or airport.

Saving Resources by Revising Packaging Materials
To conserve resources, Sysmex has introduced reusable packaging for instruments shipped within
Japan. In ﬁscal 2017, this move resulted in a savings of approximately 14 tons of cardboard.
In addition, for the steel materials introduced for shipping products overseas, we have increasedtransport strength and encouraged recycling at delivery locations, helping to reduce environmental
impact.
Furthermore, to reduce waste from packaging materials Sysmex Switzerland has introduced reusable
boxes for refrigerated cargo.
Introduction of Reusable Packaging Materials That Can Be Folded up When Returning- 113 -

Environmental Consideration

Reduction in Environmental Burden throughActivities at Business Oﬃces:
Responding to Climate Change
Reducing Greenhouse Gas Emissions
Eﬀorts to Reduce Greenhouse Gas Emissions at Business Oﬃces
We are undertaking a variety of eﬀorts to reduce direct andindirect greenhouse gas emissions by business oﬃces.
In ﬁscal 2017, unit greenhouse gas emissions decreased byapproximately 2.7% year on year. Against our Eco-Vision 2020
targets, emissions (unit per consolidated sales) were down 29%
compared with our base year (ﬁscal 2008).

LED Lighting(Ono Factory)

Initiatives to Reduce Greenhouse Gas Emissions
Initiative

Company

Content
We introduced an electricity management system(demand monitoring function)1 to understand andcontrol overall electricity use. We used this analysis tointroduce energy-saving measures tailored to businessoﬃce characteristics.
Monitoring room temperatures in summer andEnergy Conservation Sysmex Corporation

winterMeasures

Installing moving detectors to activate staircase
lighting
Upgrading to energy-saving air conditioning
equipment
Introducing LED lighting, other
Sysmex Europe
Sysmex Corporation

Shifted to higheﬃciency equipment

Sysmex Europe

Sysmex Wuxi

Introduced a new air conditioning system
At the Solution Center, switched to high-eﬃciency air
conditioning equipment that does not use gas
Switched to LED lighting in principal reagent ﬁllingrooms
Switched to a refrigerant with lower global warming
potential in cold storage- 114 -

Initiative

Company
Sysmex Corporation

Introduced
renewable energy

Content
At i-Square, installed solar panels and introduced
natural lighting in working areas to save electricity

Sysmex Europe

Used all renewable energy for electricity

Sysmex UK

Shifted to renewable energy for some electricity
Gave Greener Sysmex Points to employees who use

Sysmex Malaysia

hybrid vehicles to commute to work, reduced energy
use and decreased CO2 emissions

Employee
Awareness

Sysmex Australia

Sysmex India

Encouraged employees to use public transportation tocommute to work
Conﬁrmed that all employees who use their own cars
to commute to work have received PUC certiﬁcation2

1 Functions for continuously measuring maximum electrical demand (demand value) for 24-hour periods and sounding an alarm
if the level exceeds target values, as well as reporting on electricity use on a daily and monthly basis.
2 An acronym for pollution under control, PUC certiﬁes that vehicle emissions are below pollution control standards. Indian law
requires vehicles to undergo semiannual PUC testing, and PUC certiﬁcation is obligatory. (The PUC certiﬁcation period is one
year for new vehicles.)Greenhouse gas emissions at business oﬃces

Notes: Scope of the data: Factories and major business oﬃces[Factories]
Sysmex Corporation (Kakogawa Factory, i-Square), Sysmex International Reagents (OnoFactory, Seishin Factory), Sysmex Medica, Sysmex RA, Sysmex Europe (Reagent factoryin Germany), Sysmex Brazil, Sysmex Reagents America, Sysmex India, Sysmex Asia
Paciﬁc, Jinan Sysmex, Sysmex Wuxi
[Major Business Oﬃces]
Sysmex Corporation (head oﬃce, Technopark, Solution Center), Sysmex Europe,
Sysmex America, Sysmex Shanghai, Sysmex Asia Paciﬁc- 115 -

Decreasing CO2 Emissions from Domestic Company's Cars
To curtail fuel use and reduce CO2 emissions from some 400 company cars in Japan, we are making
use of our intranet to visualize travel distances and gasoline used by each Company car and heighten
driver awareness. We are also introducing fuel-eﬃcient vehicles and hybrid cars. CO2 emissions byCompany cars in Japan were down approximately 6% year on year.

Complying with Related Laws and Regulations
Based on the Energy Conservation Act, Sysmex Corporation has submitted to the Ministry of
Economy, Trade and Industry a medium- to long-term plan that summarizes its regular reports
aggregating annual energy usage amounts and its energy reduction plan. Going forward, we willcontinue promoting energy conservation activities throughout the Company to achieve these nonbinding targets in Japan.

- 116 -

Environmental Consideration

Reduction in Environmental Burden throughActivities at Business Oﬃces:
Resource Circulation
Managing and Recycling Waste
Reducing Waste and Promoting a Stable Recycling Rate
Sysmex engages in ongoing initiatives to reduce waste and increase the recycling rate.
As our business grows, our total amount of waste increases due to the establishment and expansionof new locations and to a rising number of employees. However, as a result of business oﬃce
initiatives our Group recycling rate remains high, at 91.3%.
Waste-Reduction Initiatives
Company
Sysmex Corporation

Sysmex RA
Sysmex Wuxi

Initiative
Reuse the glass waste formerly processed at landﬁlls as a road paving material,achieving material recycling of glass waste
Introduction of ethanol reuse equipment to process previously incinerated waste
ethanol, reducing the amount emitted as waste to one-seventh
Reuse of the polyethylene bags used to package purchased parts as trash bags

- 117 -

Business oﬃce recycling rate

Scope of data: Factories and major business oﬃces where products and/or chemical
substances are handled[Factories]
Sysmex Corporation (Kakogawa Factory, i-Square), Sysmex International Reagents (OnoFactory, Seishin Factory), Sysmex Medica, Sysmex RA, Sysmex Europe (Reagent factoryin Germany), Sysmex Brazil, Sysmex Reagents America, Sysmex India, Sysmex Asia
Paciﬁc, Jinan Sysmex, Sysmex Wuxi
[Major Business Oﬃces]
Sysmex Corporation (head oﬃce, Technopark, Solution Center)

Using Water Resources Eﬀectively
Reducing Water Use and Appropriately Processing Wastewater
Sysmex uses water, both above-ground and underground water, in its business activities, such as itscore reagent production. Recognizing the reduction of water use as an important social responsibility,
Sysmex sets targets for the reduction of water use in Sysmex Eco-Vision 2025, and is working to
improve the eﬃciency of water use at individual sites.
In ﬁscal 2017 our water usage (per unit of production volume) improved approximately 9% year on
year, resulting in an 8% increase against our Eco-Vision 2020 base year for water usage.
Major Initiatives at Business Oﬃces
Company
Reagent factories in Japan

Sysmex Asia Paciﬁc

Sysmex India

Initiative
Promote improvements in production eﬃciency, reduce work hours and decreasewater use
Upgrade of the ultrapure water plant and recycling waste water through reverse
osmosis when the factory is not in operation
Recycle industrial wastewater after treatment, use for watering greenery aroundfactory- 118 -

Water Use at Reagent Factories

Scope of data: Reagent factories (9 locations)Sysmex International Reagents (Ono Factory, Seishin Factory), Sysmex Europe (Reagent
factory in Germany), Sysmex Brazil, Sysmex Reagents America, Sysmex India, Sysmex
Asia Paciﬁc, Jinan Sysmex, Sysmex Wuxi

Reducing Paper Use
Promoting Digital Data
Sysmex Corporation is working to reduce the use of paper by utilizing personal computers, tabletsand smartphones to send and receive data electronically. These eﬀorts have boosted operatingeﬃciency and cut down on paper use and waste volume.
The use of electronic data facilitates the sending of agenda information to meeting attendees aheadof time. Checking and considering this information in advance has made meetings more eﬃcient andshorter. Eschewing the use of paper for storing materials also helps reduce the risk of internal
information leaks. Sysmex Korea has installed an approval system that has reduced paper use by
20,000 sheets. We have also begun cutting down on paper use by providing suppliers with productdrawings as electronic data rather than on paper.

- 119 -

Environmental Consideration

Reduction in Environmental Burden throughActivities at Business Oﬃces:
Preventing Pollution
Managing Chemical Substances
Determining the Status of Storage and Use and Managing Harmful Substances
Sysmex uses chemical substances in its product R&D and manufacturing processes. In addition topreventing losses or leaks, we strive to manage chemical substances appropriately to prevent
damage to the health of employees working on-site.
Methods for Managing Harmful Substances
Company

Initiative
We have established a Chemical Substance Management Committee and are
reducing chemical accidents, educating related divisions and otherwise

Sysmex Corporation

enhancing the management system (Technopark).
At the Scientiﬁc Laboratory, we conduct thorough chemical substancemanagement based on the Scientiﬁc Aﬀairs Division Standards for Laboratory
Management (Solution Center).

Sysmex International

We use ID cards and ﬁngerprint recognition to prevent unregistered personnel

Reagents

from entering areas where deleterious and hazardous substances are stored.

Emission of Harmful Substances and Management and Processing
with Regard to Their Release into the Water and Atmosphere
Managing and Processing Harmful Substances
As preparation against the danger of infection by biological substances, we strictly control thelocations where such substances are stored and used, based on manuals. Also, these substances arecarefully segregated from general waste for proper disposal.
For other harmful substances, we work to prevent aerial drift, dispersion and groundwater
permeation through countermeasures addressing both facilities and management methods. In theseways, we endeavor to keep emissions below statutory standard values.

- 120 -Wastewater Management and Processing
Sysmex prioritizes the protection of water quality. We have created our own emission standards that
we use to manage the wastewater from development locations and factories that use chemical
substances, ensuring that waterways and underground water are not aﬀected.
Methods of Managing and Processing Wastewater
Company
Sysmex International
Reagents

MethodAt the Ono Factory, we have introduced an alarm system that sounds an alarm
when biochemical oxygen demand (BOD) exceeds standards, preventing theemission of liquids containing organic matter.
We have introduced waste liquid processing equipment to heat-sterilize

Sysmex RA

infectious waste, rendering it harmless before direct release into seweragesystems.
The company has introduced a new wastewater processing system at its

Sysmex America

reagent factory, removing boron-containing compounds from the waste
produced during reagent manufacturing.

Management and Processing Related to Atmospheric Emissions
In response to the Fluorocarbons Emission Control Law, a revised version of which went into eﬀect on
April 1, 2015, Group companies in Japan established response manuals for individual companies. We
clariﬁed ﬂuorocarbon-containing equipment we own or manage and worked to determine appropriateuse, conducted inspections and determined calculated leakages. Sysmex Medica has installed local
exhaust equipment in its cleaning chamber, using activated carbon to process gas being treated withorganic solvents, reducing the oﬀ-premise impact.

- 121 -

Environmental Consideration

Biodiversity Protection
Involvement with Biodiversity
Sysmex uses water in its core reagent production and understands that it receives a host of beneﬁts
from the worldʼs living things as part of its business activities. Accordingly, we recognize that
preserving the forests that contribute to local watershed protection is an important social
responsibility. We also aim to contribute to the preservation of biodiversity.
Click here for information on our shift in animal-derived protein materials (recombinant silkworms)
in our diagnostic reagents.

Forest Conservation Activities
Contributing to Biodiversity Preservation through the “Sysmex Forest”
In ﬁscal 2013 we began taking part in forest maintenance activities based on the "Enlist theParticipation of All Citizens in Creating Woodland" project being promoted by the Hyogo Prefectural
Government. To this end, we took responsibility for a two-hectare portion of the 17-hectare Kawai
Kaiteki Forest near our reagent factory in the city of Ono, Hyogo Prefecture. We dubbed this portionthe "Sysmex Forest" and set about making the Satoyama (a human-inﬂuenced natural environment)a place of tranquility for people and wildlife. In ﬁscal 2017, a total of 205 people participated in these
activities, which took place 10 times.
Initiatives at the Sysmex Forest
Initiative

Activity
Protection of endangered species (such as protecting the habitat of the

Preservation of Biodiversity

clouded salamander1 and planting plants to attract the chestnut tiger
butterﬂy2)
Protection of rare wild plants (cultivating the Japanese lily to aid its recovery)
Conducting programs so that children can enjoy coming into contact withnature (hand-painting houses for small birds, cultivating plant cuttings,
vegetables and shiitake mushrooms, and taking part in other activities）

Education and Awareness

Registered for the Green Wave, a program being promoted by Japanʼs
Ministry of the Environment, Ministry of Agriculture, Forestry and Fisheries,
and Ministry of Land, Infrastructure, Transport and Tourism. (invited by theUnited Nations to take part in the International Day for Biological Diversity(May 22) in 2017)- 122 -

1 These small Cryptobranchoidea (primitive salamanders) are designated as Vulnerable II in the Ministry of the Environmentʼs
Red Data Book.
2 These butterﬂies are unusual for their long migratory routes; most of them arrive in Japan in spring and migrate around2,000km in autumn to Taiwan and other southern climes. They are designated as a quasi-endangered species in Chiba
Prefectureʼs Red List.

Click here for information on our system for promoting employee volunteers.
Click here for information on the “Sysmex Forest.”

Sysmex Forest(participants in forest maintenanceactivities)

Sysmex Forest(protecting scarce wildlife)

Activities in Other Regions
Company
Sysmex Spain

Activity
Participation in a biomass energy project to promote renewable energy andpreserve the environment
Support for initiatives to return unique ﬂora and fauna to their previous state,

Sysmex New Zealandsuch as the kiwi bird, which has been threatened with extinction by European
pioneers

Sysmex India

50 trees planted by employees

Eﬀorts to help preserve the kiwi bird
in New ZealandAﬀorestation activities in India- 123 -

Sustainability

GovernanceNumerous corporate scandals related to corporate governance, risk management and compliance
have come to light in recent years, and their impact on society has increased.
In this environment, Japanʼs Corporate Governance Code went into eﬀect in June 2015, calling on
companies to take governance into consideration in non-ﬁnancial areas, as well as on the ﬁnancial
front. In addition to strengthening governance and internal control, companies are being called on to
buttress their management foundations for promoting risk management and compliance. Sysmex
believes that reinforcing governance helps ensure stakeholder trust and is an important management
issue in terms of enhancing medium- to long-term corporate value.

Sysmex has established the Audit and Supervisory Committee and is strengthening the supervisory
function by external members of the Managing Board, as well as enhancing the Managing Boardʼs
eﬀectiveness and reinforcing governance in other ways. In line with these changes, we are putting inplace systems to fortify the groupwide risk management function and have established a Compliance
Committee and an internal reporting system as initiatives to strengthen our base with a view tosustainable growth.
We will continue aiming to maximize the overall corporate value of the Group through management
robustness, better transparency and improved management speed and eﬃciency.

Click here for information on corporate governance.

- 124 -

Compliance

Compliance Management
Group Policy
Pursuing Open and Aboveboard Business Activities
Based on our Group philosophy, the "Sysmex Way," we deﬁne our view of compliance as "the conductof open and aboveboard business activities on the basis of observance of laws and regulations andhigh ethical standards." In accordance with this deﬁnition, we have established a Global Compliance
Code, in which particularly important conformance rules and behavioral guidelines for all Group
executives and employees to abide by are compiled.

Sysmex Group Global Compliance Code
1. Ensuring the Safety of Our Products and Services to Customers
In all our corporate activities, we shall make it a matter of priority to provide our customers
with safety and security in the operation and use of our products and services.
2. Promoting Fair Dealing and Free Competition
We shall comply with the laws and regulations of each country and region concerning thepromotion of fair and free competition, deal fairly with all our customers and other business
partners and conduct transactions under appropriate conditions. In addition, in relation toother companies in the same business, we shall not illegally, dishonestly or unreasonably
restrict their business, nor shall we defame them.
3. Fair and Proper Information Disclosure and Exercise of Complete Information Control
Our corporate information, such as our Groupʼs ﬁnancial condition and business activities,
shall be disclosed in a fair, prompt, correct, and clear manner in accordance with applicablelaws and regulations, and we shall exercise strict control over conﬁdential informationcollected through our business activities so as not to infringe the rights of third parties.
4. Implementation of Appropriate Research and Development Activities
When carrying out research and development, we shall protect the dignity, privacy, andhuman rights of trial subjects, and shall comply with applicable laws and regulations to carryout our research activities in accordance with high ethical standards.
5. To Respect Intellectual Property
We respect both the rights of our Groupʼs intellectual property and the intellectual property ofothers.
We shall not unlawfully acquire or use any conﬁdential business information or the proprietary
assets of others.
- 125 -

6. To Maintain International Peace and Safety
We shall comply with export- and import-related laws and regulations, and shall not engage
in any transaction which may impede the maintenance of international peace and safety.
7. To Conduct Proper Accounting and Appropriate Tax Payments
We shall always apply the appropriate accounting measures and recognize the tax obligations
set forth in applicable tax laws and accounting regulations and standards.
8. To Respect Human Rights and to Improve Occupational Health and Safety
We shall support the Universal Declaration of Human Rights and Core Labour Standards, andrespect fundamental human rights, and shall not commit acts such as discrimination orharassment.
We shall also comply with applicable laws and regulations and endeavor to improve
occupational health and safety.
Further, we shall not commit any unfair labor practices against the personnel of the company.
9. Prohibition of Conﬂicts of Interest
We shall not attempt to gain any personal proﬁt in the performance of our duties, and shallnot make any unauthorized use of our Groupʼs assets, goods or information, nor shall we
perform personal acts that may cause harm to the Groupʼs business activities or reputation.
10. To Maintain Sound Relationships with Society
We shall comply with applicable laws and regulations related to anti-bribery statutes andcomply strictly with applicable laws regarding making political donations. The company shallnot be intimidated by antisocial activities, behavior and groups, nor maintain any relationshipwith them.
11. To Preserve the Global Environment
We shall comply with environment-related laws and regulations, and respect the environment
throughout our business activities, based on applicable laws and international standards, in an
endeavor to preserve and improve the global environment.
Revised May 2017

Click here for the full text of the Sysmex Group Global Compliance Code.

- 126 -

Operating an Internal Reporting System in Japan and Overseas
Sysmex has established and operates an internal reporting system for all Group companies.
In Japan, we have set up “Campanula Lines” as an internal reporting system. Through this system,
we ﬁeld consultations related to compliance-related issues such as bribery and human rights abuses
and work to resolve any issues quickly. The “Campanula Lines” allow our employees to seek
consultations and ﬁle reports via e-mail, postal mail or telephone through two lines (in-house andexternal). We have also established a line via the Audit and Supervisory Committee that enables
employees to seek consultations and ﬁle reports related to the management team. Information
received through these lines is handled anonymously and based on the Whistleblower Protection Act
to protect people consulting or providing information from any disadvantage.
The “Campanula Lines” Internal Reporting System

Overseas, consultation and reporting lines provide local-language response.
In ﬁscal 2017, we ﬁelded 32 consultations from Japan and overseas. We conducted factual inquiries
for these consultations and dealt with each of them appropriately.

Compliance Education
Continuously Providing Education on ComplianceTo ensure thorough compliance, compliance managers are in place at each Group company, andSysmex provides compliance education. In addition to educating new employees about the Groupʼs
perspectives on compliance and the Sysmex Global Compliance Code, we conduct training for
managers and e-learning on speciﬁc individual themes, thereby instilling thorough complianceawareness.

- 127 -

Main Compliance Education in Fiscal 2017
(Japan)Conducted compliance training for new employees
Conducted compliance training for newly appointed managers
Conducted training for Group employees in Japan on competition laws and anti-bribery
Conducted training for Group employees in Japan on the revised Personal Information Protection
Act
Conducted human rights training related to harassment, including LGBT*, as well as personnel
administration and the Workers Dispatch Act, for new employees, mid-career recruits and newly
appointed managers
Conducted Sysmex Promotion Code training to promote fair trade* Acronym referring to sexual minorities (lesbian, gay, bisexual and transgender)(Overseas)
Conducted compliance training for new employees
Conducted training in line with revisions to the Global Compliance Code
Conducted compliance training for managers- 128 -

Compliance

Security Export Control
Policy on Security Export Control
In line with Sysmex Global Compliance Code item “6. To Maintain International Peace and Safety,” wecomply with export-related laws and regulations of individual countries and regions, and do not
engage in transactions likely to impede the maintenance of international peace and safety.
Click here for information on the Global Compliance Code.

Structure
Sysmex has established the Security Trade Control Committee, which is under the direct control ofthe president, to prevent illegal exports. We have also assigned people at overseas regional
headquarters to take charge of managing security export control, and have conﬁgured a global
operational structure.

Initiatives
Ensuring Thorough Management and Promoting Eﬃciency
Recent years have seen an increase in the number of opportunities for Sysmex to export products
between its overseas locations, presenting the need to reform and systematize our processes andrespond to increasingly complex logistics in order to ensure thorough trade management andpromote eﬃciency.
In ﬁscal 2017, we held the Second Global Security Trade Control Council, a gathering of people
responsible for and in charge of security export control in individual countries. Going forward, we willconduct coordinated global activities, promoting groupwide initiatives.

Conducting Ongoing Education
Once each year, Sysmex Corporation conducts e-learning on thefundamentals of security trade management for all employees. We
also hold workshops on the recent global situation and regulatory
systems, brieﬁng sessions on newly introduced systems and oﬀer
various other types of education on an ongoing basis to increaseawareness of security trade management.
Training- 129 -

ComplianceIntellectual Property Management
Policy on Respect for Intellectual Property
Sysmex accords third-party intellectual property rights the same level of respect as it does its own.
As deﬁned in item “5. To Respect Intellectual Property” of the Sysmex Global Governance Code, wewill not unlawfully acquire or utilize any conﬁdential business information or the proprietary assets ofothers. We promote a thorough understanding of these rules for compliance by all executives andemployees throughout the Group.
Click here for the Sysmex Group Global Compliance Code.

Structures
When applying for patents to protect our own intellectual property and responding to third parties'
intellectual property rights, members of the intellectual property, R&D and business development
departments conduct and discuss patent reviews globally for each new product development project.

Initiatives
We conduct level-based (beginner, intermediate, advanced and senior management) training in our
R&D and business development divisions on the importance of obtaining intellectual property rights,
managing these rights appropriately, and respecting their signiﬁcance. In this way, we are enhancing
the awareness of intellectual property.

- 130 -

Compliance

Research Ethics
Research Ethics
Conducting Appropriate R&D Activities
As deﬁned in “4. Implementation of Appropriate Research and Development Activities” of the Global
Compliance Code, when carrying out research and development, Sysmex protects the dignity, privacy,
and human rights of trial subjects, and complies with applicable laws and regulations in individual
countries and regions to carry out its research activities in accordance with high ethical standards. In
addition, Sysmex has adopted the Ethics Regulations on Clinical Research and Development andHuman Genome and Genetic Analysis Research and also established a Research Ethics Examination
Committee, which includes outside members such as legal and science experts, in order to review
research content. The list of committee members and deliberation results are disclosed on our
website, thus ensuring transparency.
Click here for information on the “Ethics Regulations on Clinical Research and Development andHuman Genome and Genetic Analysis Research.”
Click here for information on the activities of the Research Ethics Examination Committee.

Consideration for Animal Experiments
Item “4.4 Animal experiments” of the Global Compliance Code states that when conducting animal
experiments, we shall comply with applicable laws and regulations related to animal protection, andwe shall limit such experiments to a minimum by studying the use of alternative methods. Whenanimal experiments are necessary, we shall take all reasonable steps to minimize the animalsʼ pain.
We conduct animal experiments in line with internal regulations that conform with public guidelines.
Our Testing Control Committee rigorously deliberate testing plans to ensure their regulatory
conformance.
Guidelines Sysmex Follows
Act on Welfare and Management of Animals (Ministry of the Environment)
Standards Relating to the Care and Management of Laboratory Animals and Relief of Pain (Ministryof the Environment)
Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in
Academic Research Institutions (Ministry of Education, Culture, Sports, Science and Technology)
Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan)
Click here for the Sysmex Group Global Compliance Code.

- 131 -

Compliance

Anti-Corruption
Preparation of Standards and Provision of Education on thePrevention of Bribery
As one of its voluntary corporate eﬀorts in accordance with the spirit of the UN Global Compact,
Sysmex undertakes thorough eﬀorts to prevent bribery, in line with Principle 10, which states that“Businesses should work against corruption in all its forms, including extortion and bribery.”
The momentum of eﬀorts to eradicate corruption is gathering pace throughout the world, and various
countries are enacting laws and stepping up enforcement. Against this backdrop, Sysmex clearlyprohibits bribery in its Global Compliance Code, which applies to all executives and employees. In
addition, we are encouraging a thorough understanding throughout the Group of our anti-bribery
regulations, which cover such topics as banned items, due diligence, the provision of education, andmanagement systems.
We have also prepared guidebooks related to legal systems in key countries, including Japan, theUnited States, the United Kingdom, and China, and conduct e-learning and other types of educationand training.

Overview of Anti-Bribery Regulations
1. Sysmex prohibits the provision of money and other tangible or intangible beneﬁts to publicoﬃcials, and people who are not public oﬃcials, for the purpose of obtaining illicit proﬁts, such as
acquiring business or for the sake of business convenience.** Such acts include avoiding or simplifying administrative procedures, obtaining or maintaining business opportunities,
obtaining accommodation on bids, or obtaining conﬁdential information.

2. Prior to conducting new transactions, or during mergers and acquisitions, in addition to routine
checks of a counterpartyʼs origin, background, and business details, Sysmex investigates whether
the counterparty has relationships with public oﬃcials or past involvement in bribery cases.
3. Sysmex prohibits the payment to business partners and other parties of bribes or other paymentsthat could be construed as bribes.
4. Sysmex has in place and operates a system for conducting regular education and training ofGroup executives and employees in relation to bribery prevention.
5. Group oﬃcers and employees who become aware of actions that contravene, or that could beconstrued as contravening these regulations must report such actions promptly to a compliancemanager.
Click here for information on the Sysmex Promotion Code.

- 132 -

Transparency in Relationships with Medical Institutions
Responses in Japan
Transactions based on a high level of ethics are required at every stage of our operations̶fromresearch and development to manufacturing, sales and after-sales support̶as the number ofopportunities for collaboration with medical institutions and medical professionals is increasing.
Sysmex Corporation and Sysmex International Reagents, which are members of the Japan
Association of Clinical Reagents Industries, concur with the philosophy outlined in the associationʼs“Guidelines on Transparency of Relationships between Corporate Activities and Medical Institutions”(2011), and disclose information related to funding provided to medical institutions.
Click here for information on the Japan Association of Clinical Reagents Industries “Guidelines on
Transparency of Relationships between Corporate Activities and Medical Institutions” (Japaneseonly) (PDF/1.07MB)
Click here for Funding details.

Responses Overseas
Sunshine Acts have been enacted in the US, France and Belgium. We report relevant payments ortransfers of value to each government regularly.** We also disclose this on our web site.

Click here for Funding details.

- 133 -

ComplianceTax Strategy
Tax Policy
Sysmex has established item “7. To Conduct Proper Accounting and Appropriate Tax Payments” in theSysmex Group Global Compliance Code to heighten tax transparency. Furthermore, in line with theinternational consensus we employ OECD guidelines when pricing internal transactions among Group
companies overseas.
Click here for information on the Global Compliance Code.

Tax Payments
We disclose Group payments of corporate and other taxes in ﬁnancial and other reports, as well as
the reasons for diﬀerences with eﬀective statutory tax rates.
Click here for our annual securities report (Japanese only).
Click here for the Sysmex Report (Financial and Other Information).

Tax Strategy in the United Kingdom
Click here for information on our tax strategy in the United Kingdom- 134 -

Risk Management

Risk Management Structure
Risk Management Structure
Promoting Risk Management by Establishing a Dedicated Committee
To control groupwide risk management activities, Sysmex has established a Risk Management
Committee (RM Committee). The committee is chaired by a risk management oﬃcer, a senior
managing director. Committee members include some members of the Managing Board, as well as
executive oﬃcers, who handle risks.
The RM Committee regularly assesses various risks, such as those related to corruption, businessethics and other aspects of compliance, human resources, occupational safety and health, theenvironment, and accounting and ﬁnance, including tax payments. The committee identiﬁes majorrisks aﬀecting the Groupʼs operations and prepares countermeasures.
The RM Committee monitors the status of risk management being conducted by the Compliance
Committee, other related committees, individual divisions and subsidiaries. The committee alsodeliberates responses to any emerging risks that have a major impact on Group management.

- 135 -

Risk Management Structure

Click here for information on corporate governance.

- 136 -

Risk Management

Disaster Response
Creation of a Structure for Responding Swiftly in Times ofEmergency
Sysmex has formulated individual business continuity plans (BCPs) for manufacturing, procurement
and other functions, to ensure the Company is able to meet its social responsibility of providing astable supply of products and services to medical institutions in the event of disasters and other crisis
situations. Our BCPs identify products to be given provision priority so that our instruments cancontinue to function in a stable manner at healthcare institutions even in crisis situations. We havealso prepared disaster-response regulations and manuals, including basic disaster-response
regulations, putting in place systems that enable us to respond swiftly in emergencies.
We have introduced safety conﬁrmation tools at Group companies in Japan as a means of emergency
communication. Sysmex has also installed wireless digital equipment at business oﬃces in Japan,
putting in place a system for communicating in the event of a communication blackout. We have alsoamassed stockpiles of supplies and other items to assist stranded personnel, setting aside enoughitems for every employee. Furthermore, we conduct e-learning on disaster prevention and response,
BCP awareness education and simulation training to augment BCP eﬀectiveness.
The groupwide backbone IT system that Sysmex operates is located at external, disaster-resistantdata centers. In addition, we created a backup structure so that we can quickly switch to a backup
system in the event that disaster renders our regular system inoperable.
Click here for details on response in times of disaster (BCP).

- 137 -

Risk Management

Information Security
Enhancing Information Security
Sysmex handles data about its customers, as well as on the entities with which it collaborates on R&D
and other testing as well as information on the Companyʼs proprietary technologies. We recognize theimportance of upholding information such as this, as well as of other important corporate secrets,
and view the leak of such corporate secrets as an important risk for the Group. Accordingly, we havein place structures to prevent this risk from materializing.
We have formulated consistent global regulations for information security and corporate secrets for all
Group companies, strengthening measures to prevent information leaks and counter cyber threats.
Group companies in Japan also regularly conduct e-learning related to information security andcorporate secrets.
Sysmex CNA has obtained certiﬁcation under ISO 27001*, the international standard for information
security management systems, ensuring conﬁdentiality, completeness and availability of information
related to service and support.
* The service and support division has obtained certiﬁcation from 2016.

- 138 -

Sustainability

External Evaluation
Incorporation in Sustainability Indexes and Rankings
Selection for Global Sustainability Indexes
A growing number of investors are evaluating companiesʼ sustainability not only from a ﬁnancial
perspective, but also from the non-ﬁnancial, environment, society and governance (ESG) perspective,in the aim of responsible investing from a long-term viewpoint. Around the world, a number ofsustainability indexes are used to benchmark responsible investment. Being a highly sustainable
company, Sysmex has been selected for numerous sustainability indexes and rankings.
Dow Jones Sustainability World Index1 (from ﬁscal 2016)
Dow Jones Sustainability Asia Paciﬁc Index1 (from ﬁscal 2012)
FTSE4Good Index2 (from ﬁscal 2008)
FTSE Blossom Japan Index3 (from ﬁscal 2017)MSCI ESG Leaders Indexes4 (from ﬁscal 2011)MSCI SRI Indexes4 (from ﬁscal 2013)MCSI Japan ESG Select Leaders Index5 (from ﬁscal 2017)MSCI Japan Empowering Women Index6 (WIN) (ﬁscal 2017)
Ethibel Excellence7 (from ﬁscal 2011)
Ethibel Pioneer7 (from ﬁscal 2014)
Ethibel Sustainability Index(ESI)8 (from ﬁscal 2015)
Global 100 (100 most sustainable companies in the world)9 (2017, 2016 and 2012)
1 An ESG investment index developed though collaboration between S&P Dow Jones Indices of the United States and Robeco
SAM of Switzerland. This index evaluates corporate sustainability through the perspectives of the economy, the environmentand society, and selects companies that are expected to achieve long-term sustainable growth based on comprehensive andadvanced initiatives. The World Index targets the worldʼs listed companies, while the Asia Paciﬁc Index targets listed companies
in the Asia-Paciﬁc region.
2 An ESG investment index announced by FTSE Russel, of the London Stock Exchange Group of the United Kingdom. Excellent
companies are selected, based on an evaluation of ESG (environment, society, governance) information disclosed to the generalpublic by the worldʼs leading companies.
3 FTSE Russell of the United Kingdom selects Japanese companies based on superior response on ESG (environment, society,governance) matters. The index uses FTSE4Good standards derived from international standards, such as the United Nationsʼ
Sustainable Development Goals (SDGs).
4 An ESG investment index developed by MCSI Inc. (Morgan Stanley Capital International), of the U.S. Morgan Stanley Group.
Companies are selected based on an evaluation that includes ESG issues considered important by various indices based on theindustry characteristics of the companies it targets.
5 An ESG investment index of MSCI of the United States. The index selects companies with relatively high ESG ratings inindividual sectors from among the top 500 Japanese stocks by market capitalization.
6 An ESG investment index by MSCI of the United States. The index selects companies in various sectors that excel in gender
diversity from among the top 500 Japanese stocks by market capitalization.
- 139 -

7 An index developed by Forum Ethibel, a Belgian non-proﬁt organization. Companies are selected that exhibit high performancefrom the perspective of corporate social responsibility. The index includes two sub-indices, Pioneer and Excellence. Companies
in the Pioneer index are selected from among those in the Excellence index as being particularly excellent.
8 This index comprises companies selected for Ethibel Excellence, based on such limiting conditions as ﬂoating market
capitalization.
9 The 100 Most Sustainable Companies in the World, selected by Corporate Knights of Canada. The selection was announced
during the World Economic Forum, held in Davos, Switzerland.

Recognition and Commendation by Third Parties
From ﬁscal 2015 to 2017
2018
March

Selected for the Companies That Care Honor Roll* 2018 for the tenth consecutive year
(Sysmex America)* Companies That Care Honor Roll: A corporate ranking that designates companies that contribute to the welfareof employees, their families and local community, based on a survey conducted by the Center for Companies
That Care, an NPO.

March

Recognized for the second time by the Ministry of Economy, Trade and Industry forexcellence in health management of “companies that excel in health management”(White 500)

February

Received an award of excellence in the environmental report division at the 21stEnvironmental Communication Awards for the Sysmex Sustainability Report 2017.

- 140 -

2017
NovemberSuper-resolution ﬂuorescence microscope received the Good Design Gold Award 2017

NovemberRanked 18th in The Best-Performing CEOs in the World 2017, published by Harvard
Business Review

October

Sysmex Asia Paciﬁc selected for HR Asia Best Companies to Work for in Asia 2017

September

Selected for inclusion in the Dow Jones Sustainability World Index

AugustNamed in Forbesʼ The World's 100 Most Innovative Companies (27th)

June

Received the Work & Family in 2017 award (Sysmex Europe)

April

Received the Fiscal 2017 Commendation for Science and Technology by the Minister of
Education, Culture, Sports, Science and Technology, Prize for Science and Technology

March

Selected for the Companies That Care Honor Roll 2017 (Sysmex America)

February

Recognized by the Ministry of Economy, Trade and Industry for excellence in healthmanagement in the ﬁrst year of “companies that excel in health management” (White
500)

February

Received the Award for Excellence at the 20th Environmental Communication Awards(Jury Awards) for the Sysmex Sustainability Report 2016

January

Selected for the 2017 Global 100 (100 most sustainable companies in the world), thethird time

2016
NovemberAt the ﬁscal 2016 Kinki Local Commendation for Inventions, received the Minister of
Education, Culture, Sports, Science and Technology Prize for one invention and the
Encouragement Prize for Inventions for three inventions

NovemberSysmex Asia Paciﬁc and Sysmex Malaysia selected for HR Asia Best Companies to Workfor in Asia 2016

OctoberRanked 27th of 462 Companies in the Nikkei ranking of “Companies that Motivate
People”

September

Received the highest ranking, level 3, as an “Eruboshi” company, based on the Act on
the Promotion of Womenʼs Participation and Advancement in the Workplace

September

Selected for the ﬁrst time for inclusion in the Dow Jones Sustainability World Index

September

Sysmexʼs automated blood coagulation analyzer certiﬁed under the 5th Heritage
Program of Legacy Analytical Instruments/Scientiﬁc Instruments

September

Ranked ﬁfth in Forbes Japanʼs “Managers that Move Japan” and 28th on the Forbes
2016 List of the Worldʼs Most Innovative Companies

AugustWon the 14th Annual Merit Award from the Minister of Economy, Trade and Industry
for Collaborative Achievement Between Industry, Academia and Government for theworldʼs ﬁrst practical realization of a system for diagnosing hepatic ﬁbrosis using
glycosylation

June

Sysmex International Reagentsʼ Ono Factory received the City of Ono Fireﬁghting
Society Excellent Business Site AwardMay

Received the ACE-Award, sponsored by Conﬁrmit (Voice of Customer and Contact
Center divisions) (Sysmex America)- 141 -

MarchSelected as a Great Place to Work (Sysmex Europe)

March

Selected for the Companies That Care Honor Roll 2016 (Sysmex America)

2015
DecemberReceived an award as a model for formulating a system for Good Distribution Practice(GDP)* in the in vitro diagnostics (IVD) industry that Taiwanʼs FDA is moving into law.
* A model for verifying that the quality (eﬀectiveness, safety) of pharmaceuticals that are produced,
distributed and stored by manufacturing companies up to customers, as well as for preventing theft andaccidents, and ensuring against counterfeit drugs and altered products being mixed into the supply route.

NovemberReceived the Japan Investor Relations Associationʼs 20th IR Grand Prix Award

October

Named by the Securities Analysts Association of Japan for Excellence in Corporate
Disclosure and selected for excellence in disclosure to individual investors

OctoberAt the Kinki Local Commendation for Inventions, received the Encouragement Prize of
the Commissioner of Japan Patent Oﬃce for one invention and the Encouragement
Prize for Invention for three inventions

Octoberi-Square received the Landscape Community Planning Award in the Design Divisionfrom the city of Kakogawa

OctoberRanked 24th of 454 Companies in the overall Nikkei ranking of "Companies that
Motivate People"

AugustSysmex Annual Report 2014 won the Gold Award in the healthcare (instruments)
category of the 2014 Vision Awards in the United States

July

Selected for HR Asia Best Companies to Work for in Asia 2015 (Sysmex Asia Paciﬁc)June

Received Fiscal 2015 Hyogo Prefecture Invention Awards for “Hemostasis Analyzer”
and “Working Procedure Display Method and Working Procedure Display System”

May

Received the ACE-Award, sponsored by Conﬁrmit (Sysmex America)

April

Named a Great Place to Work Brazil (Sysmex Brazil)

MarchReceived the Award for Excellence at the 18th Environmental Communication Awards
for the Sysmex Sustainability Report 2014

March

Ranked ﬁrst in the Toyo Keizai ranking of the top 300 "Excellent Companies for New
Employees"

March

Selected for the "Companies That Care Honor Roll 2015" (Sysmex America)- 142 -

Fiscal 2017 Performance Data

Social Data
Customers
Category

RelatedFiscal 2015

Fiscal 2016

Fiscal 2017

95,92988,90989,583

Details

9.1

9.2

9.3

Details

9.09

9.32

9.4

Details

Inquiries received by the Sysmex
Customer Support Center

ArticlesCustomer satisfaction rating in the
United States*(out of 10 possible points)* Research by Sysmex America

Customer satisfaction rating in the
United States*(out of 10 possible points)* Research by IMV ServiceTrak

Employees (All ﬁgures are results for Sysmex Corporation)
Category

New-graduate recruits

Fiscal 2015

Fiscal 2016

Fiscal 2017

Total

59

68

64

Of which, men

40

38

32

Of which, women

19

30

32

12

15

5

Total

70

73

30

Of which, men

50

56

23

Of which, women

20

17

7

1

4

2

Turnover (people)

40

74

101

Turnover (%)

1.97

3.22

4.34

Of which, nonJapanese

Mid-career recruits

Of which, nonJapaneseTurnover** Regular employees only,
excluding people who havereached the mandatory
retirement age- 143 -

Related
ArticlesDetails

Details­Sysmex
Corporation
51
Employment of people

Number of people

50

54with disabilities** Due to the establishment ofJapan

Sysmex Harmony, ﬁgures69

indicated from ﬁscal 2017
onward are the employment

Sysmex

rate not for Sysmex on a

Details

Corporation

non-consolidated basis but

1.84

including aﬃliated companies
in JapanGroup
companies in

Percentage

1.82

1.94

Group
companies in
Japan
2.04

Reemployment ofworkers after the
mandatory retirement

Applicants

25

22

38

People reemployed

25

22

38

100

100

100

New registrants

6

5

3

People reemployed

1

0

0

17

0

0

Contract employees

17

7

16

Temporary employees

2

4

10

Total

19

11

26

Work-related deaths

0

0

0

Work-related injuries

7

3

2

1.27

0.53

0.35

0.07

0.09

0.05

386

494

308

5,499,593.25

5,641,249.00

5,635,447.00

Days granted

49,534

51,66749,177

Days taken

27,605.50

31,305.00

32,063.00

55.7

60.6

65.2

39

48

39

Percentage
reemployment

Reemployment of
personnel leaving forreasons of childcare or
nursing care

Promotion to regular
employees

Percentage
reemployment

Frequency of workrelated injuries
Industrial accidents

Severity of workrelated injuries
Total work days lost
Total actual numberof working hours

Paid leave

Percentage of days
taken
People taking pre-and post-maternity leave- 144 -

Details

Details

Details

Details

DetailsWomen

32

56

32

Men

2

3

1

Women

50

47

58

work hours for childcare

Men

0

0

1

People taking nursing

Women

1

2

5

Men

1

0

0

Women (%)

100

98

97

Men (%)

100

100

100

77

78

104

1,742

1,949

2,086

People taking childcare
leave
People taking shortercare leave
Percentage of people
returning after childcare
leave

People taking accumulated paid leave
People on ﬂex-time arrangement
Children in in-house

Total during year

33

32

34

daycare centerAt ﬁscal year-end

28

26

30

179,000

108,000

103,000

22.6

19.4

15.4

23

23

14

157

135

128

5

1

9

Training expenditure*

Training results

per employee (yen)* Excludes temporary

Training time per

employees, part-time

employee (hours)

employees and executives

Number of training
programs

Number of interns
accepted

Total
Of which, nonJapaneseDetails

Details

Note: Some ﬁgures have been revised from ones disclosed before, owing to changes in deﬁnition.

(1) Employees (people)1(2) Average age (years old)(3) Average years of
employment (years)(4) Average annual salary(thousands of yen)2

Fiscal 2015

Fiscal 2016

Fiscal 2017

2,031（484）

2,083（497）

2,046（504）

40.5

40.5

40.7

11.5

11.6

12.0

7,843

7,853

7,826

1 The number of employees excludes workers dispatched from Sysmex Corporation but includes workers dispatched to Sysmex
Corporation. For the number of temporary employees, the average for the year is indicated in parentheses.
2 The average annual salary amount includes wages outside basic wages, as well as bonuses.

- 145 -

Employees (All ﬁgures are results for Sysmex)
Category

Female managers (%)(Director level orabove)

Fiscal 2015

Fiscal 2016

Fiscal 2017

8.3

8.8

8.6

SysmexCorporation (%)

14.3

(%)

16.2

Category

men andwomen in the
Group

EMEA*

China

Asia Paciﬁc

59.1

Women (%)

40.9

Men (%)

63.7

Women (%)

36.3

Men (%)

55.7

Women (%)

44.3

Regular employees, employees on

Men (%)

65.7

executives

Women (%)

34.3

Men (%)

61.4

Women (%)

38.6

the Group
employees

EMEA*

China

Asia Paciﬁcloan, and contract employees (except
executives and temporary
employees）

loan, contract employees andFiscal 2017
Regular employees, employees on

Men

2,077

Women

1,440

Men

740

Women

422

Men

1,318

Women

1,049

Regular employees, employees on

Men

412

executives

Women

215

Men

474

Women

298

Japan

Number ofRegular employees, employees on

Men (%)

Category

Americas

15.2

Fiscal 2017

Japan

Percentage of

ArticlesDetails

Overall Group

Americas

Related

Total

8,445

* Europe, the Middle East and Africa- 146 -

loan, and contract employees (except
executives and temporary
employees）

loan, contract employees andCorporate Citizenship Activities
Category

Fiscal 2017

Expenditures for corporate citizenship

About 510,000,000

activities (Sysmex Corporation, yen)

- 147 -

Fiscal 2017 Performance Data

Environmental Data
Material Balance
Please click here for detailed performance data.

INPUT
Fiscal 2015

Fiscal 2016

Fiscal 201737,47637,40340,169

1,544

1,474

734

19.4

21.1

20.9

LNG (m³)

0

0

799

Heavy oil (kL)

0

0

35

Kerosene (kL)

35

31

314

Diesel oil (kL)

19

21

317

750

734

689

23.5

25.1

23.2

391

406

395

44

42

45

0.13

0.06

0.08

Electricity use(thousands kwh)
City gas (thousandsm³)
LPG (t)Gasoline for domestic
ﬂeet (kL)
Diesel for domestic
ﬂeet (kL)
Water use (thousands
m³)
Oﬃce paper (t)PRTR（t）- 148 -

OUTPUT
Fiscal 2015

Fiscal 2016

Fiscal 2017

24,03522,76024,983

1,802

1,768

1,661

1,701

2,106

1,778

91.9

91.1

92.2

192

189

221

0

0.02

0

Greenhouse gas
emissions frombusiness oﬃces (tCO2)
CO2 emissions fromdomestic company
cars (t-CO2)
Total waste emissions(t)
Recycling rate (%)
Wastewater volume(thousands m³)
PRTR (t)Main business oﬃces in Japan, Instrument factories in Japan, Reagent factories in Japan, Sales
oﬃces in Japan, Other oﬃces in Japan, Main overseas locations, Overseas reagent factories[Main business oﬃces in Japan] Sysmex Corporation (head oﬃce, Technopark, Solution Center)[Instrument factories in Japan] Sysmex Corporation (Kakogawa Factory, i-Square), Sysmex Medica,
Sysmex RA[Reagent factories in Japan] Sysmex International Reagents (Ono Factory, Seishin Factory)[Sales oﬃces in Japan] Sysmex Corporation
1 oﬃce (Tokyo), 6 branches (Sendai, Kita Kanto, Nagoya, Osaka, Hiroshima, Fukuoka), 13 sales
oﬃces (Sapporo, Morioka, Nagano, Niigata, Chiba, Yokohama (included in scope from ﬁscal 2015),
Shizuoka, Kanazawa, Kyoto, Kobe, Takamatsu, Okayama, Kagoshima), 1 service center (Metropolitan
Area Service Center), Sysmex CNA[Other oﬃces in Japan] Sysmex Corporation (R&D Center, Protein Development Center, BMA
Laboratory, Global Communication Center (included in scope from ﬁscal 2015), Soushin dormitory(included in scope from ﬁscal 2015), Skyfront Research Campus (included in scope from ﬁscal 2017))[Main overseas locations] Sysmex Europe, Sysmex Deutschland, Sysmex America, Sysmex Shanghai,
Sysmex Asia Paciﬁc[Overseas reagent factories] Sysmex Europe(Reagent factory in Germany), Sysmex Brazil, Sysmex
Reagents America, Sysmex India, Sysmex Asia Paciﬁc, Jinan Sysmex, Sysmex Wuxi
Main business oﬃces in Japan, Instrument factories in Japan, Reagent factories in Japan, Otheroﬃces in Japan, Overseas reagent factories(Refer to 1)
Main business oﬃces in Japan (excluding head oﬃce), Instrument factories in Japan, Reagent
factories in Japan, Other oﬃces in Japan, Overseas reagent factories(Refer to 1)
Main business oﬃces in Japan, Instrument factories in Japan, Reagent factories in Japan, Sales
oﬃces in Japan, Other oﬃces in Japan(Refer to 1)- 149 -

Main business oﬃces in Japan, Instrument factories in Japan, Reagent factories in Japan(Refer to 1)
Main business oﬃces in Japan, Instrument factories in Japan, Reagent factories in Japan, Sales
oﬃces in Japan, Other oﬃces in Japan, Overseas reagent factories(Refer to 1)

Results for the Sysmex Group Environmental Action Plan (Sysmex
Eco-Vision 2020) (Related articles indicate the scope of calculation.)
Category
CO2 emissions from logistics per unit of
non-consolidated sales(t-CO2/¥100 million)

RelatedFiscal 2015

Fiscal 2016

Fiscal 2017

3.794

4.937

4.924

Details

7.26

7.36

7.16

Details

89.0

91.8

91.3

Details

25.9

25.4

23.2

Details

ArticlesGreenhouse gas emissions at businessoﬃces per unit of consolidated sales (tCO2/¥100 million)
Business oﬃce recycling rate (%)
Water use at reagent factories per unit ofamount of production (m³/ thousandboxes)- 150 -

Main Indicators and Results Related to Environmental Impact
Data Related to the Sysmex Group Environmental Action Plan, Eco-Vision 2020
AspectUnit

Content

Scope 2

Base Year
Fiscal Year

Data

Product logistics withinJapan
CO emissions fromlogistics
Environment
consciousness
in product life
cycle processt-CO

Product logistics tooverseas locations

Greenhouse gas
emissions
1

Unit CO emissions inlogistics

Product logistics within
Japan and to overseas
locations

Unit denominator

Sysmex Corporation,
non-consolidated
net sales

Sysmex Corporation

t-CO /
millionmillionMain business offices,
instrument factories
and reagent factories
in Japan
Total emissions

City gas, LPG, LNG,
heavy oil, kerosene,diesel oil and electricity

t-COGreenhouse gas
emissions
Main overseas
locations and reagent
factories

1

Environment
consciousness
at businessoffices

Total unit emissions

City gas, LPG, LNG,
heavy oil, kerosene,diesel oil and electricity

Unit denominator

Consolidated net sales

t-CO /
millionmillionTotal emissionst

Waste emissions

Waste recycling (including energy recovery)
Recycling rate for waste(including energy recovery)%

Groundwater
thousandsm

Municipal supply water
Water use

Total water usage
Total amount used per unit
Unit denominator

Boxes manufactured- 151 -

m /thousandboxes
thousandboxes

Main business offices, instrument
factories and reagent factories inJapan, as well as main overseas
locations and reagent factories‐

Main business offices,
instrument factories
and reagent factories
in Japan, as well as
overseas reagent
factories
Reagent factories in Japan–

Overseas reagent factories–

Reagent factories in Japan–

Overseas reagent factories–

Reagent factories inJapan and overseas

2013

2014

2015

2016

Data

Data

Data

Data

1,237.00

1,112.00

1,213.00

1,181.51

2017

Data

1,234.61

Coverage
Ratio 3Population of
Coverage
Ratio 4−

Calculation Method−

CO emissions from logistics from factories to warehouses in Japanand from warehouses to customers in Japan (including branches andsales offices). Calculated as ton-kilometers traveled (amounttransported times distance traveled) times CO conversion factor.
Conversion factor (source): In accordance with “Common Guidelines
for the Method of Calculating CO Emissions in the Logistics Field”
CO emissions from logistics (including to overseas customers) fromwarehouses to ports (airports) in Japan and CO emissions fromlogistics from Japanese ports (airports) to ports (airports) in overseas
regions. Calculated as ton-kilometers traveled (amount transported
times distance traveled) times CO conversion factor.
Conversion factor (source): In accordance with “Common Guidelines
for the Method of Calculating CO Emissions in the Logistics Field”

4,251.00

3,971.00

4,222.00

5,682.54

5,850.44

−

−

5.348

4.170

3.794

4.937

4.924

−

−

1,026.17

1,218.94

1,432.43

1,390.40

1,438.80−−

GRI Standard
Indicater No.

305-03305-04305-05The amount of each type of energy is multiplied by the emission factor
and the sum of the amounts is calculated.
Conversion factors (sources): (Fossil fuels) CO emission factors for

7,532.00

8,138.00

8,240.00

7,669.30

7,774.30

33.18%

8,872 provided by Osaka Gas. (The same factor is used for overseas businessoffices.)(Electricity) COfor credits) are based on the Act on Promotion of Global WarmingCountermeasures, using information announced by the powercompanies that supply individual factories and business offices.

The amount of each type of energy is multiplied by the emission
factor and the sum of the amounts is calculated.
Conversion factors (sources): (Fossil fuels) CO emission factors for

7,199.00

7,980.00 10,130.00 10,719.50

12,410.79

24.83%

8,872

305-01305-02305-04305-05gas provided by Osaka Gas. (The same factor is used for overseas
business offices.)
GHG Protocol (WBCSD/WRI).

7.98

7.28

7.26

7.36

7.16

58.01%

8,872

1,845.38

2,213.76

2,531.57

2,498.99

2,819.35−−

1,056.90

1,341.20

1,502.80

1,347.08

1,385.51

941.601,212.60

1,338.00

1,237.12

1,265.35

89.1

90.4

89.0

91.8

91.3

0.00

0.00

0.00

0.00

0.00

24.09%

1,241

8.46

9.25

9.70

12.70

12.42

75.90%

1,241

66.72

66.00

63.00

66.11

68.74

24.09%

1,241

174.02188.56216.90223.41215.5475.90%

1,241

249.20263.81

289.60302.23296.70

22.04

21.40

25.91

25.39

23.17

100%

1,241

11,305.00 12,327.00 11,177.00 11,905.80

12,804.77

43.80%

Of waste, the amount reused or used for material recycling or heat

8,872 recovery (thermal recycling).

306-02

Recycling rate (%) = (amount of waste reused + amount of valuable
substances sold) ÷ (industrial waste + general waste + amount of

The amount of groundwater used.

The amount of clean water and industrial water used.

− Boxes of the Company’s reagents manufactured per year at reagent factories.

−- 152 -

303-01

Data Related to Environmental Performance
AspectUnit

Content

Consumption of
non-renewable energy

Consumption ofrenewable energy

Electricity (non-renewable)

thousands
kwh

City gas

thousands m

LPG

t

LNG

t

Heavy oilkL

KerosenekL

Diesel oil

kLElectricity (renewable)

Total consumption

Energy consumption

Consumption of othernon-renewable energy

thousands
kwh

Scope 2Main business offices, instrument factories,
reagent factories, sales offices and other offices
in Japan, as well as main overseas locations andreagent factories

GJ

Gasoline (Company cars)kL

Diesel oil (Company cars)

Main business offices, instrument factories,
reagent factories, sales offices and otheroffices in Japan

Electricity (non-renewable) thousands kwh/
City gas
Unit consumption of
non-renewable energy

thousands m /LPG
LNG
Heavy oil

Main business offices, instrument factories,
reagent factories, sales offices and otheroffices in Japan, as well as major overseas
locations and reagent factories

Kerosene
INPUT

Diesel oil
Unit consumption ofrenewable energy

Electricity (renewable)

thousands kwh/

Total unit consumption
Unit denominator

Consolidated net sales

Non-renewable energy
consumption 1

City gas, LPG, LNG,
heavy oil, kerosene,diesel oil and electricity

Renewable energy
consumption

Electricity‐

GJ

Main business offices, instrument factories,
reagent factories, sales offices and otheroffices in Japan, as well as major overseas
locations and reagent factories

Reduction in energy
consumption
Total consumption

Unit consumption of
non-renewable energy

City gas, LPG, LNG,
heavy oil, kerosene,diesel oil and electricity

Unit consumption ofrenewable energy

Electricity

Total unit consumption- 153 -

million

2013

2014

2015

2016

Data

Data

Data

Data

31,525.65

35,779.00 37,233.00 37,193.25
851.981,543.97

1,473.61

12.38

15.11

19.39

21.09

20.88

0.00

0.00

0.00

0.00

799.00

0.00

0.00

0.00

0.00

35.00

70.17

35.02

30.65

314.17

18.72

18.91

18.84

21.17

317.25100.46209.42243.00210.01

1,301.84

794.69777.51749.86440,124.47

490,098.77

733.66689.39

11.72

19.68

23.53

25.10

23.27

17.08416.16214.70714.88313.786

0.642

0.385

0.610

0.590

0.260

0.007

0.007

0.008

0.008

0.007

0.000

0.000

0.000

0.000

0.283

0.000

0.000

0.000

0.000

0.012

0.037

0.032

0.014

0.012

0.111

0.010

0.009

0.007

0.008

0.113

0.054

0.095

0.096

0.084

0.462

199.540

178.449

173.668

176.121173.834

1,845.38

2,213.76

2,531.57

2,498.99

2,819.35▲ 45,821.51▲ 0.07▲ 45,821.58▲ 26,815.11 ▲ 44,610.71▲ 0.39▲ 0.12▲ 470.89

0.12

67.40%

8,872

Calculation Method

GRI Standard
Indicater No.

734.0067.60

395,042.86 439,653.70

Population of
Coverage
Ratio438,868.50

1,185.34

368,227.36

Coverage
Ratio 3

2017

Data

302-01302-03

The amount of each type of energy is multiplied by the emission
factor and the sum of the amounts is calculated.
Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)
Gasoline consumed by Company cars in Japan.

42.57%

8,872
Diesel oil consumed by Company cars in Japan.

67.40%

8,872

−

−

▲ 49,970.37(Energy consumed in the current fiscal year) – (energy consumed in
the previous fiscal year)▲ indicates an increase from the previous fiscal year.
Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)▲ 3.93(Energy consumed in the current fiscal year) – (energy consumed in
the previous fiscal year)▲ indicates an increase from the previous fiscal year.
8,872 Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)▲ 26,815.50 ▲ 44,610.84▲ 470.77▲ 49,974.30

21.92721.0914.780▲ 2.453

2.288

0.000

0.000

0.000

0.000

▲ 0.001

21.92721.0914.780▲ 2.4532.287

67.40%(Energy consumed in the current fiscal year) – (energy consumed in
the previous fiscal year)▲ indicates an increase from the previous fiscal year.
Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)▲ indicates an increase from the previous fiscal year.

67.40%

8,872▲ indicates an increase from the previous fiscal year.
▲ indicates an increase from the previous fiscal year.

- 154 -

302-03302-04

Aspect

Groundwater
Municipal supply water

thousands m

Total amount used

Water use

Total amount used per unit

INPUT

Unit denominator‐

Handling volumet

Main business offices, instrument factories andreagent factories in Japant

Main business offices, instrument factories,
reagent factories, sales offices and other offices
in Japan
Main business offices, instrument factories,
reagent factories, sales offices and other offices
in Japan

Japan

Greenhouse gas
emissions
1

Overseas

t-CO

City gas, LPG, LNG,
heavy oil, kerosene,diesel oil

Main overseas locations and reagent factories

Total emissions
Total unit emissions
Unit denominator

Main business offices, instrument factories, reagent factories,
sales offices and other offices in Japan, as well as major overseas
locations and reagent factories

t-CO

‐

Consolidated net sales

Main business offices, instrument factories,
reagent factories, sales offices and other offices
in Japan

Japan

Greenhouse gas
emissions
1

Main business offices in Japan (excluding head
office) and instrument factories, reagent
factories and other offices in Japan, as well as
overseas reagent factoriesmConsolidated net sales

OA paper use
PRTR input

Scope2

Unit

Content

t-COElectricity

Main overseas locations and reagent factories

Overseas

OUTPUT
Total emissions
Total unit emissions
Unit denominator

Main business offices, instrument factories, reagent factories,
sales offices and other offices in Japan, as well as major overseas
locations and reagent factories

t-CO

‐

Consolidated net sales

Product logistics within
Japan

t-CO

Product logistics tooverseas locations

t-CO

CO emissions fromlogistics
Greenhouse gas
emissions
1

Unit CO emissions
from logistics

Product logistics within
Japan and to overseas
locations

Unit denominator

Sysmex Corporation,
non-consolidated
net sales- 155 -

t-CO /

Sysmex Corporation

2013

2014

2015

2016

Data

Data

Data

Data

2017

Data

44.47

51.24

50.29

58.30

53.13

299.94316.97340.80347.79342.28344.40368.21391.09406.09395.41

186.630

166.329154.486

162.502140.248

1,845.38

2,213.76

2,531.57

2,498.99

50.46

48.79

44.48

7.88

0.15

0.13

Coverage
Ratio 3Population of
Coverage
Ratio4

Calculation Method
The amount of groundwater used.
The amount of clean water and industrial water used.

41.72%

8,872

2,819.35

−

−

41.69

45.25

33.18%

8,872

0.06

0.08

42.57%

8,872 substances.

The amount of each type of energy is multiplied by the emission factor
and the sum of the amounts is calculated.
Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)

806.50865.00501.00493.3642.57%

8,872

2,147.70

1,430.20

2,892.10

3,057.60

4,541.90

24.83%

8,872 Conversion factor (source): According to the Calculation and Reporting

The amount of each type of energy is multiplied by the emission factor
and the sum of the amounts is calculated.
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)

2,236.70

3,757.10

3,558.60

5,035.26

1.758

1.010

1.484

1.424

1.786

1,845.38

2,213.76

2,531.57

2,498.99

2,819.35

11,869.90

5,099.30

12,635.30 13,040.60

6,559.20

7,237.50

11,915.90

7,285.40

12,079.36

7,868.88

67.40%

8,872

−

−

42.57%

24.83%

303-01

PRTR handling volume at business offices in Japan that handle chemical

1,096.70

3,244.40

GRI Standard
Indicater No.

8,872

8,872

The amount of each business office electricity is multiplied by theemission factor and the sum of the amounts is calculated.
Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors
for each fiscal year, Ministry of the Environment, Ministry of Economy,
Trade and Industry)
The amount of each business office electricity is multiplied by theemission factor and the sum of the amounts is calculated.

305-01305-04305-05305-02305-04305-05are listed in the GHG Protocol (WBCSD/WRI).

16,969.20

19,194.50 20,278.10

19,201.30

19,948.25

9.196

8.671

8.010

7.684

7.075

1,845.38

2,213.76

2,531.57

2,498.99

2,819.35

1,237.00

1,112.00

1,213.00

1,181.51

1,234.61

67.40%

8,872

−

−

−

−

CO emissions from logistics from factories to warehouses in Japan andfrom warehouses to customers in Japan (including branches and sales
offices). Calculated as ton-kilometers traveled (amount transported
times distance traveled) times CO conversion factor.
Conversion factor (source): In accordance with “Common Guidelines
for the Method of Calculating CO Emissions in the Logistics Field”
CO emissions from logistics (including to overseas customers) fromwarehouses to ports (airports) in Japan and CO emissions fromlogistics from Japanese ports (airports) to ports (airports) in overseas
regions. Calculated as ton-kilometers traveled (amount transported
times distance traveled) times CO conversion factor.
Conversion factor (source): In accordance with “Common Guidelines
for the Method of Calculating CO Emissions in the Logistics Field”

4,251.00

3,971.00

4,222.00

5,682.54

5,850.44

−

−

5.348

4.170

3.794

4.937

4.924

−

−

1,026.17

1,218.94

1,432.43

1,390.40

1,438.80−−- 156 -

305-03305-04305-05Aspect

Content

Unit

Total CO emissions from Company cars

t-CO

Total unit CO emissions from Company cars

t-CO /

Greenhouse gas
emissions
1

Unit denominator

Sysmex Corporation,
non-consolidated
net sales

Total emissions

Main business offices, instrument factories,
reagent factories, sales offices and other offices
in JapanSysmex Corporationt

Main business offices, instrument factories,
reagent factories, sales offices and other offices
in Japan, as well as overseas reagent factories

Total emissions (excluding sales offices in Japan)

OUTPUT
Waste emissions

Material recycling wastet

Recycling waste (including energy recovery)
Material recycling rate
Recycling rate (including energy recovery)
Wastewater volume

PRTR Output

Total emissions

Emissions

Main business offices, instrument factories,
reagent factories and other offices in Japan,
as well as overseas reagent factories%

thousands m

Main business offices in Japan (except head
office) and instrument factories, reagent
factories and other offices in Japan, as well as
overseas reagent factoriest

Main business offices, instrument factories,
reagent factories, sales offices and other offices
in JapanTravelCompliance

Scope 2

Violations ofenvironmental
regulations

Total amount of large fines
Number of sanctions other than fines

cases

Significant spills andlosses of chemical
substances

Total number of cases

cases

Total leakage volumet

Main business offices, instrument factories,
reagent factories, sales offices and other offices
in Japan, as well as major overseas locations
and reagent factories: Standard for calculating and reporting GHGs emitted directly by Company facilities and factories. (Excluding from use of Company cars.)
ion to products and services. (Including from use of Company cars.)- 157 -

2013

2014

2015

2016

Data

Data

Data

Data

2017

Coverage
Ratio 3

Data

1,830.26

1,856.25

1,802.01

1,768.43

1,660.93

1.784

1.523

1.258

1.272

1.154

1,026.17

1,218.94

1,432.43

1,390.40

1,274.16

1,556.76

1,701.35

1,109.82

1,419.19

600.51

Population of
Coverage
Ratio442.57%

8,872

1,438.80−−

2,105.50

1,778.26

53.19%

8,872

1,534.63

1,436.45

1,404.64

788.13986.44814.25

1,169.09

988.45

1,282.60

1,410.97

1,308.91

1,294.89

54.11

55.53

64.28

56.68

83.23

89.06

90.38

91.94

91.12

92.19

144.36163.83

191.66

188.75221.00

0.00

0.00

0.00

0.02

0.00

4.84

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0

0

0

0

0

1

0

0

0

0

0.00

0.00

0.00

0.00

0.00

44.43%

8,872

41.72%

8,872

42.57%

8,872

Calculation Method

GRI Standard
Indicater No.

The amount of gasoline and diesel oil for each Company car is multipliedby the emission factor and the sum of the amounts is calculated.
Conversion factor (source): According to the Calculation and Reporting
Manual for Greenhouse Gas Emissions (using the most recent factors foreach fiscal year, Ministry of the Environment, Ministry of Economy, Tradeand Industry)

Of waste, the amount of valuable substances resulting from third-party
processing. Includes substances converted to fuel (such as RPF).

306-02

Of waste, the amount reused or used for material recycling or heatrecovery (thermal recycling).

PRTR emissions for business offices in Japan that handle chemical
substances.
PRTR travel at business offices in Japan that handle chemical substances.
307-0167.40%

8,872
306-03Main business offices in Japan: Sysmex Corporation (head office, Technopark, Solution Center)
Instrument factories in Japan: Sysmex Corporation (Kakogawa Factory, i-Square), Sysmex Medica, Sysmex RA
Reagent factories in Japan: Sysmex International Reagents (Ono Factory, Seishin Factory)
Sales offices in Japan: Sysmex Corporation (1 office (Tokyo), 6 branches (Sendai, Kita Kanto, Nagoya, Osaka, Hiroshima, Fukuoka), 13 sales offices (Sapporo, Morioka, Nagano, Niigata, Chibar (Metropolitan Area Service Center)),
Sysmex CNA
Other offices in Japan: Sysmex Corporation (R&D Center, Protein Development Center, BMA Laboratory, Global Communication Center (included in scope from fiscal 2015), Soushin dormitory, Skyfront Research Campus (included in scope from fiscal 2017)
Main overseas locations: Sysmex Europe, Sysmex Deutschland, Sysmex America, Sysmex Shanghai, Sysmex Asia PacificOverseas reagent factories: Sysmex Europe (Reagent factory in Germany), Sysmex Brazil, Sysmex Reagents America, Sysmex India, Sysmex Asia Pacific, Jinan Sysmex, Sysmex Wuxi
The coverage ratio calculation is based on the number of employees.
usage, the population is the number of employees at Group reagent factories.

- 158 -

Fiscal 2017 Performance Data

Governance Data
Information on Funding Provided to Medical Institutions*
Japan
2016
Category

Details(Amount:
1,000JPY)

Researchanddevelopment
Academic
researchsupportExpenses for trials, reports, and surveillance studies conducted under public
regulations (clinical trials for new devices, post-marketing clinical studies,nonconformity and infection case reports, post-marketing surveillance studies,etc.) in addition to those for independent investigations.
Expenses for scholarships, general and academic conference donations, aswell as academic conference co-sponsoring expenses

Manuscript

Expenses for lectures, manuscript writing, and the consignment of services,writing fees,

including consulting, to provide information regarding the appropriate use of

etc.

medical devices and clinical reagents.

Expensesrelated to
information
provision
Other
expense132,346

1,950,673

39,246

Expenses for lectures, workshops, and seminars to provide healthcare
professionals with relevant information regarding appropriate and safe use of

157,657

medical devices and clinical reagents.

Expenses for receptions and social courtesy

21,373

Total amount

2,301,298

US
Category
Relevant payments or transfer of value

Research

2015

2016

2017

Number

443

242

477

AmountUS $190,638

US $137,658

US $99,210

Number7

21

26

AmountUS $76,061

US $209,370

US $342,614- 159 -

France
Category
Relevant payments or transfer of value

Remuneration
Contracts

2015

2016

2017

Number

228

226

344

Amount€ 21,899€ 29,509€ 23,763

Number1

1

8

Amount€ 4,000€ 4,000€ 51,276

Number

4

12

14

2015

2016

2017

Number--6

Amount--€ 11,563

Belgium
Category
Relevant payments or transfer of value* This information might be modiﬁed after our disclosure according to review by government authorities or medical institutions.

Target of Disclosure
US
Payments or transfers of value to, or research agreements with, the following recipients:
Registered US physicians
Teaching hospitals in the US
FrancePayments, remuneration, or transfer of value to, or contracts with, the following recipients:
Physicians, medical professionals and medical students in France
Health institutions (educational institutions or medical companies) in France
Contract amounts are not required under the French Sunshine Act.
Belgium
Relevant payments or transfers of value to the following recipients:
Healthcare professionals registered in Belgium
Healthcare organizations in Belgium
Patient associations in Belgium
Click here for information on corporate governance.

- 160 -

Corporate Information

Corporate Overview(As of March 31, 2018)

Company name Sysmex Corporation
EstablishedFebruary 20, 1968

Paid-in capital¥12,276 million

Representative Hisashi Ietsugu,
Chairman and CEO

Head Oﬃce

1-5-1, Wakinohama-Kaigandori, Chuo-ku,
Kobe 651-0073, Japan

Line of business

Development, manufacture, sales,and export/import of laboratory testing
instruments, reagents, and related software

Number of employees Consolidated: 8,445 (Including contract workers
and part-time employees)

Disclosure System

Non-Financial Information

Financial Information

Sustainability
http://www.sysmex.co.jp/en/csr/

Sysmex Sustainability

IR Information
Searchhttp://www.sysmex.co.jp/en/ir/

Sysmex Investor Relations

SearchThis site discloses details of financial,stocks and shareholder information.
■Financial Statements etc.

This site discloses details ofsustainability initiatives■Sustainability Report"Sysmex Sustainability
Report"
PDF

Integrated Report"Sysmex Report"(Annual report)
This report summarizes financial andnon-financial information to
help stakeholders understand Sysmex’s
medium- to long-term value creation.

Corporate Governance Report

Editorial Policy
Sysmex publishes the annual “Sysmex Sustainability Report” to communicate to stakeholders our approaches and activities concerning
corporate social responsibility (CSR), and to enhance understanding of and trust in us.
Guidelines referenced- The Global Reporting Initiative (GRI)’s Sustainability Reporting Standards- The Japanese Ministry of the Environment's Environmental Reporting
Guidelines (2012 ed.)Date of publication
August 2018
Previous version: August 2017
Inquiries about this report
CSR Promotion Department, Sysmex Corporation
1-5-1, Wakinohama-Kaigandori, Chuo-ku, Kobe, Hyogo, 651-0073, Japan
Tel +81-78-265-0500, Fax +81-78-265-0524

Organizations covered
Sysmex Group (Sysmex Corporation and its subsidiaries both in Japan andabroad). In this report, “Sysmex” refers to the Sysmex Group as a whole.
“Sysmex Corporation” refers to the Company on a stand-alone basis

Cautionary Statements
This report contains both forward-looking statements, plans and facts
regarding the past about the Sysmex Group. These forward-looking
statements and plans are based on the current judgments and assumptions of
the Sysmex Group in light of the information currently available to it.
Uncertainties inherent in such judgments and assumptions, the future courseof our business operations, and future events may cause our actual results,
performance, or achievements to be materially different from any future
results, performance, or achievements either expressed or implied within suchforward-looking statements.

Period covered
Primarily fiscal 2017 (from April 1, 2017 to March 31, 2018). Some activities
conducted outside this period are also included. The most recent information
is provided on our CSR news on the CSR site.

- 161 -

1-5-1, Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan
Tel +81-78-265-0500 Fax +81-78-265-0524

www.sysmex.co.jp